US20140081255A1 - Method and Apparatuses for Tissue Treatment - Google Patents
Method and Apparatuses for Tissue Treatment Download PDFInfo
- Publication number
- US20140081255A1 US20140081255A1 US13/975,755 US201313975755A US2014081255A1 US 20140081255 A1 US20140081255 A1 US 20140081255A1 US 201313975755 A US201313975755 A US 201313975755A US 2014081255 A1 US2014081255 A1 US 2014081255A1
- Authority
- US
- United States
- Prior art keywords
- impedance
- tissue
- delivery
- ablation
- energy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1477—Needle-like probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00071—Electrical conductivity
- A61B2018/00083—Electrical conductivity low, i.e. electrically insulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
- A61B2018/00196—Moving parts reciprocating lengthwise
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
- A61B2018/00654—Sensing and controlling the application of energy with feedback, i.e. closed loop control with individual control of each of a plurality of energy emitting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/124—Generators therefor switching the output to different electrodes, e.g. sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1273—Generators therefor including multiple generators in one device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/128—Generators therefor generating two or more frequencies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1497—Electrodes covering only part of the probe circumference
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/002—Irrigation
Definitions
- This application relates generally to a method for performing tissue characterization using minimally invasive methods. More particularly, the application relates to a method and apparatus for performing an in vivo tissue characterization to identify and discriminate between diseased and healthy tissue using localized measurement of tissue impedance. Still more particularly, the application relates to method and apparatus for performing tissue characterization before, during and after ablative therapy using localized complex impedance measurement to monitor and titrate the delivery of ablative therapy to improve clinical outcomes.
- ablative therapies such as radio-frequency ablation, microwave ablation, and laser ablation can be used to treat benign and cancerous tumors.
- such methods are intended to produce physiological and structural changes to cause cell necrosis or destruction of the selected target tissue.
- ablative procedures to treat cancerous tissue include: (i) locating the target tissue, (ii) identifying or biopsying the disease state of the tumorous tissue, (iii) distinguishing between diseased tissue versus healthy tissue, (iv) placing and maintaining the position of the ablation apparatus within the target tissue site, (v) monitoring the progress of ablation (including the developing ablation volume), (vi) minimizing injury to adjacent critical structures, (vii) assuring complete ablation of the tumor mass (including assurance of a sufficient healthy tissue margin), and (viii) assessing degree of the completed ablation.
- Current ablative therapies have not considered nor provided solutions to these problems.
- One method of treatment involves providing one or more radio-frequency energy delivery members configured for tissue insertion; inserting at least one of the delivery members into a tissue; forming a tract in the tissue by the delivery member; and moving the delivery member along the formed tissue tract while ablating the formed tissue tract with radio-frequency energy that is delivered by the delivery member.
- the tissue may include living malignant cells, while the ablated tissue tract is substantially free of living malignant cells.
- the delivery member may include one or more deployable delivery members therein.
- the delivery member may include one or more fixed or movable insulative members.
- the delivery member may be an introducer.
- the delivery member may include a conductive distal portion through which the ablative radio-frequency energy is delivered to the tissue tract.
- One apparatus may include one or more radio-frequency energy delivery members configured for insertion into a tissue to form a tract therein, a radio-frequency power source coupled to at least one of the delivery members, and one or more logic resource coupled to the power source and to the at least one delivery member.
- At least one of the logic resources may include an algorithm or software configured for enabling the delivery of radio-frequency energy from the power source to the at least one delivery member for ablation of the tissue tract.
- Another apparatus may include one or more delivery members configured for insertion into a tissue to form a tract therein.
- At least one of the delivery members may include one or more electrically conductive areas for the delivery of thermal ablative energy to the tissue tract, one or more outer impedance sensor, and one or more inner impedance sensing members positionable within the delivery member.
- At least one of the outer sensors and at least one of the inner sensing members may be configured for bipolar measurement of localized impedance of a tissue volume adjacent to the at least one inner sensing member.
- the at least one delivery member may be deployable.
- the at least one delivery member may include at least one insulative member disposed adjacent to a distal portion that includes at least one of the electrically conductive areas.
- a further apparatus may include one or more delivery members configured for insertion into a tissue to form a tract therein. At least one of the delivery members may include one or more electrically conductive areas for delivery of electroporation ablation therapy to the tissue. At least one of the conductive areas may be also for the delivery of thermal ablative energy to the tissue tract.
- the apparatus may include multiple electrically conductive areas disposed on different treatment delivery devices. The apparatus may include multiple electrically conductive areas disposed on different delivery members that are parallel to each other and electrically isolated from each other. The apparatus may include multiple electrically conductive areas disposed on one of the delivery members and electrically isolated from each other.
- FIG. 1 is a lateral view illustrating the placement of a treatment apparatus at a tissue site.
- FIG. 2 is a lateral view of an apparatus including an elongated delivery device, impedance sensor array, sensors, resilient members, energy delivery device and advancement member.
- FIG. 3A is a schematic view of an impedance sensor array configured to measure impedance of a tissue volume via a plurality of selectable conductive pathways.
- FIG. 3B is a schematic view illustrating the use of primary and secondary conductive pathways and conductive pathway angle there between.
- FIG. 4A illustrates an embodiment of the apparatus having a centrally positioned return electrode surrounded by other impedance sensing members.
- FIG. 4B illustrates an embodiment of the apparatus having a centrally positioned return electrode surrounded by other impedance sensing members.
- FIG. 4C illustrates an embodiment of the apparatus having the return electrode eccentrically positioned with respect to other impedance sensing members.
- FIG. 4D illustrates an embodiment of the apparatus having multiple and independently positionable impedance sensor arrays.
- FIG. 5 is a perspective view illustrating the use of multiple groups of conductive pathways to sample multiple tissue volumes as well as to determine impedance vectors and loci of impedance for each sampled volume.
- FIG. 6 is a perspective view of an apparatus including an impedance monitoring device having memory resources and logic resources (including software modules) to analyze impedance data and generate impedance profiles and images.
- FIG. 7A is a plot of tissue impedance curve illustrating the frequency dependency of impedance.
- FIG. 7B is a plot of tissue complex impedance curves illustrating the frequency dependency of complex impedance.
- FIGS. 8A-8D are plots of impedance curves illustrating the use of multiple frequency impedance curves to monitor the time course of an ablation.
- FIGS. 8E-8G are plots of complex impedance curves (imaginary vs. real values) illustrating the use of complex impedance curves to monitor the time course of an ablation.
- FIGS. 9A-9C are plots of complex impedance curves illustrating the use of complex impedance curves to identify tissue type or condition.
- FIG. 10 is a three-dimensional plot of complex impedance.
- FIG. 11 is a plot of signal intensity verses time for a sample volume of ablating tissue, illustrating quantitative determinants of an ablation endpoint.
- FIG. 12A is a lateral view illustrating an embodiment of the introducer.
- FIGS. 12B and 12C are cross sectional profiles of the introducer.
- FIG. 13 is a lateral view of a deflectable introducer.
- FIG. 14 is a lateral view of a tissue biopsy and treatment apparatus with a hand piece and coupled aspiration device, fluid delivery device, and fluid reservoir.
- FIGS. 15A-15H are lateral views of the electrodes, including ring-like, ball, hemispherical, cylindrical, conical, needle-like, extended conical and a combination of a conical and needle-like.
- FIG. 16 is a lateral view illustrating a needle electrode configured to penetrate tissue.
- FIG. 17 is a lateral view illustrating electrodes having at least one radius of curvature.
- FIG. 18 is a lateral view illustrating electrodes having at least one radius of curvature, sensors, and a coupled advancement device.
- FIG. 19 is a perspective view illustrating insulation sleeves positioned at exterior surfaces of sensing members or resilient members so as to define an impedance sensor length or an energy delivery surface.
- FIG. 20 is a perspective view illustrating electrodes with multiple insulation sleeves that circumferentially insulate selected sections of the electrodes.
- FIG. 21 is a perspective view illustrating electrodes with insulation that extends along longitudinal sections to define adjacent longitudinal energy delivery surfaces.
- FIG. 22 is a cross-sectional view of the embodiment of FIG. 21 .
- FIG. 23 is a lateral view of an apparatus with electrodes having a lumen and apertures configured for the delivery of fluid, and the use of infused fluid to create enhanced electrodes.
- FIG. 24 is a perspective view of an impedance-sensing member that includes a conductive coating that can be configured to produce an impedance gradient along the sensing member.
- FIGS. 25A-25C are perspective views of energy delivering ablation apparatuses using frequency controlled positionable ablation fields.
- FIGS. 26A-26C are plots of energy density or concentration versus lateral distance from the electrode/energy delivery device of the embodiments of FIGS. 25A-25C .
- FIG. 27 is a flow chart illustrating a method for generating and displaying impedance derived images.
- FIG. 28 is a block diagram illustrating components for a feedback control system.
- FIG. 29 is a block diagram illustrating components for a control system.
- FIG. 30 is a lateral view illustrating a control and display unit.
- FIG. 31 is a plot showing an impedance measurement duty cycled signal superimposed on an RF treatment signal under selectable threshold conditions.
- Embodiments of the present application provide an apparatus and method for performing tissue characterization using localized impedance measurement including complex impedance measurement to locate and diagnose a tumor, accurately position an ablative apparatus, monitor the progress of an ablative treatment and determine clinical endpoints. Further, these and other embodiments can be configured to measure and analyze bioelectric parameters with enhanced predictive power of cell metabolism, along with associated images that allow for real time control of the ablative process, awhile significantly reducing the risk of incomplete ablation or unwanted damage to critical anatomical structures. Each of the disclosed embodiments may be considered individually or in combination with other variations and aspects of the application.
- the method and apparatus provided herein are useful in treating cancerous tumors in organs and tissue throughout the body, including, but not limited to, the liver, bone, breast, lung and brain. They are also useful and equally applicable for treatment of benign tumors, growths and otherwise abnormal or enlarged tissue that requires removal, resection or modification by surgical or minimally invasive means.
- ablative therapies such as RF ablation, microwave ablation, laser ablation and chemical ablation.
- ablative therapies cause disruption of cell membranes, resulting in impedance change in the interstitial fluid, but only in the affected tissue, with minimal or no changes to the surrounding tissue.
- Embodiments of present application provide solutions to these problems by detecting localized impedance changes, particularly those changes occurring during an ablation procedure, through the use of impedance arrays positioned at the target tissue to measure impedance, including complex impedance and other bioelectric properties described herein.
- the excitation current can range from 0.01 mA to 100 amps, with specific embodiments of 0.1, 1.0 and 10 amps, which can be delivered in a continuous or pulsed fashion using a duty cycle.
- the duty cycle can be in the range of 5 to 50%, with a pulse duration of 10 to 200 ms.
- the average power delivered over the course of the duty cycle can be in the range of 0.1 to 10 watts.
- the excitation current source is used to measure voltage differences between two or more selected impedance sensors/sensing member in a bipolar mode or between one or more sensors/sensor members and a common ground in a monopolar mode. The known excitation current and the measured voltage are then used to derive impedance using algorithms and methods described herein and/or known in the art.
- the sensing or excitation signal can be varied or otherwise controlled to improve one or more of the sensitivity, accuracy, precision and resolution of an impedance measurement.
- the excitation signal can be a mono-frequency signal or a multi-frequency signal, and can be constant or variable.
- improved signal resolution, and thus more precise tissue analysis and characterization can be achieved by use of a multi-frequency excitation signal and/or an excitation signal varied across a broad range of frequencies.
- this range of frequencies can be from about 1 Hz to about 1 MHz, with specific embodiments of 0.5 Hz, 1 , 5 , 10 , 25 , 50 , 100 , 250 , 500 and 750 kHz. Since the bioelectric distinctions (e.g. phase angle, impedance) between cancerous and healthy tissue can be the greatest at low frequencies, such as 100 Hz, in exemplary embodiments, measurements can be taken over a plurality of excitation frequencies below 100 Hz, with specific embodiments of 3, 4, 10 and 20 Hz. Other embodiments can be combining measurements below 100 Hz with those between 100 Hz to 5 kHz.
- bioelectric distinctions e.g. phase angle, impedance
- Complex impedance includes both real and imaginary components, which reflect the phase shift between voltage and current (e.g. the voltage can lead or lag current depending on the electrical properties of the tissue).
- Various embodiments of the application can be configured to record both the real and imaginary components of complex impedance. This provides the benefit of providing more comprehensive information on the tissue, allowing analysis with a greater degree of accuracy, precision and resolution. These components can be determined by passing an excitation current through the target tissue and measuring impedance and/or any phase shift between the current and voltage as the signal is conducted through the target tissue.
- real and imaginary components of impedance can be used to determine intracellular impedance, interstitial impedance and cell membrane capacitance. These three elements, alone or in combination, can be used to uniquely characterize and identify tissue type and condition with increased amounts of specificity.
- the monitoring device, or other logic resources can be configured to utilize one or more of these three parameters (the “three parameters”) to characterize an amount of ablation or progression of tissue ablation from an ablative treatment, such as RF ablation or ablative methods described herein. The characterization can be done by a software module resident within the monitoring device, power supply, or coupled logic resources, all described herein.
- the three parameters can be used to detect various physiologic indicators of ablation and cell necrosis, including cell lysis, cell membrane swelling (indicated by an increase in membrane capacitance), cell membrane rupture (indicated by a sharp decrease in membrane capacitance), a decrease in extracellular fluid (indicated by an increase in intracellular impedance), and an increase in intracellular fluid (indicated by a decrease in extracellular fluid).
- Other parameters which can be calculated and used for detection and control purposes include the absolute value of the impedance or admittance, the phase of the impedance (e.g. the phase difference between the current and the voltage), the capacitance, or a function of a combination of the impedance and admittance components.
- Specific embodiments of the application can be configured to detect and/or control for threshold increases or decreases in one or more of the three parameters (or other variables), including increases or decreases in the ranges of 1.1:1.0 to 100:1.0, with specific embodiments of 1.5:1.0, 2:1, 3:1, 4:1, 5:1, 10:1, 20:1 and 50:10.
- Related embodiments can be configured to detect and/or control for combinations of increases or decreases in the parameters, including, but not limited to: a rise followed by a decrease in extracellular impedance, a decrease followed by an increase in intracellular impedance; and an increase followed by a decrease in cell membrane capacitance.
- Other related embodiments can be configured to detect, monitor and control for changes in the slopes of the curves of one or more of the three parameters.
- Still other related embodiments can employ PID control methods known in the art, utilizing combinations of proportional, integral or derivative changes in the three-parameter curves.
- Embodiments of the application can incorporate the three parameters into electronic algorithms/software programs which are configured to do one or more of the following: (i) control the delivery of power to the target tissue site, (ii) provide the medical practitioner with prompts and diagnostic information about the course of the ablation/treatment process, and (iii) provide the medical practitioner with an indication of a clinical endpoint.
- FIG. 1 shows an embodiment of an impedance monitoring and treatment apparatus 10 configured to detect and treat a tumor mass 5 ′′ in a target tissue site 5 ′, by sampling the impedance 19 p of the tissue mass 5 ′′ and delivering energy or other ablative treatment to produce an ablation volume 5 ay .
- the apparatus 10 can be configured to measure impedance 19 p , including complex impedance, before, during and after an ablation, so as to perform tissue identification at the target site 5 ′, monitor the progress of an ablation procedure (including the developing ablation volume 5 av ), and quantitatively determine a clinical endpoint for the procedure.
- an embodiment of treatment apparatus 10 comprises an elongated member or introducer 12 having a lumen 13 , a proximal portion 14 , a distal end 16 , one or more resilient members 18 positionable in lumen 13 , and one or more impedance sensors 22 disposed on members 18 , or impedance sensing members 22 m positionable in lumens 72 disposed within members 18 .
- Distal end 16 may be sufficiently sharp to penetrate tissue 5 , including fibrous and/or encapsulated tumor masses, bone, cartilage and muscle.
- Lumen 13 may extend over all or a portion of the length of introducer 12 .
- Members 18 can comprise a plurality of resilient members 18 pl configured to be positionable in lumen 13 , and advancable in and out of distal end 16 by an advancement device 15 or advancement member 34 , or other means described herein.
- Resilient members 18 can be deployed with curvature from introducer 12 to collectively define a volume 5 av in target tissue site 5 ′.
- all or a portion of one or more of members 18 can be an energy delivery device or energy delivery member 18 e described herein.
- Energy delivery device 18 or member 18 e can be coupled to an energy source or power supply 20 and can also include one or more lumens 72 .
- Embodiments of the application can be adapted, integrated, or otherwise applicable to a number of ablative therapies, including, but not limited to, radio-frequency (RF) ablation, cryo-ablation, brachytherapy, alcohol tissue ablation, chemical ablation, microwave ablation, laser ablation, thermal ablation, electroporation ablation, conformal beam radiation ablation, standard radiation ablation, high intensity focused ultrasound ablation, photo-dynamic therapy ablation.
- RF radio-frequency
- the energy delivery device and sensing apparatus 10 will be an RF based apparatus and power supply 20 will be a RF power supply; however, all other embodiments discussed herein are equally applicable.
- the RF power supply 20 can be an RF generator configured to deliver a treatment current 20 t for tissue ablation, while simultaneously or near simultaneously (using a multiplexing/switching device) delivering a low power sensing or excitation signal 20 e at one or more frequencies for making complex impedance measurements and subsequent analysis of the target tissue 5 ′.
- the excitation signal 20 e can be delivered across a broad band of frequencies in the range of 1 to 1 MHz.
- the excitation signal 20 e is delivered at a lower frequency than the treatment signal 20 t (typically 460 ⁇ 60 kHz). In an embodiment, the excitation signal 20 e is less than 400 kHz. In other embodiments, the sensing signal 20 e is in the range of 1 Hz to 100 kHz, with specific embodiments of 0.25, 0.5, 1, 5, 10, 25, 50 and 75 kHz. In alternative embodiments, the excitation signal 20 e is delivered at frequencies above the treatment frequency and thus can be greater than 520 kHz. Further, the frequency and power differences between the excitation and treatment signals 20 e and 20 t can be monitored and set-point controlled using circuitry and control algorithms known in the art.
- the frequency and power difference between the two signals 20 e and 20 t can be varied responsive to one or more electrical parameters, to maximize the accuracy and precision of impedance measurements 19 p and reduce interference (e.g. bleed over) from the treatment signal 20 t .
- electrical parameters include, but are not limited to, impedance, treatment current, treatment frequency, excitation current and excitation frequency.
- introducer 12 can be flexible, articulated and steerable, and can contain fiber optics (both illumination and imaging fibers), fluid and gas paths, and sensor and electronic cabling.
- introducer 12 can be configured to both pierce tissue 5 and be maneuverable within tissue 5 . This can be achieved through the use of flexible portions coupled to a tissue piercing distal end 16 that can be a needle or trocar tip integral or joined to introducer 12 .
- Introducer 12 can be sufficiently flexible to move in any desired direction through tissue 5 to a desired tissue site 5 ′.
- introducer 12 is sufficiently flexible to reverse its direction of travel and move in a direction back upon itself. This can be achieved through the use of flexible materials and/or deflecting mechanisms described herein.
- introducer 12 can be coupled at its proximal end 14 to a handle or handpiece 24 .
- Handpiece 24 can be detachable and can include ports 24 ′ and actuators 24 ′′.
- One or more impedance sensors 22 can be coupled to introducer 12 , resilient members 18 , or energy delivery device 18 e .
- sensors 22 can comprise one or more sensing members 22 m that can be positionable within lumens 72 of members 18 , and configured to be advancable in and out of individual members 18 , or can be coupled to an exterior of resilient member 18 .
- Sensing members 22 m can comprise a plurality of members 22 mpl positioned in multiple resilient members 18 .
- apparatus 10 can have impedance sensors 22 disposed along elongated member 12 and other locations outside of the target tissue site 5 ′ for measurement and determination of the total impedance across the full electrical circuit between the terminals of power supply 20 (i.e. through the patient's body and to the ground pad). The total impedance can be monitored and otherwise utilized to improve the accuracy and precision of the localized impedance measurement from the target site 5 ′.
- Impedance sensing members 22 m , or sensors 22 , coupled to resilient members 18 can be deployed independently or simultaneously to enable probing of target tissue 5 ′ in multiple locations, so as to measure impedance 19 p in multiple locations and/or through multiple conductive pathways 22 cp ( FIGS. 3A-3B ). Deployment of impedance sensing members 22 m or sensors 22 can be controlled such that telemetry can be used with impedance feedback to identify tissue types and map the topography of tissue masses, tumors or tissue structures.
- Impedance sensing members 22 m can also be deployed with curvature from members 18 to collectively define a volume 5 sv (also called sample volume 5 sv ) that is volumetrically sampled by sensing member plurality 22 mpl .
- the plurality 22 mpl of deployed impedance sensing members 22 m or the plurality 18 pl of deployed resilient members 18 with coupled impedance sensors 22 , can comprise a three-dimensional or volumetric impedance sensor array 22 a .
- sensor array 22 a is configured to volumetrically sample (e.g. sample in multiple locations and through multiple conductive pathways) tissue within target tissue site 5 ′, including tumor mass 5 ′′.
- Sensor array 22 a is further configured to be able to simultaneously sample tissue at multiple locations within volume 5 sv or tissue site 5 ′, to perform one or more of the following: (i) locate the position of the tumor mass 5 ′′, (ii) discern the position or deployment distance of the energy delivery members 18 , (iii) monitor the developing ablation volume 5 av , (iv) perform tissue sensing identification by comparing impedances 19 p between two or more sites (e.g. known healthy tissue and suspected diseased tissue 5 ′′).
- sensor array 22 a and/or member plurality 18 pl can be configured to define a variety of shapes for sample volumes 5 sv , including, but not limited to, a hemisphere, a sphere, an oval, a cone, a pyramid, a polyhedron or a tetrahedron.
- Each resilient member 18 can have one or more impedance sensing members 22 m and/or sensors 22 that can be arranged in a variety of configurations to perform one or more of the desired functions described herein (e.g. tissue identification, ablative monitoring, etc.).
- sensing members 22 m can be configured to measure impedance in either bipolar mode (between two or more members 22 m ) or mono-polar mode (between one or more selected members 22 m and a common ground, such as a ground electrode 22 g or ground pad electrode 22 gp ). Switching between the two modes can be controlled by logic resources and/or a switching or multiplexing device 29 coupled to, or integral with, an impedance monitoring device 19 or power supply 20 .
- switching device 29 can be configured to allow the user to define and select one or more conductive pathways 22 cp to measure impedance.
- these and related embodiments allow the user to select any number of conductive pathways 22 cp and in a pattern 22 pp that circumscribe or otherwise defines a sample volume 5 sv of interest.
- the use of switching device 29 in these embodiments allows the user to measure impedance simultaneously or sequentially through the selected pathways 22 cp .
- switching device 29 and/or apparatus 10 can be so configured to allow the user to dynamically change or switch between pathways 22 cp , to do one or more of the following: (i) change the number of pathways 22 cp through a selected sample volume 5 sv , allowing increased signal resolution and statistical confidence of predicted tissue conditions; (ii) change the angle between two or more conductive pathways 22 cp ; (iii) change the size of the sample volume 5 sv ; (iv) switch between a first and second sample volumes 5 sv ; and (v) compare two or more sample volumes 5 sv simultaneously.
- conductive pathways 22 cp can include a primary pathway(s) 22 cp ′ and an alternative pathway(s) 22 cp ′′.
- the alternative pathway 22 cp ′′ can be at a selectable angle 22 cpa from the primary pathway 22 cp ′, and can share points in common with the primary pathway 22 cp ′.
- Suitable angles 22 cpa include the range of 1° to 360°, with particular embodiments of 30°, 45°, 90° and 270°, from a lateral axis 22 la of the primary pathway 22 cp ′.
- the alternative conductive pathway 22 cp ′′ can share one or more points in common with the primary pathway 22 cp ′, or be parallel with the primary pathway 22 cp ′ but offset a selectable lateral distance 22 ld .
- repetitive scans of impedance including sweep scans and sequential sweep scans (e.g. sequentially sampling from one side of a sample volume 5 sv to the other, similar to radar), can be made through one or more selected conductive pathways 22 cp of a selected sample volume 5 sv to monitor the time course of ablation, as well as to obtain improved signal to noise ratios and signal resolution for image analysis.
- Changing the angle 22 cpa and/or lateral offset 22 ld of the conductive pathways 22 cp used to measure impedance can be accomplished through a variety of means, including, but not limited to: (i) selectively switching impedance sensors 22 or sensing elements 22 m off and on; (ii) selectively switching sensing elements 22 m from a monopolar mode to a bipolar mode, and visa versa (for RF embodiments), using switching device 29 ; (iii) configuring the probe array 22 a ( FIG. 3A ) to be rotatable and/or deflectable; and (iv) using and/or deploying a second array 22 a either on the same device 10 or on a different device. Switching can be accomplished through the use of a switching or multiplexing device 29 , which can be programmable or controlled by logic resources 19 lr ( FIG. 2 ) described herein.
- the data from alternative conductive pathways 22 cp ′′ or group of pathways 22 cp can be integrated with measurements from the primary conductive pathways 22 cp ′ for analysis and imaging purpose or, in an alternative embodiment, can be analyzed and displayed separately, allowing for a comparison of both measurements and images from the primary and alternative groups of pathways 22 cp .
- the benefit of the former is a more representative and uniform sampling of impedance, and the later the ability to detect for uniformities of impedance within the sampled volume 5 sv.
- such embodiments allow the medical practitioner to sample or image a larger tissue volume 5 sv than single pathway sampling, and to sample multiple tissue volumes 5 sv , including simultaneous sampling, without having to reposition the apparatus 10 or impedance array 22 a ( FIG. 3A ). This capability reduces procedure time, and generally enhances the usability of the apparatus 10 . Further, such embodiments also provide a more accurate and representative signal of the target tissue volume 5 sv by selecting conductive pathways 22 cp to control the shape and size of the sample volume 5 sv , to sample only the area of interest, thereby eliminating any potential masking or undesired impedance contribution from surrounding non-target tissue 5 .
- the ability to switch the angle 22 cpa of the pathways 22 cp eliminates or reduces any directional bias in the impedance measurements.
- the use of multiple conductive pathway impedance measurements provides a more representative measurement of impedance for the selected volume 5 sv , thereby improving the accuracy and precision of the impedance measurement as well as improving signal and image resolution in one or all three dimensions.
- impedance sensing members 22 m can be arranged in arrays ( 22 a 1 , 22 a 2 ) having a variety of geometric arrangements and relationships, so as to electrically sample different volumes 5 sv of tissue using different conductive pathways 22 cp .
- Such embodiments provide the benefit of improved acquisition, accuracy and analysis of the impedance signal from a given sample volume 5 sv to compensate for signal hysteresis, noise (due to energy delivery etc.), directional bias, or other error. They also provide the benefit of simultaneous sampling and comparison of two or more tissue volumes 5 sv to perform tissue identifications.
- Conductive pathways 22 cp can have a variety of configurations and orientations, all selectable by the user.
- the conductive pathways 22 cp can be evenly distributed or spaced within the sample volume 5 sv . This can be achieved by either the configuration of the members 22 m , through the use of switching device 29 , or a combination of both.
- the conductive pathways 22 cp can be aligned with respect to one or more sensing members 22 m , the introducer 12 , or the tumor volume 5 ′′ itself. In an embodiment, shown in FIGS.
- one member 22 mc can be positioned at the center of sample volume 5 sv , with other members 22 m positioned in a surrounding relationship, so excitation current travels in a plurality 22 pp of conductive pathways 22 cp to and from the center of the sample volume 5 sv to the surrounding impedance sensing members 22 m .
- this configuration results in an impedance measurement for the sample volume 5 sv , which is an average of the individual impedance measurements for each conductive pathway 22 cp , providing the benefit of a more a statistically representative sample of impedance for a selected tissue volume 5 sv than provided by a single pathway sampling alone.
- Surrounding members 22 m can be collectively coupled to a positive terminal of power supply 20 , with member 22 mc configured as a return electrode and coupled to a return terminal of power supply 20 .
- member 22 mc can be eccentrically positioned with respect to members 22 m and/or positioned on the periphery of a sample volume 5 sv defined by members 22 m .
- this embodiment provides the benefit of an average, and thus more representative, impedance measurement for the sample volume 5 sv .
- this configuration also provides the benefit of being able to more readily detect and locate non-uniformities 5 nu (in impedance and hence tissue properties) occurring on the boundaries or otherwise non-centered portions of the tissue volume 5 sv .
- switching device 29 allows for the dynamic switching of any of the sensing members 22 m to a return electrode 22 mc to more readily detect the location of a potential non-uniformity within the sample volume 5 sv , by rapidly scanning different portions of the periphery of the volume 5 sv.
- members 22 m can comprise a first array 22 a 1 (such as perpendicular array) and a second array 22 a 2 .
- First array 22 a 1 can be rotated to obtain different conductive pathways to second array 22 a 2 so as to sample different tissue volumes and/or provide multiple samplings of the same volume (via different conductive pathways), to improve accuracy and precision of the measurement, and reduce noise.
- this embodiment also allows detection of incomplete ablation by comparing a measured impedance from a first group of conductive pathways 22 cp 1 defined by first array 22 a 1 to a second group of conductive pathways 22 cp 2 defined by second array 22 a 2 .
- apparatus 10 can be configured to simultaneously sample different locations within target tissue site 5 ′ utilizing switching device or multiplexer 29 , or other switching means described herein or known in the art.
- a first group of selected conductive pathways 22 cp ′ can be used to sample a local first volume 5 sv 1
- a second group of selected conductive pathways 22 cp ′′ can be selected to do so for a second volume 5 sv 2
- a third group of selected conductive pathways 22 cp ′′′ can be selected to do so for a larger or global sample volume 5 sv 3 that is defined or circumscribed by multiple sensor 22 tipped members 18 or sensing members 22 m .
- sample volumes 5 sv 1 , 5 sv 2 , and 5 sv 3 produce impedance profiles 19 p 1 , 19 p 2 , and 19 p 3 , respectively, all or portion of which can be compared to one another or a database of impedance profiles 19 db , using comparison/pattern recognition algorithms of module 19 m , or other software or computational means.
- the measured impedance signal for each sample volume can be integrated or otherwise analyzed by module 19 m , or other computational means, to determine an impedance vector 22 v and locus 221 of impedance for each respective sample volume (e.g. impedance vectors 22 v 1 , 22 v 2 , and 22 v 3 , impedance loci 2211 , 2212 , and 2213 ).
- one or more impedance sensors 22 or sensing members 22 m of apparatus 10 can be coupled to an impedance measurement and monitoring device 19 .
- Monitoring device 19 includes circuitry described herein to measure voltage from the excitation current and subsequently calculate impedance. Further, monitoring device 19 can also be configured to measure, calculate and record an impedance profile 19 p and a complex impedance profile 19 pc resulting from various tissue bioelectric properties, including impedance, conductance, capacitance, etc.
- monitoring device 19 can include logic resources 19 lr , such as a microprocessor and memory resources 19 mr (such as RAM or DRAM chip) configured to analyze, store and display tissue impedance profile 19 p and/or other bio-electric information derived from sensing member 22 m and/or sensing array 22 a .
- Impedance monitoring device 19 can also be coupled to a display device 21 so as to display real time or stored impedance profiles 19 p , images, and other data generated by impedance monitoring device 19 .
- Examples of display devices 21 include cathode ray tubes (CRTs), liquid crystal displays, plasma displays, flat panel displays, and the like. Display device 21 can also be incorporated in an external computer coupled to impedance monitoring device 19 .
- impedance monitoring device 19 or power supply 20 can be equipped with a number of features, including but not limited to the following: (i) memory resources 19 mr containing a database 19 db of characteristic impedance profiles; (ii) a readout window for the impedance-based diagnosis of tissue type and/or condition; (iii) artificial intelligence algorithms/programming enabling the generator to learn from newly acquired impedance scans; (iv) ability for the user to enter and teach the generator the correct tissue type and condition, based on biopsy or pathology data; (v) ability to sense impedance on multiple frequencies simultaneously to improve speed and accuracy, and to reduce effects of interference; (vi) ability to work with non-invasive pads (like electro-physiology pads) for measurement of complex impedance, and for performing targeted tissue assessment non-invasively; (vii) ability to monitor a reference signal and/or basic patient electro-physiological conditions, for baseline comparisons with impedance readings and as additional information for the user; and (viii) programming to utilize the reference signal or signal
- apparatus 10 along with impedance monitoring device 19 , can be configured to perform tissue identification, differentiation, ablation monitoring, and mapping of tissue masses and structures.
- monitoring device 19 is configured to perform a tissue identification function, using impedance information derived from sensors 22 , sensing members 22 m , or array 22 a .
- impedance information derived from sensors 22 , sensing members 22 m , or array 22 a .
- Impedance profile 19 p which can have one or more peaks 19 pk , curves 19 pc , and other shapes that serve as a fingerprint of the tissue type or tissue condition. Accordingly, by analyzing the impedance profile 19 p and matching peaks 19 pk , curve shapes 19 pc , thresholds, etc., profile 19 p can be utilized by embodiments of the application to identify tissue types and conditions, such as malignancy, vascularity, necrosis, thermal injury, etc. Related conditions that can also be identified using this approach include abnormally mutated tissue, abnormally dividing tissue, or hypoxic tissue.
- apparatus 10 can include electronic algorithms or software modules 19 m resident in logic resources 19 lr of monitoring device 19 or microprocessor 350 ( FIG. 29 ) that are configured to analyze an impedance profile 19 p (including real and imaginary components), and perform tissue identification and/or tissue differentiation between one or more sampled volumes 5 sv .
- Modules 19 m can include pattern recognition algorithms, curve fitting, fuzzy logic, or other numerical methods known in the art.
- modules 19 m can be configured to compare profile 19 p to a database of profiles 19 db stored in memory resources 19 mr , and use curve fitting or other numerical methods known in the art to provide and display a correlation coefficient or statistic (e.g. p value) indicative of the probability of a match to a given tissue type or condition.
- Module 19 m can also include an imaging sub-module 19 mi , described herein, to generate and display an impedance image 4 ′.
- the impedance and other bioelectric properties that can be analyzed to determine a tissue type or condition include: complex impedance (real and imaginary components), extracellular impedance, intracellular impedance, interstitial impedance, cell membrane capacitance, and intracellular capacitance.
- monitoring device 19 can be configured to analyze only selected frequencies of an impedance profile 19 p or other bioelectric property measurement that are known to identify, or correlate to, selected tissue characteristics, rather than analyzing the full frequency spectrum of the profile 19 p . Such frequencies can be selected from a pre-existing database 19 db , or determined in vivo using swept frequency methods described herein. This approach presents the advantage of shorter signal processing times, allowing a faster tissue assessment and diagnosis using fewer computational resources. In turn, this enables the size, power requirements, and complexity of the control and display instrumentation 19 to be reduced.
- apparatus 10 and monitoring device 19 can be configured to utilize complex impedance curves to identify and characterize different tissue types and conditions. Accordingly, monitoring device 19 can be configured to measure, generate, and display curves of profiles 19 pc of complex impedance. Curves 19 pc can be both two-dimensional and three-dimensional. For two-dimensional plots, the x-axis can be the real component and the y-axis the imaginary component ( FIG. 7B ); while three-dimensional plots can include an axis for time or frequency.
- FIGS. 7A and 7B because tissue conducts electrical current differently at different frequencies, measurements made across a range of excitation frequencies results in an impedance frequency response curve 19 pf ( FIG. 7A ), or a series of complex impedance frequency response curves 19 pcf ( FIG. 7B ). Using either of the frequency response curves from FIG.
- a particular frequency can be selected for subsequent impedance complex impedance measurements and analysis which has the greatest sensitivity for a given tissue type or condition and/or results in a complex impedance curve having the greatest predictive value for the desired tissue type or condition.
- the selection can be done using methods described herein, or by calibration against a set of in vitro standards representative of the desired tissue type or condition, by visual determination/estimation of the user, or a combination thereof.
- the course of an ablation can be monitored using impedance measurements made at multiple frequencies.
- the impedance at some frequencies will rise, fall or do both over the time course of the ablation.
- an ablation monitoring algorithm or module 19 m can be configured to look for impedance characteristic curve shapes, slopes threshold, etc., in two or more impedance curves made at different frequencies as predictors of an ablation endpoint.
- Such information can be used to provide a more reliable indicator of clinical endpoint, as well as to monitor and titrate the delivery of ablative energy or ablative therapy according to the requirements.
- differences in the impedance-frequency spectrum pre-, inter-, and post-ablation can also be used to monitor and evaluate the ablation process.
- complex impedance curves 19 pc can be used to monitor and assess the ablation process, including determination of clinical endpoints, as described herein.
- the apparatus can be configured to utilize complex impedance curves to identify and characterize different tissue types (tumors, etc.).
- Related embodiments can be configured to generate and display three-dimensional plots of complex impedance utilizing time and or position as the third axis. For positional 3-D plots, the locus of impedance 51 i can be calculated and graphically displayed, as is shown in FIG. 10 , or in 2-D plots as shown in FIGS. 9A-9C , or in another graphical format known in the arts.
- impedance locus 51 i can be utilized to characterize the ablation process, and can be used to perform vector analysis of RF or microwave current or other ablative energy vector (e.g. the magnitude and direction of the ablative energy), as well as vector analysis of physiologic indicators of cell necrosis, such as changes in interstitial conductivity.
- the impedance locus 51 i can be utilized to facilitate location and display of tumor volume 5 ′′, ablation volume 5 av , or other desired tissue mass or volume, at the target tissue site.
- the generation and display of the impedance locus 51 i can be configured to provide the medical practitioner an easily discernable visual cue as to the location, size, or movement of the ablation volume 5 av , the tumor volume 5 ′′, or other selected tissue volume.
- monitoring device 19 in addition to identifying tissue types, monitoring device 19 , along with impedance sensing arrays 22 a , can also be employed to monitor in real time the progression of an ablative procedure, including the progression of an ablation volume 5 av resulting from the delivery of energy to target tissue volume 5 ′. This reduces damage to tissue surrounding the targeted mass to be ablated.
- impedance sensing arrays 22 a By monitoring the impedance at various points within and outside of the interior of tissue site 5 ′, a determination of the selected tissue mass periphery can be made, as well as a determination of when cell necrosis is complete.
- sensor 22 determines that an impedance level or an ablation endpoint has been met or exceeded. If at any time sensor 22 determines that an impedance level or an ablation endpoint has been met or exceeded, then an appropriate feedback signal is inputted to power source 20 , which then stops or otherwise adjusts the levels of ablative energy delivered to electrodes 18 and 18 ′.
- the target tissue site 5 ′′ can also be probed and interrogated by sensor array 22 a after the completion of ablation, to confirm that ablation is complete for the entire desired ablation volume 5 av . By probing the ablated region with sensor array 22 a , the three-dimensional volume of the ablation 5 av can be assessed, and the margin 5 m of ablated healthy tissue beyond the tumor mass 5 ′′ can also be measured.
- the impedance signal intensity 19 si for a sample volume of tissue 5 sv bounded by two or sensing members 22 m or array 22 a can be monitored over time, using monitoring device 19 , supply 20 , or other bioelectric signal monitoring means known in the art.
- An endpoint for ablation can be determined, based on either a selectable threshold value 19 ts of signal intensity 19 si , or an inflection point or change in slope 19 ds (e.g. a derivative) of the curve of signal intensity 19 si , or a combination of both.
- the signal intensity curve can comprise the subtraction of a baseline (or reference) impedance measurement 19 sbl of a nearby, but non-ablated, tissue volume from a real time measurement 19 srt of the target tissue volume 5 ′′ during the time course of ablation. This compensates for any signal or tissue hysteresis over time.
- Values for 19 ts and 19 ds can be input and stored in logic resource 19 lr coupled to impedance monitoring 19 ( FIG. 6 ), or incorporated into an electronic algorithm controlling the delivery of energy, which can be stored in a controller or processor 338 coupled to power supply 20 ( FIG. 28 ).
- introducer 12 can be a trocar, a catheter, a multi-lumen catheter, a wire-reinforced or metal-braided polymer shaft, a port device, a subcutaneous port device, or other medical introducing device known to those skilled in the art.
- introducer 12 as well as resilient member 18 , can be configured to have varying mechanical properties along their respective lengths, including, but not limited to, variable stiffness, torquability, column strength, flexural modulus, pushability, trackability and other mechanical performance parameters known in the art. Referring to FIG.
- stiff shaft sections 12 ′′′ disposed within portions of introducer 12 along its length 12 ′. It can also be accomplished through the use of braids, varying/tapered diameters, and different materials (e.g. stiffer materials joined to flexible materials) positioned over portions of introducer 12 .
- Sections 12 ′′′ made from different materials can be joined using introducer bonding methods known in the art, such as hot melt junctions (with or without capture tubes/collates), adhesive joints, butt joints, and the like.
- the joining method can be controlled/selected so as to control the mechanical transition 12 mt between two sections 12 ′′′ to a desired gradient (e.g. smooth vs. abrupt).
- introducer 12 and/or member 18 can be configured to have stiffer proximal portions and more flexible distal portions, so as to facilitate one or more of the following: (i) introducer steerability and positioning of distal tip 16 at a selectable target tissue site 5 ′; and (ii) reduced risk of perforation, abrasion and other trauma during the positioning the introducer 12 to the tissue site 5 ′.
- the transition 12 mt from the stiffer portion to the more flexible portion can be configured to be either gradual with a linear or curve-linear transition 12 mt or a stepped or abrupt transition 12 mt , or combinations thereof.
- introducer 12 can have a substantially circular, semicircular, oval, or crescent shaped cross sectional profile 12 cs , as well as combinations thereof, along its length 12 ′.
- lumens 13 can have a circular, semicircular, oval, or crescent shaped cross sectional profile 13 cs for all or a portion of the length 12 ′ of introducer 12 .
- Suitable materials for introducer 12 and resilient member 18 include, but are not limited to, stainless steel, shape memory alloys such as nickel titanium alloys, polyesters, polyethylenes, polyurethanes, PEBAX®, polyamides, nylons, copolymers thereof, and other medical plastics known to those skilled in the art. All or portions 12 ′′′ of introducer 12 can be coated with a lubricious coating or film 12 ′′ which reduces the friction (and hence trauma) of introducer 12 with hepatic, pulmonary, bone, and other tissue. Such coatings 12 ′′ can include, but are not limited to, silicones, PTFE (including TEFLON°), and other coatings known in the art.
- apparatus 10 can be constructed of materials known in the art that are optimized and/or compatible with radiation sterilizations (e.g. Gamma or E-beam).
- all or portions of apparatus 10 can be configured (e.g. lumen diameter to length ratio, etc.) to be sterilized by plasma (e.g. H 2 O 2 ) sterilization.
- all or portions of introducer 12 or resilient members 18 can be configured to be deflectable and/or steerable using deflection mechanisms 25 , which can include pull wires 15 , ratchets, cams, latch and lock mechanisms, piezoelectric materials, and other deflection means known in the art.
- the amount of deflection of introducer 12 is selectable, and can be configured to allow the maneuvering of introducer 12 through oblique turns in tissue, organs, organ ducts, and blood vessels.
- the distal portions of introducer 12 can be configured to deflect 0-180° or more in up to three axes 12 al to allow the tip of introducer 12 to have retrograde positioning capability.
- Deflection mechanism 25 can be coupled to or integral with a moveable or slidable actuator 24 ′′ on handpiece 24 .
- Mechanism 25 and coupled actuator 25 ′ are configured to allow the physician to selectively control the amount of deflection of distal tip 16 or other portion of introducer 12 .
- Actuator 25 ′ can be configured to both rotate and deflect distal tip 16 by a combination of rotation and longitudinal movement.
- introducer 12 can be coupled at its proximal end 14 to a handle 24 or handpiece 24 .
- Handpiece 24 can be detachable and can include ports 24 ′ and actuators 24 ′′.
- Ports 24 ′ can be coupled to one or more lumens 13 (and in turn lumens 72 ) and can include fluid and gas ports/connectors and electrical, optical connectors.
- ports 24 ′ can be configured for aspiration (including the aspiration of tissue), and the delivery of cooling, electrolytic, irrigation, polymer and other fluids (both liquid and gas) described herein.
- Ports 24 ′ can include, but are not limited to, luer fittings, valves (one-way, two-way), toughy-bourst connectors, swage fittings, and other adaptors and medical fittings known in the art. Ports 24 ′ can also include lemo-connectors, computer connectors (serial, parallel, DIN, etc) micro connectors and other electrical varieties well known to those skilled in the art. Further, ports 24 ′ can include opto-electronic connections which allow optical and electronic coupling of optical fibers and/or viewing scopes to illuminating sources, eye pieces, video monitors and the like.
- Actuators 24 ′′ can include rocker switches, pivot bars, buttons, knobs, ratchets, levers, slides, and other mechanical actuators known in the art, all or portion of which can be indexed. These actuators 24 ′′ can be configured to be mechanically, electro-mechanically, or optically coupled to pull wires, deflection mechanisms, and the like, allowing selective control and steering of introducer 12 .
- Handpiece 24 can be coupled to tissue aspiration/collection devices 26 , fluid delivery devices 28 (e.g. infusion pumps), fluid reservoirs 30 (cooling, electrolytic, irrigation, etc.), or power source 20 , through the use of ports 24 ′.
- Tissue aspiration/collection devices 26 can include syringes and vacuum sources coupled to a filter or collection chamber/bag.
- Fluid delivery devices 28 can include medical infusion pumps, Harvard pumps, syringes, and the like.
- aspiration device 26 can be configured for performing thoracentesis.
- resilient members 18 and sensing members 22 m these members can be of different sizes, shapes and configurations, with various mechanical properties selected for the particular tissue site 5 ′.
- members 18 can be needles, with sizes in the range of 28 to 12 gauge, with specific embodiments of 14, 16 and 18 gauges.
- Resilient members 18 are configured to be in non-deployed positions while retained in introducer 12 . In the non-deployed positions, resilient members 18 may be in a compacted state, spring loaded and generally confined within introducer 12 , or substantially straight if made of a suitable memory metal such as nitinol.
- resilient members 18 As resilient members 18 are advanced out of introducer 12 , they become distended to a deployed state, as a result of their spring or shape memory, that collectively defines an ablative volume 5 av , from which tissue is ablated.
- the selectable deployment of resilient members 18 can be achieved through one or more of the following: (i) the amount of advancement of resilient members 18 from introducer 12 ; (ii) independent advancement of resilient members 18 from introducer 12 ; (iii) the lengths and/or sizes of energy delivery surfaces of electrodes 18 and 18 ′; (iv) variation in materials used for electrodes 18 and 18 ′; (v) selection of the amount of spring loading or shape memory of electrodes 18 and 18 ′; and (vi) variation of the geometric configurations of electrodes 18 and 18 ′ in their deployed states.
- resilient member 18 can be an energy delivery device 18 or member 18 e .
- the specific energy delivery devices 18 and power sources 20 that can be employed include, but are not limited to, the following: (i) a microwave power source coupled to a microwave antenna, providing microwave energy in the frequency range from about 915 MHz to about 2.45 GHz; (ii) a radio-frequency (RF) power source coupled to an RF electrode; (iii) a coherent light source coupled to an optical fiber or light pipe; (iv) an incoherent light source coupled to an optical fiber; (v) a heated fluid coupled to a catheter, with a closed or at least partially open lumen configured to receive the heated fluid; (vi) a cooled fluid coupled to a catheter, with a closed or at least partially open lumen configured to receive the cooled fluid; (vii) a cryogenic fluid; (viii) a resistive heating source coupled to a
- the energy delivery device 18 is one or more of RF electrodes 18 e
- the power source 20 utilized is an RF power supply 20 .
- RF power supply 20 can be configured to deliver 5 to 200 watts, preferably 5 to 100, and still more preferably 5 to 50 watts of electromagnetic energy is to the electrodes 18 e of energy delivery device 18 , without impeding out.
- the electrodes 18 e are electromagnetically coupled to energy source 20 .
- the coupling can be direct, from energy source 20 to each electrode 18 e respectively, or indirect, by using a collet, sleeve, and the like which couples one or more electrodes 18 e to energy source 20 .
- electrodes 18 e can have a variety of shapes and geometries.
- exemplary shapes and geometries can include, but are not limited to, ring-like, ball, hemispherical, cylindrical, conical, needle-like, and combinations thereof.
- electrode 18 e can be a needle with sufficient sharpness to penetrate tissue, including fibrous tissue such as encapsulated tumors, cartilage, and bone.
- the distal end 18 de of electrode 18 e can have a cut angle 68 that ranges from 1 to 60°, with preferred ranges of at least 25°, or at least 30°, and specific embodiments of 25° and 30°.
- the surface of electrode 18 e can be smooth or textured, and concave or convex.
- Electrode 18 e can have different lengths 38 ′ that are advanced from distal end 16 ′ of introducer 12 ( FIG. 2 ). The lengths 38 ′ can be determined by the actual physical length 38 of electrode 18 e , the length 38 ′ of an energy delivery surface 18 eds of electrode 18 e , and the length 38 ′′ of electrode 18 e that is covered by an insulator 36 .
- Suitable lengths 38 ′ include, but are not limited to, a range from 0.5-30 cm, with specific embodiments of 0.5, 1, 3, 5, 10, 15 and 25.0 cm.
- the conductive surface area 18 eds of electrode 18 e can range from 0.05 mm 2 to 100 cm 2 .
- the actual lengths 38 ′ of electrode 18 e depend on the location of tissue site 5 ′ to be ablated, its distance from the site, its accessibility, as well as whether or not the physician performs an endoscopic or surgical procedure.
- the conductive surface area 18 eds depends on the desired ablation volume 5 av to be created.
- electrodes 18 e can also be configured to be flexible and/or deflectable, having one or more radii of curvature 70 which can exceed 180 degrees.
- electrodes 18 e can be positioned to heat, necrotize, or ablate any selected target tissue volume 5 ′.
- a radiopaque marker 11 can be coated on electrodes 18 e for visualization purposes.
- Electrodes 18 e can be coupled to introducer 12 , and/or an advancement member or device 15 , or an advancement-retraction member 34 , using soldering, brazing, welding, crimping, adhesive bonding, and other joining methods known in the medical device arts.
- electrodes 18 e can include one or more coupled sensors 22 to measure temperature and impedance (both of the electrode and of the surrounding tissue), voltage and current, or other physical properties of the electrodes 18 e and adjacent tissue.
- Sensors 22 can be at exterior surfaces of electrodes 18 e at their distal ends or intermediate sections.
- Electrode 18 e can be made of a variety of conductive materials, both metallic and non-metallic. Suitable materials for electrode 18 e include, steel such as 304 stainless steel of hypodermic quality, platinum, gold, silver, alloys, and combinations thereof. Also, electrode 18 e can be made of conductive, solid or hollow, straight wires of various shapes, such as round, flat, triangular, rectangular, hexagonal, elliptical, and the like. In a specific embodiment, all or portions of electrodes 18 e , or a second electrode 18 e ′, can be made of a shaped memory metal, such as NiTi, commercially available from Raychem Corporation, Menlo Park, Calif.
- NiTi commercially available from Raychem Corporation, Menlo Park, Calif.
- one or more resilient members 18 or electrodes 18 e can be covered by an insulative layer 36 , so as to have an exterior surface that is wholly or partially insulated, and provide a non-insulated area which is an energy delivery surface 18 eds .
- insulative layer 36 can comprise a sleeve that can be fixed, or slidably positioned, along the length of electrode 18 e to vary and control the length 38 ′ of energy delivery surface 18 eds .
- Suitable material for insulative layer 36 includes polyamide and fluorocarbon polymers, such as TEFLON®.
- insulation 36 is formed at the exterior of electrodes 18 e in circumferential patterns, leaving a plurality of energy delivery surfaces 18 eds .
- insulation 36 extends along a longitudinal exterior surface of electrodes 18 e .
- Insulation 36 can extend along a selected distance along a longitudinal length of electrodes 18 e , and around a selectable portion of a circumference of electrodes 18 e .
- sections of electrodes 18 e can have insulation 36 along selected longitudinal lengths, as well as completely surround one or more circumferential sections of electrodes 18 e .
- Insulation 36 positioned at the exterior of electrodes 18 , 18 e can be varied to define any desired shape, size and geometry of energy delivery surface 18 eds.
- electrode 18 e can include one or more lumens 72 (which can be contiguous with, or the same as, lumen 13 ) coupled to a plurality of fluid distribution ports 23 (which can be apertures 23 ), from which a variety of fluids 27 can be introduced, including conductivity enhancing fluids, electrolytic solutions, saline solutions, cooling fluids, cryogenic fluids, gases, chemotherapeutic agents, medicaments, gene therapy agents, photo-therapeutic agents, contrast agents, infusion media, and combinations thereof.
- This is accomplished by having ports or apertures 23 that are fluidically coupled to one or more of lumens 72 or coupled to lumens 13 , which in turn coupled to fluid reservoir 30 and/or fluid delivery device 28 .
- a conductivity enhancing solution 27 can be infused into target tissue site 5 ′ including tissue mass 5 ′′.
- the conductivity enhancing solution can be infused before, during, or after the delivery of energy to the tissue site 5 ′ by the energy delivery device 10 .
- the infusion of a conductivity enhancing solution 27 into the target tissue site 5 ′ creates an infused tissue area 5 i that has an increased electrical conductivity (verses un-infused tissue), so as to act as an enhanced electrode 40 .
- the current densities in enhanced electrode 40 are greatly lowered, allowing the delivery of greater amounts of RF power into electrode 40 and target tissue site 5 ′ without impedance failures.
- the infusion of the target tissue site 5 ′ with conductivity enhancing solution 27 provides two important benefits: (i) faster ablation times, and (ii) the creation of larger lesions, both without impedance-related shut downs of the RF power supply. This is due to the fact that the conductivity enhancing solution 27 reduces current densities and prevents desiccation of tissue adjacent the electrodes 18 , 18 e , 18 e ′ that would otherwise result in increases in tissue impedance.
- a preferred example of a conductivity enhancing solution 27 is a hypertonic saline solution.
- Other examples include halide salt solutions, colloidal ferro solutions, and colloidal silver solutions.
- the conductivity of enhanced electrode 40 can be increased by control of the rate and amount of infusion, and by the use of solutions with greater concentrations of electrolytes (e.g. saline) and hence greater conductivity.
- the use of conductivity enhancing solution 27 allows the delivery of up to 2000 watts of power into the tissue site 5 ′ without impedance shut down, with specific embodiments of 50, 100, 150, 250, 500, 1000 and 1500 watts, achieved by varying the flow, amount and concentration of infusion solution 27 .
- the infusion of solution 27 can be continuous, pulsed, or combinations thereof, and can be controlled by a feedback control system described herein.
- a bolus of infusion solution 27 is delivered prior to energy delivery, followed by a continuous delivery initiated before or during energy delivery with energy delivery device 18 or other means.
- impedance sensors 22 can include all or a portion of resilient members 18 .
- resilient member 18 when resilient member 18 is made of a conductive material, the length 221 of impedance sensor 22 or sensing member 22 m can be defined by the placement of a slidable or fixed insulative layer 36 .
- impedance sensors 22 can be fabricated from a variety of conductive materials and metals known in the art, including stainless steel, copper, silver, gold, platinum, alloys, and combinations thereof. Referring now to FIG.
- all or portions of sensors 22 or sensor members 22 m can comprise a conductive coating 22 c that is coated or deposited onto a selected portion of member 18 .
- coating 22 c can comprise a conductive metal or conductive polymer coating known in the art that is applied using known methods, such as sputtering, vacuum deposition, dip coating, photolithography, and the like.
- impedance sensing members 22 m and/or sensors 22 can be configured to have a resistance gradient 22 g along all or portions of their lengths 22 l .
- the resistance gradient 22 g can be increasing or decreasing in a linear, second order, third order, exponential, or other fashion.
- the resistance gradient 22 g is configured to compensate for resistance losses (i.e. of voltage) and/or hysteresis occurring along the length 22 l of member 22 m or sensor 22 , as well as changes in the overall resistance of sensor 22 due to changes in the temperature and/or conducting/sensing length 22 lc (and area) of sensor 22 , as might occur due to advancement or retraction of slidable insulation layer 36 , or fowling of the sensor 22 with desiccated, burnt tissue or otherwise adherent tissue.
- the gradient 22 g can be so configured to produce the least resistance (e.g.
- the gradient 22 g can be produced via the use of coating 22 c by varying either the thickness or the composition of the coating 22 c , or a combination of both, along the length 22 I of the sensor 22 , using methods known in the art. Further, by compensating for such resistance changes or losses along the length or area of impedance sensor 22 , these and related embodiments also improve the measurement and detection of real and imaginary components of complex impedance.
- the resistance gradient 22 g can be in a radial direction, or a combination of radial and linear directions, with respect to the sensor length 22 l.
- sensors 22 can comprise a number of biomedical sensors known in the art, including, but not limited to, thermal sensors, acoustical sensors, optical sensors, pH sensors, gas sensors, flow sensors, positional sensors, and pressure/force sensors.
- Thermal sensors can include thermistors, thermocouples, resistive wires, and the like.
- Acoustical sensors can include ultrasound sensors, including piezoelectric sensors, which can be configured in an array.
- Pressure and force sensors can include strain gauge sensors, including silicon-based strain gauges.
- sensor 22 can be selected to measure temperature along with impedance to compensate for any temperature related bias or hysteresis in the impedance measurement. Accordingly, in an embodiment illustrated in FIG. 28 , a feedback signal from a temperature sensor 329 or temperature calculation device 342 can be inputted to the impedance calculation device 334 , described herein, to compensate for such variations. Temperature monitoring can also be used to perform real time monitoring of ablative energy delivery. If at any time sensor 22 determines that a desired cell necrosis temperature is exceeded, then an appropriate signal can be sent to power control circuitry 340 , describe herein, to reduce or regulate the amount of electromagnetic energy delivered to electrodes 18 and 18 ′.
- the position and size of an ablation volume 5 av produced by the delivery of electromagnetic energy can be controlled via the frequency of the ablative energy delivered to one or more electrodes 18 e or energy delivery devices 18 .
- lower electromagnetic frequencies such as RF frequencies (e.g. 1 kHz to 1 MHZ)
- produce a more localized energy concentration e.g. current density
- the resulting zone of energy concentration or ablation zone 5 az occurring close to the energy delivery electrode/antenna 18 , 18 e in terms of a lateral distance 18 ld or other direction.
- Such circuitry and control resources can be used to turn individual electrodes or antenna off and on as well as control/set the frequency of each.
- these and related embodiments provide the benefit of allowing the size, position and shape of the lesion to be precisely controlled and/or titrated to meet the therapeutic needs of the target tissue.
- one or more electrodes 18 can have segmented portions 18 sp so as to allow the electrodes 18 to emit or radiate energy at different wavelengths from different segmented portions 18 sp of electrode 18 . Segmentation can be achieved through the use of electrically insulated sections 36 s.
- segmented electrodes 18 sp allows the creation of segmented ablation zones 5 azs , including a first and second segmented zone 5 azs 1 and 5 azs 2 .
- the size and shape of the segmented ablation zones 5 azs can be controlled by controlling the frequency of the delivered energy to each electrode segmented portion 18 sp .
- the segmented ablation zones 5 azs can also be configured to be discontinuous or overlapping. Such embodiments also provide the ability to avoid injury to anatomical structure such as blood vessels, nerves etc., which lie in close proximity or are actually surrounded by the tumor to be treated. For example, in an embodiment shown in FIG.
- the segmented ablation zones 5 azs 1 and 5 azs 2 can be sized and positioned to have sufficient space between each zone to avoid damaging a blood vessel 5 bv or other critical structure 5 as which lies between two or more electrodes 18 .
- the ablative frequencies delivered to each electrode segmented portion 18 sp can be reconfigured to produce overlapping segmented ablation zones 5 azs , as shown in FIG. 25C .
- the medical practitioner would position the apparatus, and then image the target tissue site (using imaging systems known in the art, such as ultrasound) to identify both the tumor and critical structures, and then utilize that image to control the input frequency to the energy delivery device, to produce the desires lesion size and shape to completely ablate the tumor while avoiding the critical structure.
- the image could be electronically stored and analyzed to identify tumors and surrounding anatomy (using imaging processing methods known in the art, such as edge detection algorithms, resident within a processor of the imaging device), with the output fed into a power control software module coupled to the power supply that controls the power frequency to produce the desired ablation volume.
- imaging processing methods known in the art, such as edge detection algorithms, resident within a processor of the imaging device
- Another benefit of these and related embodiments is the ability to produce an energy or thermal gradient within a target tissue site.
- Exemplary embodiments for the use of this capability include delivering larger amounts of energy to the center of a tumor and less to the periphery, in order to produce higher temperatures and ensure complete ablation at the center and minimize risk of thermal injury to surrounding healthy tissue.
- increased energy could also be selectively directed to the tissue tract made by the RF needle or probe (or other penetrating energy delivery device 18 ) in penetrating the tumor and surrounding tissue, to ensure that no living malignant tissue is dragged back through the tract upon removal of the RF needle.
- a process 100 for generating and displaying an impedance map or impedance derived image 4 ′ includes one or more of the following steps, all or a portion of which can be implemented as an electronic instruction set on a processor or logic resources described herein.
- Impedance array 22 a and/or apparatus 10 can be positioned 101 within or near the desired sample volume 5 sv , and/or conductive paths 22 cp can be selected 105 , so as to define and thus select 110 a particular sample volume 5 sv .
- the volume 5 sv is then imaged 200 , using impedance measurements from all or a portion of the sensing members 22 m or sensors 22 that comprise array 22 a .
- a decision 300 can then be made to perform one or more re-imaging of the sample volume 5 sv , in order to enhance image resolution as needed.
- excitation currents 20 e can be applied to the target tissue site 5 ′ and the voltage measurements repeated over time to increase measurement accuracy and precision, through increased sampling and reducing signal bias or noise that may occur at a particular excitation current 20 e .
- Signals 22 i from impedance array 22 a can then be signaled or inputted 400 to logic resources 19 lr , include module 19 m , which can include an image processing sub-module 19 mi .
- Sub-module 19 mi includes subroutines or algorithms configured to generate an impedance map or derived image 4 ′ of all or a portion of the target tissue site 5 ′, using image/signal processing methods including, but not limited to, edge detection, filtering, approximating techniques, volume imaging, contrast enhancement, fuzzy logic, and other methods known in the art.
- One or more signals 22 i from array 22 a can be inputted or signaled 500 to memory resources 19 mr (or an externally coupled data storage device) and stored as an impedance data set 22 ds in memory resources 19 mr .
- all or a portion of data set 22 ds can be inputted to sub-module 19 mi and processed 600 , as described herein, to generate an impedance map or impedance derived image 4 ′, which can then be displayed 700 on display device 21 or other display means.
- a decision 800 can then be made to image a new sample volume 5 sv , and the process 100 can be repeated, starting at steps 101 or 105 .
- the imaging or mapping process 100 can be facilitated by rotating array 22 a about introducer axis 12 a 1 , or by advancing and retracting one or more sensing members 22 m from members 18 , or by a combination of both.
- module 19 m or 19 mi can include an algorithm utilizing Laplace's equation to calculate impedivity or resistivity from the known voltages and currents measured at one or more conductive pathways 22 cp within the target tissue site 5 ′. Reference measurements or normalization methods may be used to account for noise in the measurements.
- impedance and other bioelectric measurements described herein can be analyzed and converted from the frequency domain to the time domain using transform functions, including Fourier transforms, fast Fourier transforms, wavelet analysis methods, and other numerical methods known in the art. These functions and methods can be incorporated into algorithms or subroutines within module 19 m or 19 mi .
- modules 19 m or 19 mi utilize spline wavelets to allow analysis and synthesis of discrete data on uniform or non-uniform tissue sample sites without any boundary effect.
- Image module 19 mi can also include subroutines to perform interpolation, such as linear, quadratic, or cubic spline interpolation between individual measured impedance values from image data set 22 ds of a given sample volume 5 sv . This improves image quality, including resolution, without any substantial loss of spatial or contrast detail.
- the image processing module 19 mi can be configured to allow the user to select both the interpolative or other image processing algorithms to be performed, as well as the area of the image to be so processed. Thus, the user can select all or a portion of the image to be enhanced, providing faster image processing times (by not having to process the entire image) as well as improving image quality and other overall usability of the imaging apparatus/system.
- the image processing module 19 mi can also include gray scale and color contrast capabilities, which can be selectable. Both the gray scale and color contrast can be scaled or normalized against a baseline measurement obtained from the individual patient, a calibration measurement or a statistic (e.g. mean) value for a patient sample group, or a parameter (e.g. average) for a patient population, or a combination thereof.
- a statistic e.g. mean
- a parameter e.g. average
- monitoring apparatus 19 and module 19 mi can be configured to generate impedance images with the maximum visual distinction or contrast between tumorous tissue and healthy tissue. This can be accomplished by using the frequency or combination of frequencies that yield the maximum sensitivity for selected tissue types or tissue conditions indicative of a tumor (e.g. degree of vascularity temperature etc). In an embodiment, such frequencies can be determined by performing swept frequency measurements and generating an impedance map or image using one or more frequencies, which result in the best contrast between healthy tissue and tumorous tissue or other tissue condition (e.g. thermal injury, necrosis etc.).
- frequencies can be determined by performing swept frequency measurements and generating an impedance map or image using one or more frequencies, which result in the best contrast between healthy tissue and tumorous tissue or other tissue condition (e.g. thermal injury, necrosis etc.).
- a feedback control system 329 can be connected to energy source 320 , sensors 324 , impedance array 322 a , and energy delivery devices 314 and 316 .
- Feedback control system 329 uses temperature or impedance data from sensors 324 or array 322 a to modify the amount of electromagnetic energy received by energy delivery devices 314 and 316 from an initial setting of ablation energy output, ablation time, temperature, and current density (the “Four Parameters”).
- Feedback control system 329 can automatically change any of the Four Parameters.
- Feedback control system 329 can detect impedance or temperature and change any of the Four Parameters in response to either or a combination thereof.
- Feedback control system 329 can include a multiplexer (digital or analog) to multiplex different electrodes, sensors 324 , and sensor arrays 322 a , a temperature measurement device 342 or an impedance calculation device 334 that provides a control signal representative of temperature or impedance detected at one or more sensors 324 or array 322 a .
- a microprocessor can be connected to the temperature control circuit.
- RF energy delivery devices 314 and 316 will now be referred to as RF electrodes/antennas 314 and 316
- energy source 320 will now be referred to as an RF energy source 320 .
- all other energy delivery devices and sources discussed herein are equally applicable, and devices similar to those associated with treatment apparatus 10 can be utilized with laser optical fibers, microwave devices, and the like.
- the temperature of the tissue or of RF electrodes 314 and 316 is monitored, and the output power of energy source 320 is adjusted accordingly. The physician can, if desired, override the closed or open loop system.
- the user of apparatus 10 can input an impedance value that corresponds to a setting position located at apparatus 10 . Based on this value, along with measured impedance values, feedback control system 329 determines an optimal power and time needed in the delivery of RF energy. Temperature is also sensed for monitoring and feedback purposes. Temperature can be maintained to a certain level by having feedback control system 329 adjust the power output automatically to maintain that level.
- feedback control system 329 determines an optimal power and time for a baseline setting. Ablation volumes or lesions are formed at the baseline setting first. Larger lesions can be obtained by extending the time of ablation after a center core is formed at the baseline setting. The completion of lesion creation can be checked by advancing energy delivery device 316 from distal end 16 ′ of introducer 12 to a position corresponding to a desired lesion size and monitoring the temperature at the periphery of the lesion such that a temperature sufficient to produce a lesion is attained.
- the closed loop system 329 can also utilize a controller 338 to monitor the temperature, adjust the RF power, analyze the result, re-feed the result, and then modulate the power. More specifically, controller 338 governs the power levels, cycles, and duration that the RF energy is distributed to electrodes 314 and 316 , to achieve and maintain power levels appropriate to achieve the desired treatment objectives and clinical endpoints. Controller 338 can also, in tandem, analyze spectral profile 19 p and perform tissue identification and ablation monitoring functions, including endpoint determination. Further, controller 338 can, in tandem, govern the delivery of electrolytic or cooling fluids, and the removal of aspirated tissue. Controller 338 can be integral to, or otherwise coupled to, power source 320 .
- controller 338 can be coupled to a separate impedance measurement current source 317 , and can be configured to synchronize the delivery of pulsed power to tissue site 5 ′, to allow for sensing by sensors 324 or sensor array 322 a during power off intervals, to prevent or minimize signal interference, artifacts or unwanted tissue effects during sampling by sensors 324 or sensor array 322 a .
- the controller 338 can also be coupled to an input/output (I/O) device, such as a keyboard, touchpad, PDA, microphone (coupled to speech recognition software resident in controller 338 or other computer), and the like.
- current source 317 can be a multi-frequency generator, such as those manufactured by the Hewlett Packard Corporation (Palo Alto, Calif.), and can include or be coupled to a spectrum analyzer, manufactured by the same company.
- a control signal is generated by controller 338 that is proportional to the difference between an actual measured value and a desired value.
- the control signal is used by power circuits 340 to adjust the power output in an appropriate amount in order to maintain the desired power delivered at the respective primary and/or secondary antennas 314 and 316 .
- temperatures detected at sensors 324 provide feedback for maintaining a selected power.
- the actual temperatures are measured at temperature measurement device 342 , and the temperatures are displayed at user interface and display 336 .
- a control signal is generated by controller 338 that is proportional to the difference between an actual measured temperature, and a desired temperature.
- the control signal is used by power circuits 340 to adjust the power output in an appropriate amount in order to maintain the desired temperature delivered at the respective sensors 324 .
- a multiplexer 346 can be included for measurement of current, voltage, and temperature at the numerous sensors 330 , 332 and 324 , as well as for delivery and distribution of energy between primary electrodes 314 and secondary electrodes 316 .
- Suitable multiplexers 346 include, but are not limited to, those manufactured by the National Semiconductor Corporation (Santa Clara, Calif.), such as the CLC 522 and CLC 533 series; and those manufactured the Analog Devices Corporation (Norwood, Mass.).
- Controller 338 can be a digital or analog controller, or a computer with embedded, resident, or otherwise coupled software.
- controller 338 can be a PENTIUM° family microprocessor, manufacture by the Intel Corporation (Santa Clara, Calif.).
- controller 338 can include a CPU coupled through a system bus.
- On this system bus can be a keyboard, a disk drive, or other non-volatile memory systems, a display, and other peripherals, as are known in the art.
- Also coupled to the bus are a program memory and a data memory.
- controller 338 can be coupled to imaging systems, including, but not limited to, ultrasound, CT scanners (including fast CT scanners, such as those manufacture by the Imatron Corporation of South San Francisco, Calif.), X-ray, MRI, mammographic X-ray, and the like. Further, direct visualization and tactile imaging can be utilized.
- imaging systems including, but not limited to, ultrasound, CT scanners (including fast CT scanners, such as those manufacture by the Imatron Corporation of South San Francisco, Calif.), X-ray, MRI, mammographic X-ray, and the like. Further, direct visualization and tactile imaging can be utilized.
- User interface and display 336 can include operator controls and a display.
- user interface 336 can be a PDA device known in the art, such as a PALM° family computer, manufactured by Palm Computing (Santa Clara, Calif.).
- Interface 336 can be configured to allow the user to input control and processing variables to enable the controller to generate appropriate command signals.
- Interface 336 can also receive real time processing feedback information from one or more sensors 324 for processing by controller 338 , to govern the delivery and distribution of energy, fluid, etc.
- the outputs of current sensor 330 and voltage sensor 332 are used by controller 338 to maintain a selected power level at primary and secondary antennas 314 and 316 .
- the amount of RF energy delivered controls the amount of power.
- a profile of power delivered can be incorporated in controller 338 , and a preset amount of energy to be delivered can also be profiled.
- Circuitry, software, and feedback to controller 338 result in process control and maintenance of the selected power, and are used to change: (i) the selected power, including RF, microwave, laser, and the like, (ii) the duty cycle (on-off and wattage), (iii) bipolar or monopolar energy delivery mode, and (iv) infusion medium delivery, including flow rate and pressure, from infusion source 312 .
- These process variables are controlled and varied to maintain the desired delivery of power, independent of changes in voltage or current, based on temperatures monitored at sensors 324 .
- a controller 338 can be incorporated into feedback control system 329 to switch power on and off, as well as to modulate the power.
- tissue adjacent to RF electrodes 314 and 316 can be maintained at a desired temperature for a selected period of time, without causing a shutdown of the power circuit 340 to electrodes 314 and 316 due to the development of excessive electrical impedance at electrodes 314 and 316 or in adjacent tissue.
- Analog amplifier 344 can be a conventional differential amplifier circuit for use with sensors 324 .
- the output of analog amplifier 344 is sequentially connected by an analog multiplexer 346 to the input of A/D converter 348 .
- the output of analog amplifier 344 is a voltage which represents the respective sensed impedances/temperatures.
- Digitized amplifier output voltages are supplied by A/D converter 348 to a microprocessor 350 .
- Microprocessor 350 may be a Power PC chip available from Motorola, or an INTEL® PENTIUM® Series chip. However, it will be appreciated that any suitable microprocessor, or general purpose digital or analog computer, can be used to calculate impedance or temperature, or perform image processing and tissue identification functions.
- Microprocessor 350 sequentially receives and stores digital representations of impedance and temperatures. Each digital value received by microprocessor 350 corresponds to different temperatures and impedances. Calculated power and impedance values can be indicated on user interface and display 336 . Alternatively, or in addition to the numerical indication of power or impedance, calculated impedance and power values can be compared by microprocessor 350 with predetermined power and impedance limits. When the values exceed predetermined power or impedance values, a warning can be given on user interface and display 336 , and additionally, the delivery of RF energy can be reduced, modified, or interrupted. A control signal from microprocessor 350 can modify the power level supplied by energy source 320 to RF electrodes 314 and 316 .
- temperatures detected at sensors 324 provide feedback for determining the extent and rate of: (i) tissue hyperthermia, (ii) cell necrosis; and (iii) when a boundary of desired cell necrosis has reached the physical location of sensors 324 .
- impedance measurement device 19 can be incorporated or integrated into a single control and display device or unit 20 cd .
- Device 20 cd can be configured to include displays for one or more of the following: impedance profile 19 p , tissue site image 4 ′, tumor volume image 4 ′′, ablation volume image 4 av , time-temperature profiles, tissue identification information, and ablation setting information (e.g. power setting, delivery time, etc.).
- Device 20 cd can also be configured to superimpose ablation volume image 4 av onto tumor volume image 4 ′′ or tissue site image 4 ′, as well as to superimpose visual cues 4 c on the placement (including proper and improper placement) of apparatus 10 (including energy delivery devices 18 ) within the tumor volume 5 ′′ or tissue site 5 ′.
- Device 20 cd can also include controls 20 ck for manipulating any of the images ( 4 ′, 4 ′′ or 4 av ) in one or more axis.
- impedance measurement device 19 or control system 329 can be configured to switch from a first mode of measuring impedance to a second mode, when certain system impedance or power conditions occur.
- the first mode of measuring impedance is done utilizing the RF treatment power, and then impedance is calculated using a measured current and voltage as described herein.
- the accuracy and precision of localized impedance measurements decreases as a result of the decrease in the impedance measurement current in relation to noise levels of the RF power system. This is a problem not recognized nor addressed by current RF ablative and related impedance measurement devices.
- logic resources 19 lr within monitoring device 19 can be configured to switch to a second mode of measuring localized impedance.
- the threshold event causing the mode switching can be selectable, and include one or more of the following events: decreases in treatment (e.g. RF) power below a threshold level 20 pt , increases in system impedance above a threshold level 20 it , changes in slope (e.g. derivative) of the RF power or system impedance curves.
- the threshold level 20 pt of RF treatment power 20 p causing mode switching can be in the range from 1 to 50 watts, with specific embodiments of 5, 10 and 25 watts.
- the second or alternative mode of measuring impedance can comprise superimposing a duty cycled measurement signal 20 e onto the treatment signal 20 t .
- the pulse duration 20 pd of signal 20 e can be in the range of 1 to 500 ms, with specific embodiments of 50, 100 and 250 ms.
- the duty cycle 20 dc of signal 20 e can be in the range from 1 to 99%, with specific embodiments of 10, 25, 50 and 75%.
- Monitoring device 19 , power source 20 , or control system 329 can be configured to control the power amplitude of the measurement signal 20 e to maintain a selected total amplitude 20 at .
- the total power amplitude 20 at can range from about 5 to about 50 watts, with specific embodiments of 10, 20, 30 and 40 watts.
- the duty cycle, pulse duration, and total power amplitude can be controlled to deliver a selectable average power over the duty cycle, which can be in the range of about 0.5 to about 10 watts, with specific embodiments 1, 2, 5 and 5 watts.
- a selectable average power over the duty cycle can be in the range of about 0.5 to about 10 watts, with specific embodiments 1, 2, 5 and 5 watts.
- these and related embodiments of alternative mode of impedance measurements provide the benefit of improved accuracy and signal to noise ratios of impedance and related bio-electric measurements under conditions of high system impedance and/or low levels of delivered RF treatment power (i.e. ablative power).
- the duty cycle and/or pulse duration can be configured to vary responsive to one or more selected parameters, which can include frequency of the treatment signal, power for the treatment signal, or tissue impedance to the treatment signal.
- the variation in either the pulse duration or duty cycle can be controlled by control system 329 and/or logic resources 19 lr of the impedance monitoring device 19 or power supply 20 , using control methods known in the art, such as PID control.
- these embodiments allow the impedance measurements to be continuously fine tuned to changing system conditions to improve the accuracy and precision of impedance and related bioelectric measurements.
Abstract
Description
- This is a continuation of U.S. application Ser. No. 09/916,214, filed Jul. 25, 2001, which claims priority to provisional application No. 60/220,639, filed Jul. 25, 2000. These related applications are incorporated herein in their entirety by express reference thereto.
- This application relates generally to a method for performing tissue characterization using minimally invasive methods. More particularly, the application relates to a method and apparatus for performing an in vivo tissue characterization to identify and discriminate between diseased and healthy tissue using localized measurement of tissue impedance. Still more particularly, the application relates to method and apparatus for performing tissue characterization before, during and after ablative therapy using localized complex impedance measurement to monitor and titrate the delivery of ablative therapy to improve clinical outcomes.
- Various ablative therapies such as radio-frequency ablation, microwave ablation, and laser ablation can be used to treat benign and cancerous tumors. In theory, such methods are intended to produce physiological and structural changes to cause cell necrosis or destruction of the selected target tissue. However, in practice, there are numerous difficulties in the use of ablative procedures to treat cancerous tissue; these include: (i) locating the target tissue, (ii) identifying or biopsying the disease state of the tumorous tissue, (iii) distinguishing between diseased tissue versus healthy tissue, (iv) placing and maintaining the position of the ablation apparatus within the target tissue site, (v) monitoring the progress of ablation (including the developing ablation volume), (vi) minimizing injury to adjacent critical structures, (vii) assuring complete ablation of the tumor mass (including assurance of a sufficient healthy tissue margin), and (viii) assessing degree of the completed ablation. Current ablative therapies have not considered nor provided solutions to these problems. Thus, there is a need for an apparatus and method to address these difficulties and other unmet needs in performing ablative therapies for the treatment of cancer, tumors and other diseases.
- One method of treatment involves providing one or more radio-frequency energy delivery members configured for tissue insertion; inserting at least one of the delivery members into a tissue; forming a tract in the tissue by the delivery member; and moving the delivery member along the formed tissue tract while ablating the formed tissue tract with radio-frequency energy that is delivered by the delivery member. The tissue may include living malignant cells, while the ablated tissue tract is substantially free of living malignant cells. The delivery member may include one or more deployable delivery members therein. The delivery member may include one or more fixed or movable insulative members. The delivery member may be an introducer. The delivery member may include a conductive distal portion through which the ablative radio-frequency energy is delivered to the tissue tract.
- One apparatus may include one or more radio-frequency energy delivery members configured for insertion into a tissue to form a tract therein, a radio-frequency power source coupled to at least one of the delivery members, and one or more logic resource coupled to the power source and to the at least one delivery member. At least one of the logic resources may include an algorithm or software configured for enabling the delivery of radio-frequency energy from the power source to the at least one delivery member for ablation of the tissue tract.
- Another apparatus may include one or more delivery members configured for insertion into a tissue to form a tract therein. At least one of the delivery members may include one or more electrically conductive areas for the delivery of thermal ablative energy to the tissue tract, one or more outer impedance sensor, and one or more inner impedance sensing members positionable within the delivery member. At least one of the outer sensors and at least one of the inner sensing members may be configured for bipolar measurement of localized impedance of a tissue volume adjacent to the at least one inner sensing member. The at least one delivery member may be deployable. The at least one delivery member may include at least one insulative member disposed adjacent to a distal portion that includes at least one of the electrically conductive areas.
- A further apparatus may include one or more delivery members configured for insertion into a tissue to form a tract therein. At least one of the delivery members may include one or more electrically conductive areas for delivery of electroporation ablation therapy to the tissue. At least one of the conductive areas may be also for the delivery of thermal ablative energy to the tissue tract. The apparatus may include multiple electrically conductive areas disposed on different treatment delivery devices. The apparatus may include multiple electrically conductive areas disposed on different delivery members that are parallel to each other and electrically isolated from each other. The apparatus may include multiple electrically conductive areas disposed on one of the delivery members and electrically isolated from each other.
-
FIG. 1 is a lateral view illustrating the placement of a treatment apparatus at a tissue site. -
FIG. 2 is a lateral view of an apparatus including an elongated delivery device, impedance sensor array, sensors, resilient members, energy delivery device and advancement member. -
FIG. 3A is a schematic view of an impedance sensor array configured to measure impedance of a tissue volume via a plurality of selectable conductive pathways. -
FIG. 3B is a schematic view illustrating the use of primary and secondary conductive pathways and conductive pathway angle there between. -
FIG. 4A illustrates an embodiment of the apparatus having a centrally positioned return electrode surrounded by other impedance sensing members. -
FIG. 4B illustrates an embodiment of the apparatus having a centrally positioned return electrode surrounded by other impedance sensing members. -
FIG. 4C illustrates an embodiment of the apparatus having the return electrode eccentrically positioned with respect to other impedance sensing members. -
FIG. 4D illustrates an embodiment of the apparatus having multiple and independently positionable impedance sensor arrays. -
FIG. 5 is a perspective view illustrating the use of multiple groups of conductive pathways to sample multiple tissue volumes as well as to determine impedance vectors and loci of impedance for each sampled volume. -
FIG. 6 is a perspective view of an apparatus including an impedance monitoring device having memory resources and logic resources (including software modules) to analyze impedance data and generate impedance profiles and images. -
FIG. 7A is a plot of tissue impedance curve illustrating the frequency dependency of impedance. -
FIG. 7B is a plot of tissue complex impedance curves illustrating the frequency dependency of complex impedance. -
FIGS. 8A-8D are plots of impedance curves illustrating the use of multiple frequency impedance curves to monitor the time course of an ablation. -
FIGS. 8E-8G are plots of complex impedance curves (imaginary vs. real values) illustrating the use of complex impedance curves to monitor the time course of an ablation. -
FIGS. 9A-9C are plots of complex impedance curves illustrating the use of complex impedance curves to identify tissue type or condition. -
FIG. 10 is a three-dimensional plot of complex impedance. -
FIG. 11 is a plot of signal intensity verses time for a sample volume of ablating tissue, illustrating quantitative determinants of an ablation endpoint. -
FIG. 12A is a lateral view illustrating an embodiment of the introducer. -
FIGS. 12B and 12C are cross sectional profiles of the introducer. -
FIG. 13 is a lateral view of a deflectable introducer. -
FIG. 14 is a lateral view of a tissue biopsy and treatment apparatus with a hand piece and coupled aspiration device, fluid delivery device, and fluid reservoir. -
FIGS. 15A-15H are lateral views of the electrodes, including ring-like, ball, hemispherical, cylindrical, conical, needle-like, extended conical and a combination of a conical and needle-like. -
FIG. 16 is a lateral view illustrating a needle electrode configured to penetrate tissue. -
FIG. 17 is a lateral view illustrating electrodes having at least one radius of curvature. -
FIG. 18 is a lateral view illustrating electrodes having at least one radius of curvature, sensors, and a coupled advancement device. -
FIG. 19 is a perspective view illustrating insulation sleeves positioned at exterior surfaces of sensing members or resilient members so as to define an impedance sensor length or an energy delivery surface. -
FIG. 20 is a perspective view illustrating electrodes with multiple insulation sleeves that circumferentially insulate selected sections of the electrodes. -
FIG. 21 is a perspective view illustrating electrodes with insulation that extends along longitudinal sections to define adjacent longitudinal energy delivery surfaces. -
FIG. 22 is a cross-sectional view of the embodiment ofFIG. 21 . -
FIG. 23 is a lateral view of an apparatus with electrodes having a lumen and apertures configured for the delivery of fluid, and the use of infused fluid to create enhanced electrodes. -
FIG. 24 is a perspective view of an impedance-sensing member that includes a conductive coating that can be configured to produce an impedance gradient along the sensing member. -
FIGS. 25A-25C are perspective views of energy delivering ablation apparatuses using frequency controlled positionable ablation fields. -
FIGS. 26A-26C are plots of energy density or concentration versus lateral distance from the electrode/energy delivery device of the embodiments ofFIGS. 25A-25C . -
FIG. 27 is a flow chart illustrating a method for generating and displaying impedance derived images. -
FIG. 28 is a block diagram illustrating components for a feedback control system. -
FIG. 29 is a block diagram illustrating components for a control system. -
FIG. 30 is a lateral view illustrating a control and display unit. -
FIG. 31 is a plot showing an impedance measurement duty cycled signal superimposed on an RF treatment signal under selectable threshold conditions. - Embodiments of the present application provide an apparatus and method for performing tissue characterization using localized impedance measurement including complex impedance measurement to locate and diagnose a tumor, accurately position an ablative apparatus, monitor the progress of an ablative treatment and determine clinical endpoints. Further, these and other embodiments can be configured to measure and analyze bioelectric parameters with enhanced predictive power of cell metabolism, along with associated images that allow for real time control of the ablative process, awhile significantly reducing the risk of incomplete ablation or unwanted damage to critical anatomical structures. Each of the disclosed embodiments may be considered individually or in combination with other variations and aspects of the application. The method and apparatus provided herein are useful in treating cancerous tumors in organs and tissue throughout the body, including, but not limited to, the liver, bone, breast, lung and brain. They are also useful and equally applicable for treatment of benign tumors, growths and otherwise abnormal or enlarged tissue that requires removal, resection or modification by surgical or minimally invasive means.
- Localized monitoring of impedance is particularly beneficial for use in the treatment of tumors and tumorous tissue by ablative therapies, such as RF ablation, microwave ablation, laser ablation and chemical ablation. These and related ablative therapies cause disruption of cell membranes, resulting in impedance change in the interstitial fluid, but only in the affected tissue, with minimal or no changes to the surrounding tissue. Previous attempts to measure impedance using a full electrical circuit through the patient's body had the drawback of not being able to detect tissue localized impedance by failing to consider the problems involved, including the following: (i) the signal is too small in relation to, and/or masked out by, the impedance of the entire impedance measurement system (including the conductive pathway through body, the ground pad electrodes, and associated wires); (ii) the measurement is made too far away on the body from the desired tissue site, and is thus again masked out; and (iii) the localized impedance is masked out by RF or other ablative energy signal delivered to the tissue. Embodiments of present application provide solutions to these problems by detecting localized impedance changes, particularly those changes occurring during an ablation procedure, through the use of impedance arrays positioned at the target tissue to measure impedance, including complex impedance and other bioelectric properties described herein.
- A discussion will now be presented of impedance measurement theory and impedance measurement methods employed by embodiments of the application. In order to measure tissue impedance or impedivity (which typically has units of impedance/cc of tissue at 20° C.), a current is applied across the tissue and the resulting voltages are measured. This current, known as the excitation current or excitation signal, is relatively small in comparison to an ablative RF or other ablative current, and hence results in no appreciable ablative effect. In various embodiments, the excitation current can range from 0.01 mA to 100 amps, with specific embodiments of 0.1, 1.0 and 10 amps, which can be delivered in a continuous or pulsed fashion using a duty cycle. In various embodiments, the duty cycle can be in the range of 5 to 50%, with a pulse duration of 10 to 200 ms. The average power delivered over the course of the duty cycle can be in the range of 0.1 to 10 watts. In these and related embodiments, the excitation current source is used to measure voltage differences between two or more selected impedance sensors/sensing member in a bipolar mode or between one or more sensors/sensor members and a common ground in a monopolar mode. The known excitation current and the measured voltage are then used to derive impedance using algorithms and methods described herein and/or known in the art.
- Because different frequencies are conducted differently through different tissue types, some tissue is more or less conductive at certain frequencies than others. Accordingly, depending upon the tissue type or condition to be detected, the sensing or excitation signal can be varied or otherwise controlled to improve one or more of the sensitivity, accuracy, precision and resolution of an impedance measurement. In various embodiments, the excitation signal can be a mono-frequency signal or a multi-frequency signal, and can be constant or variable. In an embodiment, improved signal resolution, and thus more precise tissue analysis and characterization, can be achieved by use of a multi-frequency excitation signal and/or an excitation signal varied across a broad range of frequencies. In various embodiments, this range of frequencies can be from about 1 Hz to about 1 MHz, with specific embodiments of 0.5 Hz, 1, 5, 10, 25, 50, 100, 250, 500 and 750 kHz. Since the bioelectric distinctions (e.g. phase angle, impedance) between cancerous and healthy tissue can be the greatest at low frequencies, such as 100 Hz, in exemplary embodiments, measurements can be taken over a plurality of excitation frequencies below 100 Hz, with specific embodiments of 3, 4, 10 and 20 Hz. Other embodiments can be combining measurements below 100 Hz with those between 100 Hz to 5 kHz.
- Further embodiments of the application can be configured to measure impedance at different excitation frequencies (either concurrently or sequentially), to obtain more robust data and hence more refined clinical diagnostic information. Using these and other data and methods, a plot of impedance versus frequency can be generated for a sampled tissue volume and analyzed to determine tissue type and tissue conditions of the sampled volume, as is more fully described herein.
- Complex impedance includes both real and imaginary components, which reflect the phase shift between voltage and current (e.g. the voltage can lead or lag current depending on the electrical properties of the tissue). Various embodiments of the application can be configured to record both the real and imaginary components of complex impedance. This provides the benefit of providing more comprehensive information on the tissue, allowing analysis with a greater degree of accuracy, precision and resolution. These components can be determined by passing an excitation current through the target tissue and measuring impedance and/or any phase shift between the current and voltage as the signal is conducted through the target tissue.
- In related embodiments, real and imaginary components of impedance can be used to determine intracellular impedance, interstitial impedance and cell membrane capacitance. These three elements, alone or in combination, can be used to uniquely characterize and identify tissue type and condition with increased amounts of specificity. In an embodiment, the monitoring device, or other logic resources, can be configured to utilize one or more of these three parameters (the “three parameters”) to characterize an amount of ablation or progression of tissue ablation from an ablative treatment, such as RF ablation or ablative methods described herein. The characterization can be done by a software module resident within the monitoring device, power supply, or coupled logic resources, all described herein.
- In specific embodiments, the three parameters can be used to detect various physiologic indicators of ablation and cell necrosis, including cell lysis, cell membrane swelling (indicated by an increase in membrane capacitance), cell membrane rupture (indicated by a sharp decrease in membrane capacitance), a decrease in extracellular fluid (indicated by an increase in intracellular impedance), and an increase in intracellular fluid (indicated by a decrease in extracellular fluid). Other parameters which can be calculated and used for detection and control purposes include the absolute value of the impedance or admittance, the phase of the impedance (e.g. the phase difference between the current and the voltage), the capacitance, or a function of a combination of the impedance and admittance components.
- Specific embodiments of the application can be configured to detect and/or control for threshold increases or decreases in one or more of the three parameters (or other variables), including increases or decreases in the ranges of 1.1:1.0 to 100:1.0, with specific embodiments of 1.5:1.0, 2:1, 3:1, 4:1, 5:1, 10:1, 20:1 and 50:10. Related embodiments can be configured to detect and/or control for combinations of increases or decreases in the parameters, including, but not limited to: a rise followed by a decrease in extracellular impedance, a decrease followed by an increase in intracellular impedance; and an increase followed by a decrease in cell membrane capacitance. Other related embodiments can be configured to detect, monitor and control for changes in the slopes of the curves of one or more of the three parameters. Still other related embodiments can employ PID control methods known in the art, utilizing combinations of proportional, integral or derivative changes in the three-parameter curves.
- Embodiments of the application can incorporate the three parameters into electronic algorithms/software programs which are configured to do one or more of the following: (i) control the delivery of power to the target tissue site, (ii) provide the medical practitioner with prompts and diagnostic information about the course of the ablation/treatment process, and (iii) provide the medical practitioner with an indication of a clinical endpoint.
- Referring now to the drawings,
FIG. 1 shows an embodiment of an impedance monitoring andtreatment apparatus 10 configured to detect and treat atumor mass 5″ in atarget tissue site 5′, by sampling theimpedance 19 p of thetissue mass 5″ and delivering energy or other ablative treatment to produce anablation volume 5 ay. Theapparatus 10 can be configured to measureimpedance 19 p, including complex impedance, before, during and after an ablation, so as to perform tissue identification at thetarget site 5′, monitor the progress of an ablation procedure (including the developingablation volume 5 av), and quantitatively determine a clinical endpoint for the procedure. - Referring now to
FIGS. 1 and 2 , an embodiment oftreatment apparatus 10 comprises an elongated member orintroducer 12 having alumen 13, aproximal portion 14, adistal end 16, one or moreresilient members 18 positionable inlumen 13, and one ormore impedance sensors 22 disposed onmembers 18, orimpedance sensing members 22 m positionable inlumens 72 disposed withinmembers 18.Distal end 16 may be sufficiently sharp to penetratetissue 5, including fibrous and/or encapsulated tumor masses, bone, cartilage and muscle.Lumen 13 may extend over all or a portion of the length ofintroducer 12.Members 18 can comprise a plurality ofresilient members 18 pl configured to be positionable inlumen 13, and advancable in and out ofdistal end 16 by anadvancement device 15 oradvancement member 34, or other means described herein.Resilient members 18 can be deployed with curvature fromintroducer 12 to collectively define avolume 5 av intarget tissue site 5′. In an embodiment, all or a portion of one or more ofmembers 18 can be an energy delivery device orenergy delivery member 18 e described herein.Energy delivery device 18 ormember 18 e can be coupled to an energy source orpower supply 20 and can also include one ormore lumens 72. - Embodiments of the application can be adapted, integrated, or otherwise applicable to a number of ablative therapies, including, but not limited to, radio-frequency (RF) ablation, cryo-ablation, brachytherapy, alcohol tissue ablation, chemical ablation, microwave ablation, laser ablation, thermal ablation, electroporation ablation, conformal beam radiation ablation, standard radiation ablation, high intensity focused ultrasound ablation, photo-dynamic therapy ablation. These and related embodiments can comprise an energy delivery device and sensing device coupled to a power supply.
- For ease of discussion, the energy delivery device and
sensing apparatus 10 will be an RF based apparatus andpower supply 20 will be a RF power supply; however, all other embodiments discussed herein are equally applicable. In an embodiment, theRF power supply 20 can be an RF generator configured to deliver a treatment current 20 t for tissue ablation, while simultaneously or near simultaneously (using a multiplexing/switching device) delivering a low power sensing orexcitation signal 20 e at one or more frequencies for making complex impedance measurements and subsequent analysis of thetarget tissue 5′. Theexcitation signal 20 e can be delivered across a broad band of frequencies in the range of 1 to 1 MHz. In various embodiments, theexcitation signal 20 e is delivered at a lower frequency than the treatment signal 20 t (typically 460±60 kHz). In an embodiment, theexcitation signal 20 e is less than 400 kHz. In other embodiments, thesensing signal 20 e is in the range of 1 Hz to 100 kHz, with specific embodiments of 0.25, 0.5, 1, 5, 10, 25, 50 and 75 kHz. In alternative embodiments, theexcitation signal 20 e is delivered at frequencies above the treatment frequency and thus can be greater than 520 kHz. Further, the frequency and power differences between the excitation and treatment signals 20 e and 20 t can be monitored and set-point controlled using circuitry and control algorithms known in the art. Also, the frequency and power difference between the twosignals 20 e and 20 t can be varied responsive to one or more electrical parameters, to maximize the accuracy and precision ofimpedance measurements 19 p and reduce interference (e.g. bleed over) from the treatment signal 20 t. These electrical parameters include, but are not limited to, impedance, treatment current, treatment frequency, excitation current and excitation frequency. - In various embodiments,
introducer 12 can be flexible, articulated and steerable, and can contain fiber optics (both illumination and imaging fibers), fluid and gas paths, and sensor and electronic cabling. In an embodiment,introducer 12 can be configured to both piercetissue 5 and be maneuverable withintissue 5. This can be achieved through the use of flexible portions coupled to a tissue piercingdistal end 16 that can be a needle or trocar tip integral or joined tointroducer 12.Introducer 12 can be sufficiently flexible to move in any desired direction throughtissue 5 to a desiredtissue site 5′. In related embodiments,introducer 12 is sufficiently flexible to reverse its direction of travel and move in a direction back upon itself. This can be achieved through the use of flexible materials and/or deflecting mechanisms described herein. Also,introducer 12 can be coupled at itsproximal end 14 to a handle orhandpiece 24.Handpiece 24 can be detachable and can includeports 24′ andactuators 24″. - One or
more impedance sensors 22 can be coupled tointroducer 12,resilient members 18, orenergy delivery device 18 e. In an embodiment,sensors 22 can comprise one ormore sensing members 22 m that can be positionable withinlumens 72 ofmembers 18, and configured to be advancable in and out ofindividual members 18, or can be coupled to an exterior ofresilient member 18.Sensing members 22 m can comprise a plurality ofmembers 22 mpl positioned in multipleresilient members 18. Also,apparatus 10 can haveimpedance sensors 22 disposed along elongatedmember 12 and other locations outside of thetarget tissue site 5′ for measurement and determination of the total impedance across the full electrical circuit between the terminals of power supply 20 (i.e. through the patient's body and to the ground pad). The total impedance can be monitored and otherwise utilized to improve the accuracy and precision of the localized impedance measurement from thetarget site 5′. -
Impedance sensing members 22 m, orsensors 22, coupled toresilient members 18 can be deployed independently or simultaneously to enable probing oftarget tissue 5′ in multiple locations, so as to measureimpedance 19 p in multiple locations and/or through multipleconductive pathways 22 cp (FIGS. 3A-3B ). Deployment ofimpedance sensing members 22 m orsensors 22 can be controlled such that telemetry can be used with impedance feedback to identify tissue types and map the topography of tissue masses, tumors or tissue structures. -
Impedance sensing members 22 m can also be deployed with curvature frommembers 18 to collectively define avolume 5 sv (also calledsample volume 5 sv) that is volumetrically sampled by sensingmember plurality 22 mpl. Collectively, theplurality 22 mpl of deployedimpedance sensing members 22 m, or theplurality 18 pl of deployedresilient members 18 with coupledimpedance sensors 22, can comprise a three-dimensional or volumetricimpedance sensor array 22 a. By havingsensors 22 in multiple locations and planes,sensor array 22 a is configured to volumetrically sample (e.g. sample in multiple locations and through multiple conductive pathways) tissue withintarget tissue site 5′, includingtumor mass 5″.Sensor array 22 a is further configured to be able to simultaneously sample tissue at multiple locations withinvolume 5 sv ortissue site 5′, to perform one or more of the following: (i) locate the position of thetumor mass 5″, (ii) discern the position or deployment distance of theenergy delivery members 18, (iii) monitor the developingablation volume 5 av, (iv) perform tissue sensing identification by comparingimpedances 19 p between two or more sites (e.g. known healthy tissue and suspecteddiseased tissue 5″). In variousembodiments sensor array 22 a and/ormember plurality 18 pl can be configured to define a variety of shapes forsample volumes 5 sv, including, but not limited to, a hemisphere, a sphere, an oval, a cone, a pyramid, a polyhedron or a tetrahedron. - Each
resilient member 18 can have one or moreimpedance sensing members 22 m and/orsensors 22 that can be arranged in a variety of configurations to perform one or more of the desired functions described herein (e.g. tissue identification, ablative monitoring, etc.). Referring now toFIG. 3A , sensingmembers 22 m can be configured to measure impedance in either bipolar mode (between two ormore members 22 m) or mono-polar mode (between one or more selectedmembers 22 m and a common ground, such as aground electrode 22 g orground pad electrode 22 gp). Switching between the two modes can be controlled by logic resources and/or a switching or multiplexingdevice 29 coupled to, or integral with, animpedance monitoring device 19 orpower supply 20. Further, switchingdevice 29 can be configured to allow the user to define and select one or moreconductive pathways 22 cp to measure impedance. In use, these and related embodiments allow the user to select any number ofconductive pathways 22 cp and in apattern 22 pp that circumscribe or otherwise defines asample volume 5 sv of interest. Also, the use of switchingdevice 29 in these embodiments allows the user to measure impedance simultaneously or sequentially through the selectedpathways 22 cp. Further, switchingdevice 29 and/orapparatus 10 can be so configured to allow the user to dynamically change or switch betweenpathways 22 cp, to do one or more of the following: (i) change the number ofpathways 22 cp through a selectedsample volume 5 sv, allowing increased signal resolution and statistical confidence of predicted tissue conditions; (ii) change the angle between two or moreconductive pathways 22 cp; (iii) change the size of thesample volume 5 sv; (iv) switch between a first andsecond sample volumes 5 sv; and (v) compare two ormore sample volumes 5 sv simultaneously. - In an embodiment shown in
FIG. 3B ,conductive pathways 22 cp can include a primary pathway(s) 22 cp′ and an alternative pathway(s) 22 cp″. Thealternative pathway 22 cp″ can be at aselectable angle 22 cpa from theprimary pathway 22 cp′, and can share points in common with theprimary pathway 22 cp′.Suitable angles 22 cpa include the range of 1° to 360°, with particular embodiments of 30°, 45°, 90° and 270°, from alateral axis 22 la of theprimary pathway 22 cp′. Alternatively, the alternativeconductive pathway 22 cp″ can share one or more points in common with theprimary pathway 22 cp′, or be parallel with theprimary pathway 22 cp′ but offset aselectable lateral distance 22 ld. Also, repetitive scans of impedance, including sweep scans and sequential sweep scans (e.g. sequentially sampling from one side of asample volume 5 sv to the other, similar to radar), can be made through one or more selectedconductive pathways 22 cp of a selectedsample volume 5 sv to monitor the time course of ablation, as well as to obtain improved signal to noise ratios and signal resolution for image analysis. - Changing the
angle 22 cpa and/or lateral offset 22 ld of theconductive pathways 22 cp used to measure impedance can be accomplished through a variety of means, including, but not limited to: (i) selectively switchingimpedance sensors 22 orsensing elements 22 m off and on; (ii) selectively switchingsensing elements 22 m from a monopolar mode to a bipolar mode, and visa versa (for RF embodiments), usingswitching device 29; (iii) configuring theprobe array 22 a (FIG. 3A ) to be rotatable and/or deflectable; and (iv) using and/or deploying asecond array 22 a either on thesame device 10 or on a different device. Switching can be accomplished through the use of a switching or multiplexingdevice 29, which can be programmable or controlled bylogic resources 19 lr (FIG. 2 ) described herein. - In one embodiment, the data from alternative
conductive pathways 22 cp″ or group ofpathways 22 cp can be integrated with measurements from the primaryconductive pathways 22 cp′ for analysis and imaging purpose or, in an alternative embodiment, can be analyzed and displayed separately, allowing for a comparison of both measurements and images from the primary and alternative groups ofpathways 22 cp. The benefit of the former is a more representative and uniform sampling of impedance, and the later the ability to detect for uniformities of impedance within the sampledvolume 5 sv. - In use, such embodiments allow the medical practitioner to sample or image a
larger tissue volume 5 sv than single pathway sampling, and to samplemultiple tissue volumes 5 sv, including simultaneous sampling, without having to reposition theapparatus 10 orimpedance array 22 a (FIG. 3A ). This capability reduces procedure time, and generally enhances the usability of theapparatus 10. Further, such embodiments also provide a more accurate and representative signal of thetarget tissue volume 5 sv by selectingconductive pathways 22 cp to control the shape and size of thesample volume 5 sv, to sample only the area of interest, thereby eliminating any potential masking or undesired impedance contribution from surroundingnon-target tissue 5. Also, the ability to switch theangle 22 cpa of thepathways 22 cp eliminates or reduces any directional bias in the impedance measurements. Finally, by virtue of having a larger and volume distributed sample size for a given volume oftissue 5 sv, the use of multiple conductive pathway impedance measurements provides a more representative measurement of impedance for the selectedvolume 5 sv, thereby improving the accuracy and precision of the impedance measurement as well as improving signal and image resolution in one or all three dimensions. - Referring now to
FIGS. 4A-4D , in various embodiments,impedance sensing members 22 m can be arranged in arrays (22 a 1, 22 a 2) having a variety of geometric arrangements and relationships, so as to electrically sampledifferent volumes 5 sv of tissue using differentconductive pathways 22 cp. Such embodiments provide the benefit of improved acquisition, accuracy and analysis of the impedance signal from a givensample volume 5 sv to compensate for signal hysteresis, noise (due to energy delivery etc.), directional bias, or other error. They also provide the benefit of simultaneous sampling and comparison of two ormore tissue volumes 5 sv to perform tissue identifications. -
Conductive pathways 22 cp can have a variety of configurations and orientations, all selectable by the user. In an embodiment, theconductive pathways 22 cp can be evenly distributed or spaced within thesample volume 5 sv. This can be achieved by either the configuration of themembers 22 m, through the use of switchingdevice 29, or a combination of both. Alternatively, theconductive pathways 22 cp can be aligned with respect to one ormore sensing members 22 m, theintroducer 12, or thetumor volume 5″ itself. In an embodiment, shown inFIGS. 4A-4B , onemember 22 mc can be positioned at the center ofsample volume 5 sv, withother members 22 m positioned in a surrounding relationship, so excitation current travels in aplurality 22 pp ofconductive pathways 22 cp to and from the center of thesample volume 5 sv to the surroundingimpedance sensing members 22 m. In use, this configuration results in an impedance measurement for thesample volume 5 sv, which is an average of the individual impedance measurements for eachconductive pathway 22 cp, providing the benefit of a more a statistically representative sample of impedance for a selectedtissue volume 5 sv than provided by a single pathway sampling alone. Surroundingmembers 22 m can be collectively coupled to a positive terminal ofpower supply 20, withmember 22 mc configured as a return electrode and coupled to a return terminal ofpower supply 20. - In a related embodiment, shown in
FIG. 4C ,member 22 mc can be eccentrically positioned with respect tomembers 22 m and/or positioned on the periphery of asample volume 5 sv defined bymembers 22 m. Again, this embodiment provides the benefit of an average, and thus more representative, impedance measurement for thesample volume 5 sv. However, this configuration also provides the benefit of being able to more readily detect and locate non-uniformities 5 nu (in impedance and hence tissue properties) occurring on the boundaries or otherwise non-centered portions of thetissue volume 5 sv. Use of switchingdevice 29 allows for the dynamic switching of any of thesensing members 22 m to areturn electrode 22 mc to more readily detect the location of a potential non-uniformity within thesample volume 5 sv, by rapidly scanning different portions of the periphery of thevolume 5 sv. - Alternatively, as shown
FIG. 4D ,members 22 m can comprise afirst array 22 a 1 (such as perpendicular array) and asecond array 22 a 2.First array 22 a 1 can be rotated to obtain different conductive pathways tosecond array 22 a 2 so as to sample different tissue volumes and/or provide multiple samplings of the same volume (via different conductive pathways), to improve accuracy and precision of the measurement, and reduce noise. In use, this embodiment also allows detection of incomplete ablation by comparing a measured impedance from a first group ofconductive pathways 22cp 1 defined byfirst array 22 a 1 to a second group ofconductive pathways 22cp 2 defined bysecond array 22 a 2. - In various embodiments,
apparatus 10 can be configured to simultaneously sample different locations withintarget tissue site 5′ utilizing switching device ormultiplexer 29, or other switching means described herein or known in the art. In an embodiment, shown inFIG. 5 , a first group of selectedconductive pathways 22 cp′ can be used to sample a localfirst volume 5sv 1, and a second group of selectedconductive pathways 22 cp″ can be selected to do so for asecond volume 5sv 2, and a third group of selectedconductive pathways 22 cp′″ can be selected to do so for a larger orglobal sample volume 5sv 3 that is defined or circumscribed bymultiple sensor 22 tippedmembers 18 orsensing members 22 m. Each sample volume results in aseparate impedance profile 19 p. Thus,sample volumes 5sv sv sv 3produce impedance profiles 19p p p 3, respectively, all or portion of which can be compared to one another or a database ofimpedance profiles 19 db, using comparison/pattern recognition algorithms ofmodule 19 m, or other software or computational means. In a related embodiment, the measured impedance signal for each sample volume can be integrated or otherwise analyzed bymodule 19 m, or other computational means, to determine an impedance vector 22 v andlocus 221 of impedance for each respective sample volume (e.g. impedance vectors 22v 1, 22v 2, and 22v 3,impedance loci - Referring now to
FIG. 6 , in an embodiment, one ormore impedance sensors 22 orsensing members 22 m ofapparatus 10 can be coupled to an impedance measurement andmonitoring device 19.Monitoring device 19 includes circuitry described herein to measure voltage from the excitation current and subsequently calculate impedance. Further,monitoring device 19 can also be configured to measure, calculate and record animpedance profile 19 p and acomplex impedance profile 19 pc resulting from various tissue bioelectric properties, including impedance, conductance, capacitance, etc. In an embodiment,monitoring device 19 can includelogic resources 19 lr, such as a microprocessor andmemory resources 19 mr (such as RAM or DRAM chip) configured to analyze, store and displaytissue impedance profile 19 p and/or other bio-electric information derived from sensingmember 22 m and/orsensing array 22 a.Impedance monitoring device 19 can also be coupled to adisplay device 21 so as to display real time or storedimpedance profiles 19 p, images, and other data generated byimpedance monitoring device 19. Examples ofdisplay devices 21 include cathode ray tubes (CRTs), liquid crystal displays, plasma displays, flat panel displays, and the like.Display device 21 can also be incorporated in an external computer coupled toimpedance monitoring device 19. - In various embodiments, impedance monitoring device 19 or power supply 20 can be equipped with a number of features, including but not limited to the following: (i) memory resources 19 mr containing a database 19 db of characteristic impedance profiles; (ii) a readout window for the impedance-based diagnosis of tissue type and/or condition; (iii) artificial intelligence algorithms/programming enabling the generator to learn from newly acquired impedance scans; (iv) ability for the user to enter and teach the generator the correct tissue type and condition, based on biopsy or pathology data; (v) ability to sense impedance on multiple frequencies simultaneously to improve speed and accuracy, and to reduce effects of interference; (vi) ability to work with non-invasive pads (like electro-physiology pads) for measurement of complex impedance, and for performing targeted tissue assessment non-invasively; (vii) ability to monitor a reference signal and/or basic patient electro-physiological conditions, for baseline comparisons with impedance readings and as additional information for the user; and (viii) programming to utilize the reference signal or signal to account for hysteresis, signal noise, cross talk and other signal interference, using digital subtraction, suppression and other signal processing methods known in the art, and thus improving a signal to noise ratio, signal sensitivity or resolution.
- In various embodiments,
apparatus 10, along withimpedance monitoring device 19, can be configured to perform tissue identification, differentiation, ablation monitoring, and mapping of tissue masses and structures. In specific embodiments,monitoring device 19 is configured to perform a tissue identification function, using impedance information derived fromsensors 22, sensingmembers 22 m, orarray 22 a. A discussion will now be presented on the background of tissue monitoring and identification using impedance measurement. Owing to variations in composition and morphology, various tissue types have different electrical properties (e.g. conductance, inductance, capacitance, etc.), and therefore conduct electrical energy differently, particularly at certain frequencies. For example cancerous tissue will typically have a significantly higher phase than the health tissue, particularly at low frequencies. These differences in electrical properties, particularly in conductance, result in acharacteristic impedance profile 19 p for a given tissue type or condition when the tissue is exposed to an excitation current at one or more specific frequencies.Impedance profile 19 p, which can have one ormore peaks 19 pk, curves 19 pc, and other shapes that serve as a fingerprint of the tissue type or tissue condition. Accordingly, by analyzing theimpedance profile 19 p and matchingpeaks 19 pk, curve shapes 19 pc, thresholds, etc.,profile 19 p can be utilized by embodiments of the application to identify tissue types and conditions, such as malignancy, vascularity, necrosis, thermal injury, etc. Related conditions that can also be identified using this approach include abnormally mutated tissue, abnormally dividing tissue, or hypoxic tissue. - Further, many tissue types, including cancerous tissues such as metastatic tissue, will have a
signature profile 19 p that can be readily identified and matched to a database ofprofiles 19 db, using pattern recognition techniques or algorithms known in the art. Accordingly,apparatus 10 can include electronic algorithms orsoftware modules 19 m resident inlogic resources 19 lr ofmonitoring device 19 or microprocessor 350 (FIG. 29 ) that are configured to analyze animpedance profile 19 p (including real and imaginary components), and perform tissue identification and/or tissue differentiation between one or more sampledvolumes 5 sv.Modules 19 m can include pattern recognition algorithms, curve fitting, fuzzy logic, or other numerical methods known in the art. Also in an embodiment,modules 19 m can be configured to compareprofile 19 p to a database ofprofiles 19 db stored inmemory resources 19 mr, and use curve fitting or other numerical methods known in the art to provide and display a correlation coefficient or statistic (e.g. p value) indicative of the probability of a match to a given tissue type or condition.Module 19 m can also include animaging sub-module 19 mi, described herein, to generate and display animpedance image 4′. - In various embodiments, the impedance and other bioelectric properties that can be analyzed to determine a tissue type or condition include: complex impedance (real and imaginary components), extracellular impedance, intracellular impedance, interstitial impedance, cell membrane capacitance, and intracellular capacitance. In an embodiment,
monitoring device 19 can be configured to analyze only selected frequencies of animpedance profile 19 p or other bioelectric property measurement that are known to identify, or correlate to, selected tissue characteristics, rather than analyzing the full frequency spectrum of theprofile 19 p. Such frequencies can be selected from apre-existing database 19 db, or determined in vivo using swept frequency methods described herein. This approach presents the advantage of shorter signal processing times, allowing a faster tissue assessment and diagnosis using fewer computational resources. In turn, this enables the size, power requirements, and complexity of the control anddisplay instrumentation 19 to be reduced. - Referring now to
FIGS. 7A-10 , in related embodiments,apparatus 10 andmonitoring device 19 can be configured to utilize complex impedance curves to identify and characterize different tissue types and conditions. Accordingly,monitoring device 19 can be configured to measure, generate, and display curves ofprofiles 19 pc of complex impedance.Curves 19 pc can be both two-dimensional and three-dimensional. For two-dimensional plots, the x-axis can be the real component and the y-axis the imaginary component (FIG. 7B ); while three-dimensional plots can include an axis for time or frequency. This can be accomplished via algorithms withinmodules impedance array 22 a, perform complex impedance calculations known in the art and curve fitting or transform functions described herein, and subsequently output animpedance profile 19 p that is displayed on display device 21 (FIG. 6 ). As shown inFIGS. 7A and 7B , because tissue conducts electrical current differently at different frequencies, measurements made across a range of excitation frequencies results in an impedancefrequency response curve 19 pf (FIG. 7A ), or a series of complex impedance frequency response curves 19 pcf (FIG. 7B ). Using either of the frequency response curves fromFIG. 7A or 7B, a particular frequency can be selected for subsequent impedance complex impedance measurements and analysis which has the greatest sensitivity for a given tissue type or condition and/or results in a complex impedance curve having the greatest predictive value for the desired tissue type or condition. The selection can be done using methods described herein, or by calibration against a set of in vitro standards representative of the desired tissue type or condition, by visual determination/estimation of the user, or a combination thereof. - As shown in
FIGS. 8A-8C , in an embodiment, the course of an ablation can be monitored using impedance measurements made at multiple frequencies. The impedance at some frequencies will rise, fall or do both over the time course of the ablation. By combining impedance data from multiple curves, the overall predictive value of the measurements for an ablation event or endpoint is greatly increased. Accordingly, using differential diagnosis methodology, an ablation monitoring algorithm ormodule 19 m can be configured to look for impedance characteristic curve shapes, slopes threshold, etc., in two or more impedance curves made at different frequencies as predictors of an ablation endpoint. Such information can be used to provide a more reliable indicator of clinical endpoint, as well as to monitor and titrate the delivery of ablative energy or ablative therapy according to the requirements. Similarly, as shown inFIG. 8 d, differences in the impedance-frequency spectrum pre-, inter-, and post-ablation can also be used to monitor and evaluate the ablation process. - In related embodiments, shown in
FIGS. 8E-8G , complex impedance curves 19 pc can be used to monitor and assess the ablation process, including determination of clinical endpoints, as described herein. Further, as shown inFIGS. 9A-9C , the apparatus can be configured to utilize complex impedance curves to identify and characterize different tissue types (tumors, etc.). Related embodiments can be configured to generate and display three-dimensional plots of complex impedance utilizing time and or position as the third axis. For positional 3-D plots, the locus of impedance 51 i can be calculated and graphically displayed, as is shown inFIG. 10 , or in 2-D plots as shown inFIGS. 9A-9C , or in another graphical format known in the arts. Also, impedance locus 51 i can be utilized to characterize the ablation process, and can be used to perform vector analysis of RF or microwave current or other ablative energy vector (e.g. the magnitude and direction of the ablative energy), as well as vector analysis of physiologic indicators of cell necrosis, such as changes in interstitial conductivity. In various embodiments, the impedance locus 51 i can be utilized to facilitate location and display oftumor volume 5″,ablation volume 5 av, or other desired tissue mass or volume, at the target tissue site. The generation and display of the impedance locus 51 i (in 2-D or 3-D) can be configured to provide the medical practitioner an easily discernable visual cue as to the location, size, or movement of theablation volume 5 av, thetumor volume 5″, or other selected tissue volume. - Referring to
FIG. 1 , in addition to identifying tissue types,monitoring device 19, along withimpedance sensing arrays 22 a, can also be employed to monitor in real time the progression of an ablative procedure, including the progression of anablation volume 5 av resulting from the delivery of energy to targettissue volume 5′. This reduces damage to tissue surrounding the targeted mass to be ablated. By monitoring the impedance at various points within and outside of the interior oftissue site 5′, a determination of the selected tissue mass periphery can be made, as well as a determination of when cell necrosis is complete. If at anytime sensor 22 determines that an impedance level or an ablation endpoint has been met or exceeded, then an appropriate feedback signal is inputted topower source 20, which then stops or otherwise adjusts the levels of ablative energy delivered toelectrodes target tissue site 5″ can also be probed and interrogated bysensor array 22 a after the completion of ablation, to confirm that ablation is complete for the entire desiredablation volume 5 av. By probing the ablated region withsensor array 22 a, the three-dimensional volume of theablation 5 av can be assessed, and themargin 5 m of ablated healthy tissue beyond thetumor mass 5″ can also be measured. - Referring now to
FIG. 11 , in embodiment for monitoring the ablative process, theimpedance signal intensity 19 si for a sample volume oftissue 5 sv bounded by two orsensing members 22 m orarray 22 a can be monitored over time, usingmonitoring device 19,supply 20, or other bioelectric signal monitoring means known in the art. An endpoint for ablation can be determined, based on either aselectable threshold value 19 ts ofsignal intensity 19 si, or an inflection point or change inslope 19 ds (e.g. a derivative) of the curve ofsignal intensity 19 si, or a combination of both. In an embodiment, the signal intensity curve can comprise the subtraction of a baseline (or reference)impedance measurement 19 sbl of a nearby, but non-ablated, tissue volume from areal time measurement 19 srt of thetarget tissue volume 5″ during the time course of ablation. This compensates for any signal or tissue hysteresis over time. Values for 19 ts and 19 ds can be input and stored inlogic resource 19 lr coupled to impedance monitoring 19 (FIG. 6 ), or incorporated into an electronic algorithm controlling the delivery of energy, which can be stored in a controller orprocessor 338 coupled to power supply 20 (FIG. 28 ). - Turning now to
FIGS. 12A-13 for a further discussion ofintroducer 12, in various embodiments,introducer 12 can be a trocar, a catheter, a multi-lumen catheter, a wire-reinforced or metal-braided polymer shaft, a port device, a subcutaneous port device, or other medical introducing device known to those skilled in the art. In various embodiments,introducer 12, as well asresilient member 18, can be configured to have varying mechanical properties along their respective lengths, including, but not limited to, variable stiffness, torquability, column strength, flexural modulus, pushability, trackability and other mechanical performance parameters known in the art. Referring toFIG. 12A , this can be achieved through the use ofstiff shaft sections 12′″ disposed within portions ofintroducer 12 along itslength 12′. It can also be accomplished through the use of braids, varying/tapered diameters, and different materials (e.g. stiffer materials joined to flexible materials) positioned over portions ofintroducer 12.Sections 12′″ made from different materials can be joined using introducer bonding methods known in the art, such as hot melt junctions (with or without capture tubes/collates), adhesive joints, butt joints, and the like. The joining method can be controlled/selected so as to control themechanical transition 12 mt between twosections 12′″ to a desired gradient (e.g. smooth vs. abrupt). In related embodiments,introducer 12 and/ormember 18 can be configured to have stiffer proximal portions and more flexible distal portions, so as to facilitate one or more of the following: (i) introducer steerability and positioning ofdistal tip 16 at a selectabletarget tissue site 5′; and (ii) reduced risk of perforation, abrasion and other trauma during the positioning theintroducer 12 to thetissue site 5′. In various embodiments, thetransition 12 mt from the stiffer portion to the more flexible portion can be configured to be either gradual with a linear or curve-linear transition 12 mt or a stepped orabrupt transition 12 mt, or combinations thereof. - Referring to
FIGS. 12B and 12C ,introducer 12 can have a substantially circular, semicircular, oval, or crescent shaped crosssectional profile 12 cs, as well as combinations thereof, along itslength 12′. Similarly,lumens 13 can have a circular, semicircular, oval, or crescent shaped crosssectional profile 13 cs for all or a portion of thelength 12′ ofintroducer 12. - Suitable materials for
introducer 12 andresilient member 18 include, but are not limited to, stainless steel, shape memory alloys such as nickel titanium alloys, polyesters, polyethylenes, polyurethanes, PEBAX®, polyamides, nylons, copolymers thereof, and other medical plastics known to those skilled in the art. All orportions 12′″ ofintroducer 12 can be coated with a lubricious coating orfilm 12″ which reduces the friction (and hence trauma) ofintroducer 12 with hepatic, pulmonary, bone, and other tissue.Such coatings 12″ can include, but are not limited to, silicones, PTFE (including TEFLON°), and other coatings known in the art. Also, all or portions ofapparatus 10, includingintroducer 12 andmembers 18, can be constructed of materials known in the art that are optimized and/or compatible with radiation sterilizations (e.g. Gamma or E-beam). In related embodiments, all or portions ofapparatus 10 can be configured (e.g. lumen diameter to length ratio, etc.) to be sterilized by plasma (e.g. H2O2) sterilization. - Referring now to
FIG. 13 , in other embodiments, all or portions ofintroducer 12 orresilient members 18 can be configured to be deflectable and/or steerable using deflection mechanisms 25, which can include pullwires 15, ratchets, cams, latch and lock mechanisms, piezoelectric materials, and other deflection means known in the art. The amount of deflection ofintroducer 12 is selectable, and can be configured to allow the maneuvering ofintroducer 12 through oblique turns in tissue, organs, organ ducts, and blood vessels. In specific embodiments, the distal portions ofintroducer 12 can be configured to deflect 0-180° or more in up to threeaxes 12 al to allow the tip ofintroducer 12 to have retrograde positioning capability. Deflection mechanism 25 can be coupled to or integral with a moveable orslidable actuator 24″ onhandpiece 24. Mechanism 25 and coupled actuator 25′ are configured to allow the physician to selectively control the amount of deflection ofdistal tip 16 or other portion ofintroducer 12. Actuator 25′ can be configured to both rotate and deflectdistal tip 16 by a combination of rotation and longitudinal movement. - Referring now to
FIG. 14 , in various embodiments,introducer 12 can be coupled at itsproximal end 14 to ahandle 24 orhandpiece 24.Handpiece 24 can be detachable and can includeports 24′ andactuators 24″.Ports 24′ can be coupled to one or more lumens 13 (and in turn lumens 72) and can include fluid and gas ports/connectors and electrical, optical connectors. In various embodiments,ports 24′ can be configured for aspiration (including the aspiration of tissue), and the delivery of cooling, electrolytic, irrigation, polymer and other fluids (both liquid and gas) described herein.Ports 24′ can include, but are not limited to, luer fittings, valves (one-way, two-way), toughy-bourst connectors, swage fittings, and other adaptors and medical fittings known in the art.Ports 24′ can also include lemo-connectors, computer connectors (serial, parallel, DIN, etc) micro connectors and other electrical varieties well known to those skilled in the art. Further,ports 24′ can include opto-electronic connections which allow optical and electronic coupling of optical fibers and/or viewing scopes to illuminating sources, eye pieces, video monitors and the like.Actuators 24″ can include rocker switches, pivot bars, buttons, knobs, ratchets, levers, slides, and other mechanical actuators known in the art, all or portion of which can be indexed. Theseactuators 24″ can be configured to be mechanically, electro-mechanically, or optically coupled to pull wires, deflection mechanisms, and the like, allowing selective control and steering ofintroducer 12.Handpiece 24 can be coupled to tissue aspiration/collection devices 26, fluid delivery devices 28 (e.g. infusion pumps), fluid reservoirs 30 (cooling, electrolytic, irrigation, etc.), orpower source 20, through the use ofports 24′. Tissue aspiration/collection devices 26 can include syringes and vacuum sources coupled to a filter or collection chamber/bag.Fluid delivery devices 28 can include medical infusion pumps, Harvard pumps, syringes, and the like. In specific embodiments,aspiration device 26 can be configured for performing thoracentesis. - Turning now to
FIGS. 1 , 2 and 14 for a discussion ofresilient members 18 andsensing members 22 m, these members can be of different sizes, shapes and configurations, with various mechanical properties selected for theparticular tissue site 5′. In one embodiment,members 18 can be needles, with sizes in the range of 28 to 12 gauge, with specific embodiments of 14, 16 and 18 gauges.Resilient members 18 are configured to be in non-deployed positions while retained inintroducer 12. In the non-deployed positions,resilient members 18 may be in a compacted state, spring loaded and generally confined withinintroducer 12, or substantially straight if made of a suitable memory metal such as nitinol. Asresilient members 18 are advanced out ofintroducer 12, they become distended to a deployed state, as a result of their spring or shape memory, that collectively defines anablative volume 5 av, from which tissue is ablated. The selectable deployment ofresilient members 18 can be achieved through one or more of the following: (i) the amount of advancement ofresilient members 18 fromintroducer 12; (ii) independent advancement ofresilient members 18 fromintroducer 12; (iii) the lengths and/or sizes of energy delivery surfaces ofelectrodes electrodes electrodes electrodes - As described herein, in various embodiments, all or a portion of
resilient member 18 can be anenergy delivery device 18 ormember 18 e. Turning to a discussion ofenergy delivery device 18 andpower sources 20, the specificenergy delivery devices 18 andpower sources 20 that can be employed include, but are not limited to, the following: (i) a microwave power source coupled to a microwave antenna, providing microwave energy in the frequency range from about 915 MHz to about 2.45 GHz; (ii) a radio-frequency (RF) power source coupled to an RF electrode; (iii) a coherent light source coupled to an optical fiber or light pipe; (iv) an incoherent light source coupled to an optical fiber; (v) a heated fluid coupled to a catheter, with a closed or at least partially open lumen configured to receive the heated fluid; (vi) a cooled fluid coupled to a catheter, with a closed or at least partially open lumen configured to receive the cooled fluid; (vii) a cryogenic fluid; (viii) a resistive heating source coupled to a conductive wire; (ix) an ultrasound power source coupled to an ultrasound emitter, wherein the ultrasound power source produces ultrasound energy in the range of about 300 KHZ to about 3 GHz; and (x) combinations thereof. For ease of discussion, for the remainder of this application, theenergy delivery device 18 is one or more ofRF electrodes 18 e, and thepower source 20 utilized is anRF power supply 20. For these and related embodiments,RF power supply 20 can be configured to deliver 5 to 200 watts, preferably 5 to 100, and still more preferably 5 to 50 watts of electromagnetic energy is to theelectrodes 18 e ofenergy delivery device 18, without impeding out. Theelectrodes 18 e are electromagnetically coupled toenergy source 20. The coupling can be direct, fromenergy source 20 to eachelectrode 18 e respectively, or indirect, by using a collet, sleeve, and the like which couples one ormore electrodes 18 e toenergy source 20. - In various embodiments,
electrodes 18 e, includingimpedance sensors 22 andsensing members 22 m, can have a variety of shapes and geometries. Referring now toFIGS. 15A-15H , exemplary shapes and geometries can include, but are not limited to, ring-like, ball, hemispherical, cylindrical, conical, needle-like, and combinations thereof. Referring toFIG. 16 , in an embodiment,electrode 18 e can be a needle with sufficient sharpness to penetrate tissue, including fibrous tissue such as encapsulated tumors, cartilage, and bone. Thedistal end 18 de ofelectrode 18 e can have acut angle 68 that ranges from 1 to 60°, with preferred ranges of at least 25°, or at least 30°, and specific embodiments of 25° and 30°. The surface ofelectrode 18 e can be smooth or textured, and concave or convex.Electrode 18 e can havedifferent lengths 38′ that are advanced fromdistal end 16′ of introducer 12 (FIG. 2 ). Thelengths 38′ can be determined by the actualphysical length 38 ofelectrode 18 e, thelength 38′ of anenergy delivery surface 18 eds ofelectrode 18 e, and thelength 38″ ofelectrode 18 e that is covered by aninsulator 36.Suitable lengths 38′ include, but are not limited to, a range from 0.5-30 cm, with specific embodiments of 0.5, 1, 3, 5, 10, 15 and 25.0 cm. Theconductive surface area 18 eds ofelectrode 18 e can range from 0.05 mm2 to 100 cm2. Theactual lengths 38′ ofelectrode 18 e depend on the location oftissue site 5′ to be ablated, its distance from the site, its accessibility, as well as whether or not the physician performs an endoscopic or surgical procedure. Theconductive surface area 18 eds depends on the desiredablation volume 5 av to be created. - Referring now to
FIGS. 17 and 18 ,electrodes 18 e can also be configured to be flexible and/or deflectable, having one or more radii ofcurvature 70 which can exceed 180 degrees. In use,electrodes 18 e can be positioned to heat, necrotize, or ablate any selectedtarget tissue volume 5′. Aradiopaque marker 11 can be coated onelectrodes 18 e for visualization purposes.Electrodes 18 e can be coupled tointroducer 12, and/or an advancement member ordevice 15, or an advancement-retraction member 34, using soldering, brazing, welding, crimping, adhesive bonding, and other joining methods known in the medical device arts. Also,electrodes 18 e can include one or more coupledsensors 22 to measure temperature and impedance (both of the electrode and of the surrounding tissue), voltage and current, or other physical properties of theelectrodes 18 e and adjacent tissue.Sensors 22 can be at exterior surfaces ofelectrodes 18 e at their distal ends or intermediate sections. -
Electrode 18 e can be made of a variety of conductive materials, both metallic and non-metallic. Suitable materials forelectrode 18 e include, steel such as 304 stainless steel of hypodermic quality, platinum, gold, silver, alloys, and combinations thereof. Also,electrode 18 e can be made of conductive, solid or hollow, straight wires of various shapes, such as round, flat, triangular, rectangular, hexagonal, elliptical, and the like. In a specific embodiment, all or portions ofelectrodes 18 e, or asecond electrode 18 e′, can be made of a shaped memory metal, such as NiTi, commercially available from Raychem Corporation, Menlo Park, Calif. - Referring now to
FIGS. 19 through 22 , in various embodiments, one or moreresilient members 18 orelectrodes 18 e can be covered by aninsulative layer 36, so as to have an exterior surface that is wholly or partially insulated, and provide a non-insulated area which is anenergy delivery surface 18 eds. In an embodiment, shown inFIG. 19 ,insulative layer 36 can comprise a sleeve that can be fixed, or slidably positioned, along the length ofelectrode 18 e to vary and control thelength 38′ ofenergy delivery surface 18 eds. Suitable material forinsulative layer 36 includes polyamide and fluorocarbon polymers, such as TEFLON®. - In the embodiment shown in
FIG. 20 ,insulation 36 is formed at the exterior ofelectrodes 18 e in circumferential patterns, leaving a plurality of energy delivery surfaces 18 eds. In an embodiment, shown inFIGS. 21 and 22 ,insulation 36 extends along a longitudinal exterior surface ofelectrodes 18 e.Insulation 36 can extend along a selected distance along a longitudinal length ofelectrodes 18 e, and around a selectable portion of a circumference ofelectrodes 18 e. In various embodiments, sections ofelectrodes 18 e can haveinsulation 36 along selected longitudinal lengths, as well as completely surround one or more circumferential sections ofelectrodes 18 e.Insulation 36 positioned at the exterior ofelectrodes energy delivery surface 18 eds. - Referring now to
FIG. 23 , in various embodiments,electrode 18 e can include one or more lumens 72 (which can be contiguous with, or the same as, lumen 13) coupled to a plurality of fluid distribution ports 23 (which can be apertures 23), from which a variety offluids 27 can be introduced, including conductivity enhancing fluids, electrolytic solutions, saline solutions, cooling fluids, cryogenic fluids, gases, chemotherapeutic agents, medicaments, gene therapy agents, photo-therapeutic agents, contrast agents, infusion media, and combinations thereof. This is accomplished by having ports orapertures 23 that are fluidically coupled to one or more oflumens 72 or coupled tolumens 13, which in turn coupled tofluid reservoir 30 and/orfluid delivery device 28. - In an embodiment, shown in
FIG. 23 , aconductivity enhancing solution 27 can be infused intotarget tissue site 5′ includingtissue mass 5″. The conductivity enhancing solution can be infused before, during, or after the delivery of energy to thetissue site 5′ by theenergy delivery device 10. The infusion of aconductivity enhancing solution 27 into thetarget tissue site 5′ creates an infused tissue area 5 i that has an increased electrical conductivity (verses un-infused tissue), so as to act as anenhanced electrode 40. During RF energy delivery, the current densities inenhanced electrode 40 are greatly lowered, allowing the delivery of greater amounts of RF power intoelectrode 40 andtarget tissue site 5′ without impedance failures. In use, the infusion of thetarget tissue site 5′ withconductivity enhancing solution 27 provides two important benefits: (i) faster ablation times, and (ii) the creation of larger lesions, both without impedance-related shut downs of the RF power supply. This is due to the fact that theconductivity enhancing solution 27 reduces current densities and prevents desiccation of tissue adjacent theelectrodes conductivity enhancing solution 27 is a hypertonic saline solution. Other examples include halide salt solutions, colloidal ferro solutions, and colloidal silver solutions. The conductivity of enhancedelectrode 40 can be increased by control of the rate and amount of infusion, and by the use of solutions with greater concentrations of electrolytes (e.g. saline) and hence greater conductivity. In various embodiments, the use ofconductivity enhancing solution 27 allows the delivery of up to 2000 watts of power into thetissue site 5′ without impedance shut down, with specific embodiments of 50, 100, 150, 250, 500, 1000 and 1500 watts, achieved by varying the flow, amount and concentration ofinfusion solution 27. The infusion ofsolution 27 can be continuous, pulsed, or combinations thereof, and can be controlled by a feedback control system described herein. In a specific embodiment, a bolus ofinfusion solution 27 is delivered prior to energy delivery, followed by a continuous delivery initiated before or during energy delivery withenergy delivery device 18 or other means. - Turning now to a discussion of
impedance sensors 22, in various embodiments,impedance sensors 22 can include all or a portion ofresilient members 18. Referring back toFIG. 19 , whenresilient member 18 is made of a conductive material, thelength 221 ofimpedance sensor 22 or sensingmember 22 m can be defined by the placement of a slidable or fixedinsulative layer 36. Also, in various embodiments,impedance sensors 22 can be fabricated from a variety of conductive materials and metals known in the art, including stainless steel, copper, silver, gold, platinum, alloys, and combinations thereof. Referring now toFIG. 24 , similarly, all or portions ofsensors 22 orsensor members 22 m can comprise aconductive coating 22 c that is coated or deposited onto a selected portion ofmember 18. In various embodiments, coating 22 c can comprise a conductive metal or conductive polymer coating known in the art that is applied using known methods, such as sputtering, vacuum deposition, dip coating, photolithography, and the like. In related embodiments,impedance sensing members 22 m and/orsensors 22 can be configured to have aresistance gradient 22 g along all or portions of their lengths 22 l. Theresistance gradient 22 g can be increasing or decreasing in a linear, second order, third order, exponential, or other fashion. In a specific embodiment, theresistance gradient 22 g is configured to compensate for resistance losses (i.e. of voltage) and/or hysteresis occurring along the length 22 l ofmember 22 m orsensor 22, as well as changes in the overall resistance ofsensor 22 due to changes in the temperature and/or conducting/sensing length 22 lc (and area) ofsensor 22, as might occur due to advancement or retraction ofslidable insulation layer 36, or fowling of thesensor 22 with desiccated, burnt tissue or otherwise adherent tissue. In this and related embodiments, thegradient 22 g can be so configured to produce the least resistance (e.g. maximum conductance) at thedistal tip 22 d of thesensor 22, and increasing resistance moving in a proximal direction along thesensor 22 or sensingmember 22 m. Thegradient 22 g can be produced via the use ofcoating 22 c by varying either the thickness or the composition of thecoating 22 c, or a combination of both, along the length 22I of thesensor 22, using methods known in the art. Further, by compensating for such resistance changes or losses along the length or area ofimpedance sensor 22, these and related embodiments also improve the measurement and detection of real and imaginary components of complex impedance. In other related embodiments, theresistance gradient 22 g can be in a radial direction, or a combination of radial and linear directions, with respect to the sensor length 22 l. - In other embodiments,
sensors 22 can comprise a number of biomedical sensors known in the art, including, but not limited to, thermal sensors, acoustical sensors, optical sensors, pH sensors, gas sensors, flow sensors, positional sensors, and pressure/force sensors. Thermal sensors can include thermistors, thermocouples, resistive wires, and the like. Acoustical sensors can include ultrasound sensors, including piezoelectric sensors, which can be configured in an array. Pressure and force sensors can include strain gauge sensors, including silicon-based strain gauges. - In an embodiment,
sensor 22 can be selected to measure temperature along with impedance to compensate for any temperature related bias or hysteresis in the impedance measurement. Accordingly, in an embodiment illustrated inFIG. 28 , a feedback signal from atemperature sensor 329 ortemperature calculation device 342 can be inputted to theimpedance calculation device 334, described herein, to compensate for such variations. Temperature monitoring can also be used to perform real time monitoring of ablative energy delivery. If at anytime sensor 22 determines that a desired cell necrosis temperature is exceeded, then an appropriate signal can be sent topower control circuitry 340, describe herein, to reduce or regulate the amount of electromagnetic energy delivered toelectrodes - Referring now to
FIGS. 25A-25C and 26A-26C, in an embodiment, the position and size of anablation volume 5 av produced by the delivery of electromagnetic energy can be controlled via the frequency of the ablative energy delivered to one ormore electrodes 18 e orenergy delivery devices 18. As shown inFIG. 26A , lower electromagnetic frequencies, such as RF frequencies (e.g. 1 kHz to 1 MHZ), produce a more localized energy concentration (e.g. current density), with the resulting zone of energy concentration orablation zone 5 az occurring close to the energy delivery electrode/antenna lateral distance 18 ld or other direction. As shown inFIGS. 26B and 26C , higher frequencies, such as microwave frequencies, result in a progressively more distant energy concentration and resultingablation zone 5 az. As shown inFIGS. 25A-25C , by varying the frequency of the delivered energy and/or utilizing energy delivery electrodes/antenna coupled to different frequency energy source (e.g. microwave vs. RF), the position, shape, and size of the resulting lesion can be precisely controlled and even steered. This can be accomplished by electrically isolating one ormore electrodes 18 to allow for the use of separate frequencies for each electrode. Further, one or more isolated electrodes can be coupled to multiplexing circuitry, and/or control resources coupled to the power sources and individual electrodes/antenna. Such circuitry and control resources can be used to turn individual electrodes or antenna off and on as well as control/set the frequency of each. In use, these and related embodiments provide the benefit of allowing the size, position and shape of the lesion to be precisely controlled and/or titrated to meet the therapeutic needs of the target tissue. - Referring now to
FIGS. 25B and 25C , in various embodiments, one ormore electrodes 18 can have segmentedportions 18 sp so as to allow theelectrodes 18 to emit or radiate energy at different wavelengths from differentsegmented portions 18 sp ofelectrode 18. Segmentation can be achieved through the use of electrically insulatedsections 36 s. - In an embodiment, shown in
FIG. 25B , the use ofsegmented electrodes 18 sp allows the creation ofsegmented ablation zones 5 azs, including a first and secondsegmented zone 5azs azs 2. The size and shape of thesegmented ablation zones 5 azs can be controlled by controlling the frequency of the delivered energy to each electrode segmentedportion 18 sp. Thesegmented ablation zones 5 azs can also be configured to be discontinuous or overlapping. Such embodiments also provide the ability to avoid injury to anatomical structure such as blood vessels, nerves etc., which lie in close proximity or are actually surrounded by the tumor to be treated. For example, in an embodiment shown inFIG. 25B , thesegmented ablation zones 5azs azs 2 can be sized and positioned to have sufficient space between each zone to avoid damaging ablood vessel 5 bv or othercritical structure 5 as which lies between two ormore electrodes 18. Alternatively, if desired, the ablative frequencies delivered to each electrode segmentedportion 18 sp can be reconfigured to produce overlappingsegmented ablation zones 5 azs, as shown inFIG. 25C . - In use, the medical practitioner would position the apparatus, and then image the target tissue site (using imaging systems known in the art, such as ultrasound) to identify both the tumor and critical structures, and then utilize that image to control the input frequency to the energy delivery device, to produce the desires lesion size and shape to completely ablate the tumor while avoiding the critical structure. In an embodiment, the image could be electronically stored and analyzed to identify tumors and surrounding anatomy (using imaging processing methods known in the art, such as edge detection algorithms, resident within a processor of the imaging device), with the output fed into a power control software module coupled to the power supply that controls the power frequency to produce the desired ablation volume. Another benefit of these and related embodiments is the ability to produce an energy or thermal gradient within a target tissue site. That is the ability to deliver more or less energy to discrete sections of the target tissue volume, in order to titrate the delivery of energy, to address the physical and thermal conditions of a particular tumor mass, and even subsections of the tumor mass. This is an important capability, because tumors are often morphologically, and therefore thermally, non-homogeneous, a problem which current ablative therapies have not recognized or addressed.
- Exemplary embodiments for the use of this capability include delivering larger amounts of energy to the center of a tumor and less to the periphery, in order to produce higher temperatures and ensure complete ablation at the center and minimize risk of thermal injury to surrounding healthy tissue. Alternatively, increased energy could also be selectively directed to the tissue tract made by the RF needle or probe (or other penetrating energy delivery device 18) in penetrating the tumor and surrounding tissue, to ensure that no living malignant tissue is dragged back through the tract upon removal of the RF needle.
- Referring now to
FIGS. 6 and 27 , various embodiments can be configured to generate and display images ormaps 4′ from one or more impedance measurements, including, but not limited to, complex impedance, impedance vectors, impedance loci, and combinations thereof. In an embodiment, a process 100 for generating and displaying an impedance map or impedance derivedimage 4′ includes one or more of the following steps, all or a portion of which can be implemented as an electronic instruction set on a processor or logic resources described herein.Impedance array 22 a and/orapparatus 10 can be positioned 101 within or near the desiredsample volume 5 sv, and/orconductive paths 22 cp can be selected 105, so as to define and thus select 110 aparticular sample volume 5 sv. Thevolume 5 sv is then imaged 200, using impedance measurements from all or a portion of thesensing members 22 m orsensors 22 that comprisearray 22 a. Adecision 300 can then be made to perform one or more re-imaging of thesample volume 5 sv, in order to enhance image resolution as needed. Further,different excitation currents 20 e can be applied to thetarget tissue site 5′ and the voltage measurements repeated over time to increase measurement accuracy and precision, through increased sampling and reducing signal bias or noise that may occur at a particular excitation current 20 e. Signals 22 i fromimpedance array 22 a can then be signaled or inputted 400 tologic resources 19 lr, includemodule 19 m, which can include animage processing sub-module 19 mi. Sub-module 19 mi includes subroutines or algorithms configured to generate an impedance map or derivedimage 4′ of all or a portion of thetarget tissue site 5′, using image/signal processing methods including, but not limited to, edge detection, filtering, approximating techniques, volume imaging, contrast enhancement, fuzzy logic, and other methods known in the art. One or more signals 22 i fromarray 22 a can be inputted or signaled 500 tomemory resources 19 mr (or an externally coupled data storage device) and stored as animpedance data set 22 ds inmemory resources 19 mr. Subsequently, all or a portion of data set 22 ds can be inputted to sub-module 19 mi and processed 600, as described herein, to generate an impedance map or impedance derivedimage 4′, which can then be displayed 700 ondisplay device 21 or other display means. Adecision 800 can then be made to image anew sample volume 5 sv, and the process 100 can be repeated, starting atsteps array 22 a about introducer axis 12 a 1, or by advancing and retracting one ormore sensing members 22 m frommembers 18, or by a combination of both. - In an embodiment,
module conductive pathways 22 cp within thetarget tissue site 5′. Reference measurements or normalization methods may be used to account for noise in the measurements. In related embodiments, impedance and other bioelectric measurements described herein can be analyzed and converted from the frequency domain to the time domain using transform functions, including Fourier transforms, fast Fourier transforms, wavelet analysis methods, and other numerical methods known in the art. These functions and methods can be incorporated into algorithms or subroutines withinmodule module modules -
Image module 19 mi can also include subroutines to perform interpolation, such as linear, quadratic, or cubic spline interpolation between individual measured impedance values from image data set 22 ds of a givensample volume 5 sv. This improves image quality, including resolution, without any substantial loss of spatial or contrast detail. In related embodiments, theimage processing module 19 mi can be configured to allow the user to select both the interpolative or other image processing algorithms to be performed, as well as the area of the image to be so processed. Thus, the user can select all or a portion of the image to be enhanced, providing faster image processing times (by not having to process the entire image) as well as improving image quality and other overall usability of the imaging apparatus/system. Theimage processing module 19 mi can also include gray scale and color contrast capabilities, which can be selectable. Both the gray scale and color contrast can be scaled or normalized against a baseline measurement obtained from the individual patient, a calibration measurement or a statistic (e.g. mean) value for a patient sample group, or a parameter (e.g. average) for a patient population, or a combination thereof. - In related embodiments,
monitoring apparatus 19 andmodule 19 mi can be configured to generate impedance images with the maximum visual distinction or contrast between tumorous tissue and healthy tissue. This can be accomplished by using the frequency or combination of frequencies that yield the maximum sensitivity for selected tissue types or tissue conditions indicative of a tumor (e.g. degree of vascularity temperature etc). In an embodiment, such frequencies can be determined by performing swept frequency measurements and generating an impedance map or image using one or more frequencies, which result in the best contrast between healthy tissue and tumorous tissue or other tissue condition (e.g. thermal injury, necrosis etc.). - Referring now to
FIGS. 28 and 29 , afeedback control system 329 can be connected toenergy source 320,sensors 324,impedance array 322 a, andenergy delivery devices Feedback control system 329 uses temperature or impedance data fromsensors 324 orarray 322 a to modify the amount of electromagnetic energy received byenergy delivery devices Feedback control system 329 can automatically change any of the Four Parameters.Feedback control system 329 can detect impedance or temperature and change any of the Four Parameters in response to either or a combination thereof.Feedback control system 329 can include a multiplexer (digital or analog) to multiplex different electrodes,sensors 324, andsensor arrays 322 a, atemperature measurement device 342 or animpedance calculation device 334 that provides a control signal representative of temperature or impedance detected at one ormore sensors 324 orarray 322 a. A microprocessor can be connected to the temperature control circuit. - The following discussion pertains particularly to the use of RF energy as an ablative energy source for
apparatus 10. For purposes of this discussion,energy delivery devices antennas energy source 320 will now be referred to as anRF energy source 320. However, it will be appreciated that all other energy delivery devices and sources discussed herein are equally applicable, and devices similar to those associated withtreatment apparatus 10 can be utilized with laser optical fibers, microwave devices, and the like. The temperature of the tissue or ofRF electrodes energy source 320 is adjusted accordingly. The physician can, if desired, override the closed or open loop system. - The user of
apparatus 10 can input an impedance value that corresponds to a setting position located atapparatus 10. Based on this value, along with measured impedance values,feedback control system 329 determines an optimal power and time needed in the delivery of RF energy. Temperature is also sensed for monitoring and feedback purposes. Temperature can be maintained to a certain level by havingfeedback control system 329 adjust the power output automatically to maintain that level. - In another embodiment,
feedback control system 329 determines an optimal power and time for a baseline setting. Ablation volumes or lesions are formed at the baseline setting first. Larger lesions can be obtained by extending the time of ablation after a center core is formed at the baseline setting. The completion of lesion creation can be checked by advancingenergy delivery device 316 fromdistal end 16′ ofintroducer 12 to a position corresponding to a desired lesion size and monitoring the temperature at the periphery of the lesion such that a temperature sufficient to produce a lesion is attained. - The
closed loop system 329 can also utilize acontroller 338 to monitor the temperature, adjust the RF power, analyze the result, re-feed the result, and then modulate the power. More specifically,controller 338 governs the power levels, cycles, and duration that the RF energy is distributed toelectrodes Controller 338 can also, in tandem, analyzespectral profile 19 p and perform tissue identification and ablation monitoring functions, including endpoint determination. Further,controller 338 can, in tandem, govern the delivery of electrolytic or cooling fluids, and the removal of aspirated tissue.Controller 338 can be integral to, or otherwise coupled to,power source 320. In this and related embodiments,controller 338 can be coupled to a separate impedance measurementcurrent source 317, and can be configured to synchronize the delivery of pulsed power totissue site 5′, to allow for sensing bysensors 324 orsensor array 322 a during power off intervals, to prevent or minimize signal interference, artifacts or unwanted tissue effects during sampling bysensors 324 orsensor array 322 a. Thecontroller 338 can also be coupled to an input/output (I/O) device, such as a keyboard, touchpad, PDA, microphone (coupled to speech recognition software resident incontroller 338 or other computer), and the like. In an embodiment,current source 317 can be a multi-frequency generator, such as those manufactured by the Hewlett Packard Corporation (Palo Alto, Calif.), and can include or be coupled to a spectrum analyzer, manufactured by the same company. - Referring now to
FIGS. 28 and 29 , all or portions offeedback control system 329 are illustrated. Current delivered throughRF electrodes 314 and 316 (also called primary and secondary RF electrodes/antennas 314 and 316) is measured by acurrent sensor 330. Voltage is measured byvoltage sensor 332. Impedance and power are then calculated at power andimpedance calculation device 334. These values can then be displayed at a user interface anddisplay 336. Signals representative of power and impedance values are received bycontroller 338, which can be a microprocessor. - A control signal is generated by
controller 338 that is proportional to the difference between an actual measured value and a desired value. The control signal is used bypower circuits 340 to adjust the power output in an appropriate amount in order to maintain the desired power delivered at the respective primary and/orsecondary antennas sensors 324 provide feedback for maintaining a selected power. The actual temperatures are measured attemperature measurement device 342, and the temperatures are displayed at user interface anddisplay 336. A control signal is generated bycontroller 338 that is proportional to the difference between an actual measured temperature, and a desired temperature. The control signal is used bypower circuits 340 to adjust the power output in an appropriate amount in order to maintain the desired temperature delivered at therespective sensors 324. Amultiplexer 346 can be included for measurement of current, voltage, and temperature at thenumerous sensors primary electrodes 314 andsecondary electrodes 316.Suitable multiplexers 346 include, but are not limited to, those manufactured by the National Semiconductor Corporation (Santa Clara, Calif.), such as the CLC 522 and CLC 533 series; and those manufactured the Analog Devices Corporation (Norwood, Mass.). -
Controller 338 can be a digital or analog controller, or a computer with embedded, resident, or otherwise coupled software. In an embodiment,controller 338 can be a PENTIUM° family microprocessor, manufacture by the Intel Corporation (Santa Clara, Calif.). Whencontroller 338 is a computer, it can include a CPU coupled through a system bus. On this system bus can be a keyboard, a disk drive, or other non-volatile memory systems, a display, and other peripherals, as are known in the art. Also coupled to the bus are a program memory and a data memory. In various embodiments,controller 338 can be coupled to imaging systems, including, but not limited to, ultrasound, CT scanners (including fast CT scanners, such as those manufacture by the Imatron Corporation of South San Francisco, Calif.), X-ray, MRI, mammographic X-ray, and the like. Further, direct visualization and tactile imaging can be utilized. - User interface and display 336 can include operator controls and a display. In an embodiment,
user interface 336 can be a PDA device known in the art, such as a PALM° family computer, manufactured by Palm Computing (Santa Clara, Calif.).Interface 336 can be configured to allow the user to input control and processing variables to enable the controller to generate appropriate command signals.Interface 336 can also receive real time processing feedback information from one ormore sensors 324 for processing bycontroller 338, to govern the delivery and distribution of energy, fluid, etc. - The outputs of
current sensor 330 andvoltage sensor 332 are used bycontroller 338 to maintain a selected power level at primary andsecondary antennas controller 338, and a preset amount of energy to be delivered can also be profiled. - Circuitry, software, and feedback to
controller 338 result in process control and maintenance of the selected power, and are used to change: (i) the selected power, including RF, microwave, laser, and the like, (ii) the duty cycle (on-off and wattage), (iii) bipolar or monopolar energy delivery mode, and (iv) infusion medium delivery, including flow rate and pressure, frominfusion source 312. These process variables are controlled and varied to maintain the desired delivery of power, independent of changes in voltage or current, based on temperatures monitored atsensors 324. Acontroller 338 can be incorporated intofeedback control system 329 to switch power on and off, as well as to modulate the power. Also, with the use ofsensor 324 andfeedback control system 329, tissue adjacent toRF electrodes power circuit 340 toelectrodes electrodes - Referring now to
FIG. 29 ,current sensor 330 andvoltage sensor 332 are connected to the input of ananalog amplifier 344.Analog amplifier 344 can be a conventional differential amplifier circuit for use withsensors 324. The output ofanalog amplifier 344 is sequentially connected by ananalog multiplexer 346 to the input of A/D converter 348. The output ofanalog amplifier 344 is a voltage which represents the respective sensed impedances/temperatures. Digitized amplifier output voltages are supplied by A/D converter 348 to amicroprocessor 350.Microprocessor 350 may be a Power PC chip available from Motorola, or an INTEL® PENTIUM® Series chip. However, it will be appreciated that any suitable microprocessor, or general purpose digital or analog computer, can be used to calculate impedance or temperature, or perform image processing and tissue identification functions. -
Microprocessor 350 sequentially receives and stores digital representations of impedance and temperatures. Each digital value received bymicroprocessor 350 corresponds to different temperatures and impedances. Calculated power and impedance values can be indicated on user interface anddisplay 336. Alternatively, or in addition to the numerical indication of power or impedance, calculated impedance and power values can be compared bymicroprocessor 350 with predetermined power and impedance limits. When the values exceed predetermined power or impedance values, a warning can be given on user interface anddisplay 336, and additionally, the delivery of RF energy can be reduced, modified, or interrupted. A control signal frommicroprocessor 350 can modify the power level supplied byenergy source 320 toRF electrodes sensors 324 provide feedback for determining the extent and rate of: (i) tissue hyperthermia, (ii) cell necrosis; and (iii) when a boundary of desired cell necrosis has reached the physical location ofsensors 324. - Referring now to
FIG. 30 , in an embodiment, one or more ofimpedance measurement device 19,power supply 20,display device 21,control system 329,controller 338 can be incorporated or integrated into a single control and display device orunit 20 cd.Device 20 cd can be configured to include displays for one or more of the following:impedance profile 19 p,tissue site image 4′,tumor volume image 4″,ablation volume image 4 av, time-temperature profiles, tissue identification information, and ablation setting information (e.g. power setting, delivery time, etc.).Device 20 cd can also be configured to superimposeablation volume image 4 av ontotumor volume image 4″ ortissue site image 4′, as well as to superimpose visual cues 4 c on the placement (including proper and improper placement) of apparatus 10 (including energy delivery devices 18) within thetumor volume 5″ ortissue site 5′.Device 20 cd can also includecontrols 20 ck for manipulating any of the images (4′, 4″ or 4 av) in one or more axis. - Referring now to
FIG. 31 , in various embodiments,impedance measurement device 19 orcontrol system 329 can be configured to switch from a first mode of measuring impedance to a second mode, when certain system impedance or power conditions occur. In an embodiment, the first mode of measuring impedance is done utilizing the RF treatment power, and then impedance is calculated using a measured current and voltage as described herein. However, when system impedance rises too greatly and the resulting RF power treatment power level drops below a threshold, the accuracy and precision of localized impedance measurements decreases as a result of the decrease in the impedance measurement current in relation to noise levels of the RF power system. This is a problem not recognized nor addressed by current RF ablative and related impedance measurement devices. Under such conditions,logic resources 19 lr withinmonitoring device 19 can be configured to switch to a second mode of measuring localized impedance. The threshold event causing the mode switching can be selectable, and include one or more of the following events: decreases in treatment (e.g. RF) power below athreshold level 20 pt, increases in system impedance above athreshold level 20 it, changes in slope (e.g. derivative) of the RF power or system impedance curves. In various embodiments, thethreshold level 20 pt ofRF treatment power 20 p causing mode switching can be in the range from 1 to 50 watts, with specific embodiments of 5, 10 and 25 watts. - In an embodiment, shown in
FIG. 31 , the second or alternative mode of measuring impedance can comprise superimposing a duty cycledmeasurement signal 20 e onto the treatment signal 20 t. Thepulse duration 20 pd ofsignal 20 e can be in the range of 1 to 500 ms, with specific embodiments of 50, 100 and 250 ms. Theduty cycle 20 dc ofsignal 20 e can be in the range from 1 to 99%, with specific embodiments of 10, 25, 50 and 75%.Monitoring device 19,power source 20, orcontrol system 329 can be configured to control the power amplitude of themeasurement signal 20 e to maintain a selectedtotal amplitude 20 at. In an embodiment, thetotal power amplitude 20 at can range from about 5 to about 50 watts, with specific embodiments of 10, 20, 30 and 40 watts. Also, the duty cycle, pulse duration, and total power amplitude can be controlled to deliver a selectable average power over the duty cycle, which can be in the range of about 0.5 to about 10 watts, withspecific embodiments higher measurement currents 20 e can be used in short pulse duration without appreciably affecting delivered treatment power or system performance, or causing additional or unwanted energy delivery to the target tissue site. In use, these and related embodiments of alternative mode of impedance measurements (including superimposed duty cycle measurement) provide the benefit of improved accuracy and signal to noise ratios of impedance and related bio-electric measurements under conditions of high system impedance and/or low levels of delivered RF treatment power (i.e. ablative power). - In related embodiments, the duty cycle and/or pulse duration can be configured to vary responsive to one or more selected parameters, which can include frequency of the treatment signal, power for the treatment signal, or tissue impedance to the treatment signal. The variation in either the pulse duration or duty cycle can be controlled by
control system 329 and/orlogic resources 19 lr of theimpedance monitoring device 19 orpower supply 20, using control methods known in the art, such as PID control. In use, these embodiments allow the impedance measurements to be continuously fine tuned to changing system conditions to improve the accuracy and precision of impedance and related bioelectric measurements. - The foregoing description of various embodiment of the application has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the application to the precise forms disclosed. Embodiments of the application can be configured for the treatment of tumor and tissue masses at or beneath a tissue surface in a number of organs, including, but not limited to, the liver, breast, bone and lung. However, embodiments of the application are applicable to other organs and tissues as well. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. Further, elements from one embodiment can be readily recombined with elements from one or more of other embodiments. Such combinations can form a number of embodiments within the scope of the application. It is intended that the scope of the application be defined by the following claims and their equivalents.
Claims (9)
- 9. An apparatus, comprising:a radio-frequency energy delivery member configured for insertion into a tissue to form a tract therein;a radio-frequency power source coupled to the delivery member; anda logic resource coupled to the power source and to the delivery member, the logic resource comprising an algorithm or software configured for enabling the delivery of radio-frequency energy from the power source to the delivery member for ablation of the tissue tract.
- 2. The apparatus of claim 1, wherein the delivery member further comprises one or more deployable delivery members therein.
- 3. The apparatus of claim 1, wherein the delivery member comprises a fixed insulative member.
- 4. The apparatus of claim 1, wherein the delivery member comprises a movable insulative member.
- 5. The apparatus of claim 1, wherein the delivery member is an introducer.
- 6. The apparatus of
claim 5 , wherein the delivery member comprises a conductive distal portion for the delivery of the ablative radio-frequency energy to the tissue tract. - 7. An apparatus, comprising a delivery member configured for insertion into a tissue to form a tract therein, wherein the delivery member comprises:an electrically conductive area for the delivery of thermal ablative energy to the tissue tract,an outer impedance sensor, andan inner impedance sensing member positionable within the delivery member, wherein the outer sensor and the inner sensing member are configured for bipolar measurement of localized impedance of a tissue volume adjacent to the inner sensing member.
- 8. The apparatus of
claim 7 , wherein the delivery member is deployable. - 9. The apparatus of
claim 7 , wherein the delivery member comprises an insulative member disposed adjacent to a distal portion that comprises the electrically conductive area.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/975,755 US20140081255A1 (en) | 2000-07-25 | 2013-10-15 | Method and Apparatuses for Tissue Treatment |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22063900P | 2000-07-25 | 2000-07-25 | |
US09/916,214 US7419487B2 (en) | 2000-07-25 | 2001-07-25 | Apparatus for detecting and treating tumors using localized impedance measurement |
US12/178,684 US20080281314A1 (en) | 2000-07-25 | 2008-07-24 | Methods and apparatuses for tissue treatment |
US13/975,755 US20140081255A1 (en) | 2000-07-25 | 2013-10-15 | Method and Apparatuses for Tissue Treatment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/178,684 Division US20080281314A1 (en) | 2000-07-25 | 2008-07-24 | Methods and apparatuses for tissue treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140081255A1 true US20140081255A1 (en) | 2014-03-20 |
Family
ID=22824349
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/916,214 Expired - Lifetime US7419487B2 (en) | 2000-07-25 | 2001-07-25 | Apparatus for detecting and treating tumors using localized impedance measurement |
US09/916,235 Expired - Lifetime US6962587B2 (en) | 2000-07-25 | 2001-07-25 | Method for detecting and treating tumors using localized impedance measurement |
US12/178,684 Abandoned US20080281314A1 (en) | 2000-07-25 | 2008-07-24 | Methods and apparatuses for tissue treatment |
US13/609,369 Expired - Fee Related US8540710B2 (en) | 2000-07-25 | 2012-09-11 | Methods and apparatuses for tissue treatment |
US13/975,755 Abandoned US20140081255A1 (en) | 2000-07-25 | 2013-10-15 | Method and Apparatuses for Tissue Treatment |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/916,214 Expired - Lifetime US7419487B2 (en) | 2000-07-25 | 2001-07-25 | Apparatus for detecting and treating tumors using localized impedance measurement |
US09/916,235 Expired - Lifetime US6962587B2 (en) | 2000-07-25 | 2001-07-25 | Method for detecting and treating tumors using localized impedance measurement |
US12/178,684 Abandoned US20080281314A1 (en) | 2000-07-25 | 2008-07-24 | Methods and apparatuses for tissue treatment |
US13/609,369 Expired - Fee Related US8540710B2 (en) | 2000-07-25 | 2012-09-11 | Methods and apparatuses for tissue treatment |
Country Status (6)
Country | Link |
---|---|
US (5) | US7419487B2 (en) |
EP (1) | EP1304971A1 (en) |
JP (1) | JP2004520865A (en) |
AU (2) | AU2001279026B2 (en) |
CA (1) | CA2416581A1 (en) |
WO (1) | WO2002032335A1 (en) |
Cited By (151)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9757196B2 (en) | 2011-09-28 | 2017-09-12 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US9770295B2 (en) | 2003-06-23 | 2017-09-26 | Angiodynamics, Inc. | Radiation applicator for microwave medical treatment |
US9788896B2 (en) | 2004-07-02 | 2017-10-17 | Angiodynamics, Inc. | Radiation applicator and method of radiating tissue |
WO2017217760A1 (en) * | 2016-06-14 | 2017-12-21 | (주)더스탠다드 | Therapeutic device employing endoscope-interworking electrode |
IT201600068691A1 (en) * | 2016-07-01 | 2018-01-01 | Igea S P A | HANDLING AND CONTROL SYSTEM FOR EXPANDABLE ELECTRODES OF A HANDPIECE USED IN AN ELECTRO-PORTION PROCESS |
US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US10117707B2 (en) | 2008-04-29 | 2018-11-06 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10154874B2 (en) | 2008-04-29 | 2018-12-18 | Virginia Tech Intellectual Properties, Inc. | Immunotherapeutic methods using irreversible electroporation |
US10238447B2 (en) | 2008-04-29 | 2019-03-26 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
US10245105B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Electroporation with cooling to treat tissue |
US10272178B2 (en) | 2008-04-29 | 2019-04-30 | Virginia Tech Intellectual Properties Inc. | Methods for blood-brain barrier disruption using electrical energy |
US10286108B2 (en) | 2008-04-29 | 2019-05-14 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation to create tissue scaffolds |
US10292755B2 (en) | 2009-04-09 | 2019-05-21 | Virginia Tech Intellectual Properties, Inc. | High frequency electroporation for cancer therapy |
EP3501595A1 (en) * | 2017-12-22 | 2019-06-26 | IGEA S.p.A. | Handpiece having of expandable electrodes used for electroporation |
EP3536263A1 (en) * | 2018-03-08 | 2019-09-11 | Ethicon LLC | Using spectroscopy to determine device use state in combo instrument |
WO2019173191A1 (en) * | 2018-03-08 | 2019-09-12 | Ethicon Llc | Using spectroscopy to determine device use state in combo instrument |
US10471254B2 (en) | 2014-05-12 | 2019-11-12 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US10470822B2 (en) | 2008-04-29 | 2019-11-12 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US10595887B2 (en) | 2017-12-28 | 2020-03-24 | Ethicon Llc | Systems for adjusting end effector parameters based on perioperative information |
US10660691B2 (en) | 2015-10-07 | 2020-05-26 | Angiodynamics, Inc. | Multiple use subassembly with integrated fluid delivery system for use with single or dual-lumen peristaltic tubing |
US10694972B2 (en) | 2014-12-15 | 2020-06-30 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US10695081B2 (en) | 2017-12-28 | 2020-06-30 | Ethicon Llc | Controlling a surgical instrument according to sensed closure parameters |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US10755813B2 (en) | 2017-12-28 | 2020-08-25 | Ethicon Llc | Communication of smoke evacuation system parameters to hub or cloud in smoke evacuation module for interactive surgical platform |
US10758310B2 (en) | 2017-12-28 | 2020-09-01 | Ethicon Llc | Wireless pairing of a surgical device with another device within a sterile surgical field based on the usage and situational awareness of devices |
US10772651B2 (en) | 2017-10-30 | 2020-09-15 | Ethicon Llc | Surgical instruments comprising a system for articulation and rotation compensation |
US10849697B2 (en) | 2017-12-28 | 2020-12-01 | Ethicon Llc | Cloud interface for coupled surgical devices |
US10892995B2 (en) | 2017-12-28 | 2021-01-12 | Ethicon Llc | Surgical network determination of prioritization of communication, interaction, or processing based on system or device needs |
US10892899B2 (en) | 2017-12-28 | 2021-01-12 | Ethicon Llc | Self describing data packets generated at an issuing instrument |
US10898622B2 (en) | 2017-12-28 | 2021-01-26 | Ethicon Llc | Surgical evacuation system with a communication circuit for communication between a filter and a smoke evacuation device |
US10932872B2 (en) | 2017-12-28 | 2021-03-02 | Ethicon Llc | Cloud-based medical analytics for linking of local usage trends with the resource acquisition behaviors of larger data set |
US10943454B2 (en) | 2017-12-28 | 2021-03-09 | Ethicon Llc | Detection and escalation of security responses of surgical instruments to increasing severity threats |
US10944728B2 (en) | 2017-12-28 | 2021-03-09 | Ethicon Llc | Interactive surgical systems with encrypted communication capabilities |
US10966791B2 (en) | 2017-12-28 | 2021-04-06 | Ethicon Llc | Cloud-based medical analytics for medical facility segmented individualization of instrument function |
US10973520B2 (en) | 2018-03-28 | 2021-04-13 | Ethicon Llc | Surgical staple cartridge with firing member driven camming assembly that has an onboard tissue cutting feature |
US10987178B2 (en) | 2017-12-28 | 2021-04-27 | Ethicon Llc | Surgical hub control arrangements |
US11013563B2 (en) | 2017-12-28 | 2021-05-25 | Ethicon Llc | Drive arrangements for robot-assisted surgical platforms |
US11026687B2 (en) | 2017-10-30 | 2021-06-08 | Cilag Gmbh International | Clip applier comprising clip advancing systems |
US11026751B2 (en) | 2017-12-28 | 2021-06-08 | Cilag Gmbh International | Display of alignment of staple cartridge to prior linear staple line |
US11039887B2 (en) | 2013-08-09 | 2021-06-22 | The General Hospital Corporation | Method and apparatus for treating dermal melasma |
US11051876B2 (en) | 2017-12-28 | 2021-07-06 | Cilag Gmbh International | Surgical evacuation flow paths |
US11056244B2 (en) | 2017-12-28 | 2021-07-06 | Cilag Gmbh International | Automated data scaling, alignment, and organizing based on predefined parameters within surgical networks |
US11058498B2 (en) | 2017-12-28 | 2021-07-13 | Cilag Gmbh International | Cooperative surgical actions for robot-assisted surgical platforms |
US11069012B2 (en) | 2017-12-28 | 2021-07-20 | Cilag Gmbh International | Interactive surgical systems with condition handling of devices and data capabilities |
US11076921B2 (en) | 2017-12-28 | 2021-08-03 | Cilag Gmbh International | Adaptive control program updates for surgical hubs |
US11090047B2 (en) | 2018-03-28 | 2021-08-17 | Cilag Gmbh International | Surgical instrument comprising an adaptive control system |
US11096693B2 (en) | 2017-12-28 | 2021-08-24 | Cilag Gmbh International | Adjustment of staple height of at least one row of staples based on the sensed tissue thickness or force in closing |
US11096688B2 (en) | 2018-03-28 | 2021-08-24 | Cilag Gmbh International | Rotary driven firing members with different anvil and channel engagement features |
US11100631B2 (en) | 2017-12-28 | 2021-08-24 | Cilag Gmbh International | Use of laser light and red-green-blue coloration to determine properties of back scattered light |
US11109866B2 (en) | 2017-12-28 | 2021-09-07 | Cilag Gmbh International | Method for circular stapler control algorithm adjustment based on situational awareness |
US11114195B2 (en) | 2017-12-28 | 2021-09-07 | Cilag Gmbh International | Surgical instrument with a tissue marking assembly |
US11129611B2 (en) | 2018-03-28 | 2021-09-28 | Cilag Gmbh International | Surgical staplers with arrangements for maintaining a firing member thereof in a locked configuration unless a compatible cartridge has been installed therein |
US11132462B2 (en) | 2017-12-28 | 2021-09-28 | Cilag Gmbh International | Data stripping method to interrogate patient records and create anonymized record |
US11147607B2 (en) | 2017-12-28 | 2021-10-19 | Cilag Gmbh International | Bipolar combination device that automatically adjusts pressure based on energy modality |
US11160605B2 (en) | 2017-12-28 | 2021-11-02 | Cilag Gmbh International | Surgical evacuation sensing and motor control |
US11166772B2 (en) | 2017-12-28 | 2021-11-09 | Cilag Gmbh International | Surgical hub coordination of control and communication of operating room devices |
US11179208B2 (en) | 2017-12-28 | 2021-11-23 | Cilag Gmbh International | Cloud-based medical analytics for security and authentication trends and reactive measures |
US11179175B2 (en) | 2017-12-28 | 2021-11-23 | Cilag Gmbh International | Controlling an ultrasonic surgical instrument according to tissue location |
US11202570B2 (en) | 2017-12-28 | 2021-12-21 | Cilag Gmbh International | Communication hub and storage device for storing parameters and status of a surgical device to be shared with cloud based analytics systems |
US11207067B2 (en) | 2018-03-28 | 2021-12-28 | Cilag Gmbh International | Surgical stapling device with separate rotary driven closure and firing systems and firing member that engages both jaws while firing |
US11219453B2 (en) | 2018-03-28 | 2022-01-11 | Cilag Gmbh International | Surgical stapling devices with cartridge compatible closure and firing lockout arrangements |
US11229436B2 (en) | 2017-10-30 | 2022-01-25 | Cilag Gmbh International | Surgical system comprising a surgical tool and a surgical hub |
US11234756B2 (en) | 2017-12-28 | 2022-02-01 | Cilag Gmbh International | Powered surgical tool with predefined adjustable control algorithm for controlling end effector parameter |
US11257589B2 (en) | 2017-12-28 | 2022-02-22 | Cilag Gmbh International | Real-time analysis of comprehensive cost of all instrumentation used in surgery utilizing data fluidity to track instruments through stocking and in-house processes |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
US11253315B2 (en) | 2017-12-28 | 2022-02-22 | Cilag Gmbh International | Increasing radio frequency to create pad-less monopolar loop |
US11259830B2 (en) | 2018-03-08 | 2022-03-01 | Cilag Gmbh International | Methods for controlling temperature in ultrasonic device |
US11259807B2 (en) | 2019-02-19 | 2022-03-01 | Cilag Gmbh International | Staple cartridges with cam surfaces configured to engage primary and secondary portions of a lockout of a surgical stapling device |
US11259806B2 (en) | 2018-03-28 | 2022-03-01 | Cilag Gmbh International | Surgical stapling devices with features for blocking advancement of a camming assembly of an incompatible cartridge installed therein |
US11266468B2 (en) | 2017-12-28 | 2022-03-08 | Cilag Gmbh International | Cooperative utilization of data derived from secondary sources by intelligent surgical hubs |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US11273001B2 (en) | 2017-12-28 | 2022-03-15 | Cilag Gmbh International | Surgical hub and modular device response adjustment based on situational awareness |
US11278280B2 (en) | 2018-03-28 | 2022-03-22 | Cilag Gmbh International | Surgical instrument comprising a jaw closure lockout |
US11278281B2 (en) | 2017-12-28 | 2022-03-22 | Cilag Gmbh International | Interactive surgical system |
US11284936B2 (en) | 2017-12-28 | 2022-03-29 | Cilag Gmbh International | Surgical instrument having a flexible electrode |
US11291510B2 (en) | 2017-10-30 | 2022-04-05 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11291495B2 (en) | 2017-12-28 | 2022-04-05 | Cilag Gmbh International | Interruption of energy due to inadvertent capacitive coupling |
US11304763B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Image capturing of the areas outside the abdomen to improve placement and control of a surgical device in use |
US11304699B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Method for adaptive control schemes for surgical network control and interaction |
US11304720B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Activation of energy devices |
US11308075B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Surgical network, instrument, and cloud responses based on validation of received dataset and authentication of its source and integrity |
US11304745B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Surgical evacuation sensing and display |
US11311306B2 (en) | 2017-12-28 | 2022-04-26 | Cilag Gmbh International | Surgical systems for detecting end effector tissue distribution irregularities |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US11311342B2 (en) | 2017-10-30 | 2022-04-26 | Cilag Gmbh International | Method for communicating with surgical instrument systems |
USD950728S1 (en) | 2019-06-25 | 2022-05-03 | Cilag Gmbh International | Surgical staple cartridge |
US11317919B2 (en) | 2017-10-30 | 2022-05-03 | Cilag Gmbh International | Clip applier comprising a clip crimping system |
US11317915B2 (en) | 2019-02-19 | 2022-05-03 | Cilag Gmbh International | Universal cartridge based key feature that unlocks multiple lockout arrangements in different surgical staplers |
US11317937B2 (en) | 2018-03-08 | 2022-05-03 | Cilag Gmbh International | Determining the state of an ultrasonic end effector |
US11324557B2 (en) | 2017-12-28 | 2022-05-10 | Cilag Gmbh International | Surgical instrument with a sensing array |
USD952144S1 (en) | 2019-06-25 | 2022-05-17 | Cilag Gmbh International | Surgical staple cartridge retainer with firing system authentication key |
US11337746B2 (en) | 2018-03-08 | 2022-05-24 | Cilag Gmbh International | Smart blade and power pulsing |
US11357503B2 (en) | 2019-02-19 | 2022-06-14 | Cilag Gmbh International | Staple cartridge retainers with frangible retention features and methods of using same |
US11364075B2 (en) | 2017-12-28 | 2022-06-21 | Cilag Gmbh International | Radio frequency energy device for delivering combined electrical signals |
US11369377B2 (en) | 2019-02-19 | 2022-06-28 | Cilag Gmbh International | Surgical stapling assembly with cartridge based retainer configured to unlock a firing lockout |
US11376002B2 (en) | 2017-12-28 | 2022-07-05 | Cilag Gmbh International | Surgical instrument cartridge sensor assemblies |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
US11389164B2 (en) | 2017-12-28 | 2022-07-19 | Cilag Gmbh International | Method of using reinforced flexible circuits with multiple sensors to optimize performance of radio frequency devices |
US11410259B2 (en) | 2017-12-28 | 2022-08-09 | Cilag Gmbh International | Adaptive control program updates for surgical devices |
US11419630B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Surgical system distributed processing |
US11424027B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Method for operating surgical instrument systems |
US11419667B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Ultrasonic energy device which varies pressure applied by clamp arm to provide threshold control pressure at a cut progression location |
US11423007B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Adjustment of device control programs based on stratified contextual data in addition to the data |
US11432885B2 (en) | 2017-12-28 | 2022-09-06 | Cilag Gmbh International | Sensing arrangements for robot-assisted surgical platforms |
US11446052B2 (en) | 2017-12-28 | 2022-09-20 | Cilag Gmbh International | Variation of radio frequency and ultrasonic power level in cooperation with varying clamp arm pressure to achieve predefined heat flux or power applied to tissue |
USD964564S1 (en) | 2019-06-25 | 2022-09-20 | Cilag Gmbh International | Surgical staple cartridge retainer with a closure system authentication key |
US11453873B2 (en) | 2008-04-29 | 2022-09-27 | Virginia Tech Intellectual Properties, Inc. | Methods for delivery of biphasic electrical pulses for non-thermal ablation |
US11464559B2 (en) | 2017-12-28 | 2022-10-11 | Cilag Gmbh International | Estimating state of ultrasonic end effector and control system therefor |
US11464535B2 (en) | 2017-12-28 | 2022-10-11 | Cilag Gmbh International | Detection of end effector emersion in liquid |
US11464511B2 (en) | 2019-02-19 | 2022-10-11 | Cilag Gmbh International | Surgical staple cartridges with movable authentication key arrangements |
US11471156B2 (en) | 2018-03-28 | 2022-10-18 | Cilag Gmbh International | Surgical stapling devices with improved rotary driven closure systems |
US11504192B2 (en) | 2014-10-30 | 2022-11-22 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11510741B2 (en) | 2017-10-30 | 2022-11-29 | Cilag Gmbh International | Method for producing a surgical instrument comprising a smart electrical system |
EP3941353A4 (en) * | 2019-03-18 | 2022-12-14 | The Regents of the University of California | Systems and methods for compact laser wakefield accelerated electrons and x-rays |
US11529187B2 (en) | 2017-12-28 | 2022-12-20 | Cilag Gmbh International | Surgical evacuation sensor arrangements |
US11540855B2 (en) | 2017-12-28 | 2023-01-03 | Cilag Gmbh International | Controlling activation of an ultrasonic surgical instrument according to the presence of tissue |
US11559307B2 (en) | 2017-12-28 | 2023-01-24 | Cilag Gmbh International | Method of robotic hub communication, detection, and control |
US11559308B2 (en) | 2017-12-28 | 2023-01-24 | Cilag Gmbh International | Method for smart energy device infrastructure |
US11564756B2 (en) | 2017-10-30 | 2023-01-31 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11571234B2 (en) | 2017-12-28 | 2023-02-07 | Cilag Gmbh International | Temperature control of ultrasonic end effector and control system therefor |
US11576677B2 (en) | 2017-12-28 | 2023-02-14 | Cilag Gmbh International | Method of hub communication, processing, display, and cloud analytics |
US11589932B2 (en) | 2017-12-28 | 2023-02-28 | Cilag Gmbh International | Usage and technique analysis of surgeon / staff performance against a baseline to optimize device utilization and performance for both current and future procedures |
US11589888B2 (en) | 2017-12-28 | 2023-02-28 | Cilag Gmbh International | Method for controlling smart energy devices |
US11596291B2 (en) | 2017-12-28 | 2023-03-07 | Cilag Gmbh International | Method of compressing tissue within a stapling device and simultaneously displaying of the location of the tissue within the jaws |
US11602393B2 (en) | 2017-12-28 | 2023-03-14 | Cilag Gmbh International | Surgical evacuation sensing and generator control |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
US11612444B2 (en) | 2017-12-28 | 2023-03-28 | Cilag Gmbh International | Adjustment of a surgical device function based on situational awareness |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11659023B2 (en) | 2017-12-28 | 2023-05-23 | Cilag Gmbh International | Method of hub communication |
US11666331B2 (en) | 2017-12-28 | 2023-06-06 | Cilag Gmbh International | Systems for detecting proximity of surgical end effector to cancerous tissue |
US11707629B2 (en) | 2009-05-28 | 2023-07-25 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US11723710B2 (en) | 2016-11-17 | 2023-08-15 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
US11744604B2 (en) | 2017-12-28 | 2023-09-05 | Cilag Gmbh International | Surgical instrument with a hardware-only control circuit |
US11771487B2 (en) | 2017-12-28 | 2023-10-03 | Cilag Gmbh International | Mechanisms for controlling different electromechanical systems of an electrosurgical instrument |
US11786245B2 (en) | 2017-12-28 | 2023-10-17 | Cilag Gmbh International | Surgical systems with prioritized data transmission capabilities |
US11786251B2 (en) | 2017-12-28 | 2023-10-17 | Cilag Gmbh International | Method for adaptive control schemes for surgical network control and interaction |
US11801098B2 (en) | 2017-10-30 | 2023-10-31 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11818052B2 (en) | 2017-12-28 | 2023-11-14 | Cilag Gmbh International | Surgical network determination of prioritization of communication, interaction, or processing based on system or device needs |
US11832899B2 (en) | 2017-12-28 | 2023-12-05 | Cilag Gmbh International | Surgical systems with autonomously adjustable control programs |
US11832840B2 (en) | 2017-12-28 | 2023-12-05 | Cilag Gmbh International | Surgical instrument having a flexible circuit |
US11857152B2 (en) | 2017-12-28 | 2024-01-02 | Cilag Gmbh International | Surgical hub spatial awareness to determine devices in operating theater |
US11864728B2 (en) | 2017-12-28 | 2024-01-09 | Cilag Gmbh International | Characterization of tissue irregularities through the use of mono-chromatic light refractivity |
US11871901B2 (en) | 2012-05-20 | 2024-01-16 | Cilag Gmbh International | Method for situational awareness for surgical network or surgical network connected device capable of adjusting function based on a sensed situation or usage |
US11896322B2 (en) | 2017-12-28 | 2024-02-13 | Cilag Gmbh International | Sensing the patient position and contact utilizing the mono-polar return pad electrode to provide situational awareness to the hub |
US11896443B2 (en) | 2017-12-28 | 2024-02-13 | Cilag Gmbh International | Control of a surgical system through a surgical barrier |
US11903601B2 (en) | 2017-12-28 | 2024-02-20 | Cilag Gmbh International | Surgical instrument comprising a plurality of drive systems |
US11911045B2 (en) | 2017-10-30 | 2024-02-27 | Cllag GmbH International | Method for operating a powered articulating multi-clip applier |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
US11931096B2 (en) | 2010-10-13 | 2024-03-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US11937769B2 (en) | 2017-12-28 | 2024-03-26 | Cilag Gmbh International | Method of hub communication, processing, storage and display |
US11952568B2 (en) | 2019-04-05 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of biphasic electrical pulses for non-thermal ablation |
Families Citing this family (1002)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999004710A1 (en) † | 1997-07-25 | 1999-02-04 | Cosman Eric R | Cluster ablation electrode system |
US7901400B2 (en) | 1998-10-23 | 2011-03-08 | Covidien Ag | Method and system for controlling output of RF medical generator |
US7364577B2 (en) | 2002-02-11 | 2008-04-29 | Sherwood Services Ag | Vessel sealing system |
US7137980B2 (en) | 1998-10-23 | 2006-11-21 | Sherwood Services Ag | Method and system for controlling output of RF medical generator |
US6300108B1 (en) | 1999-07-21 | 2001-10-09 | The Regents Of The University Of California | Controlled electroporation and mass transfer across cell membranes |
WO2001074251A2 (en) * | 2000-03-31 | 2001-10-11 | Rita Medical Systems Inc. | Tissue biopsy and treatment apparatus and method |
CA2416581A1 (en) | 2000-07-25 | 2002-04-25 | Rita Medical Systems, Inc. | Apparatus for detecting and treating tumors using localized impedance measurement |
US8251986B2 (en) * | 2000-08-17 | 2012-08-28 | Angiodynamics, Inc. | Method of destroying tissue cells by eletroporation |
US6697670B2 (en) | 2001-08-17 | 2004-02-24 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients |
US6892099B2 (en) | 2001-02-08 | 2005-05-10 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation |
US6795728B2 (en) | 2001-08-17 | 2004-09-21 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits by electroporation |
CN100518685C (en) * | 2001-05-10 | 2009-07-29 | 脉管动力股份有限公司 | RF tissue ablation apparatus and method |
DE20109099U1 (en) * | 2001-05-30 | 2001-08-09 | Schoenfeld Andreas | Device for the treatment of tumors |
US7865427B2 (en) * | 2001-05-30 | 2011-01-04 | Cybersource Corporation | Method and apparatus for evaluating fraud risk in an electronic commerce transaction |
US6994706B2 (en) * | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
USRE42016E1 (en) | 2001-08-13 | 2010-12-28 | Angiodynamics, Inc. | Apparatus and method for the treatment of benign prostatic hyperplasia |
CN100450456C (en) * | 2001-09-28 | 2009-01-14 | 锐达医疗系统公司 | Impedance controlled tissue ablation apparatus and method |
US7505811B2 (en) | 2001-11-19 | 2009-03-17 | Dune Medical Devices Ltd. | Method and apparatus for examining tissue for predefined target cells, particularly cancerous cells, and a probe useful in such method and apparatus |
US7769432B2 (en) * | 2001-12-10 | 2010-08-03 | Board Of Trustees Of The University Of Arkansas | Minimally invasive diagnosis and treatment for breast cancer |
US8721565B2 (en) | 2005-08-04 | 2014-05-13 | Dune Medical Devices Ltd. | Device for forming an effective sensor-to-tissue contact |
US8116845B2 (en) | 2005-08-04 | 2012-02-14 | Dune Medical Devices Ltd. | Tissue-characterization probe with effective sensor-to-tissue contact |
US7720532B2 (en) | 2004-03-23 | 2010-05-18 | Dune Medical Ltd. | Clean margin assessment tool |
WO2006072947A2 (en) * | 2005-01-04 | 2006-07-13 | Dune Medical Devices Ltd. | Endoscopic system for in-vivo procedures |
US8032211B2 (en) | 2002-01-04 | 2011-10-04 | Dune Medical Devices Ltd. | Probes, systems, and methods for examining tissue according to the dielectric properties thereof |
US8019411B2 (en) | 2002-01-04 | 2011-09-13 | Dune Medical Devices Ltd. | Probes, systems, and methods for examining tissue according to the dielectric properties thereof |
US7809425B2 (en) | 2003-07-24 | 2010-10-05 | Dune Medical Devices Ltd. | Method and apparatus for examining a substance, particularly tissue, to characterize its type |
US20080287750A1 (en) * | 2002-01-04 | 2008-11-20 | Dune Medical Devices Ltd. | Ergonomic probes |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US6752767B2 (en) | 2002-04-16 | 2004-06-22 | Vivant Medical, Inc. | Localization element with energized tip |
US6922586B2 (en) * | 2002-05-20 | 2005-07-26 | Richard J. Davies | Method and system for detecting electrophysiological changes in pre-cancerous and cancerous tissue |
US20040152997A1 (en) * | 2002-05-20 | 2004-08-05 | Davies Richard J. | Electrophysiological approaches to assess resection and tumor ablation margins and responses to drug therapy |
US8262575B2 (en) * | 2002-05-20 | 2012-09-11 | Epi-Sci, Llc | Method and system for detecting electrophysiological changes in pre-cancerous and cancerous tissue |
US7630759B2 (en) | 2002-05-20 | 2009-12-08 | Epi-Sci, Llc | Method and system for detecting electrophysiological changes in pre-cancerous and cancerous breast tissue and epithelium |
EP1511534B1 (en) * | 2002-05-27 | 2011-07-06 | Celon AG Medical Instruments | Device for electrosurgically destroying body tissue |
DE10224154A1 (en) * | 2002-05-27 | 2003-12-18 | Celon Ag Medical Instruments | Application device for electrosurgical device for body tissue removal via of HF current has electrode subset selected from active electrode set in dependence on measured impedance of body tissue |
US7063698B2 (en) * | 2002-06-14 | 2006-06-20 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US6893442B2 (en) | 2002-06-14 | 2005-05-17 | Ablatrics, Inc. | Vacuum coagulation probe for atrial fibrillation treatment |
DE10234533A1 (en) * | 2002-07-30 | 2004-02-12 | Richard Wolf Gmbh | Ultrasound thermal therapy method, e.g. for ultrasound surgery, wherein multi-frequency ultrasound signals are matched to the tissue properties to optimize the non-linear properties of the ultrasound in targeted tissue heating |
US7001383B2 (en) * | 2002-10-21 | 2006-02-21 | Biosense, Inc. | Real-time monitoring and mapping of ablation lesion formation in the heart |
US7306593B2 (en) * | 2002-10-21 | 2007-12-11 | Biosense, Inc. | Prediction and assessment of ablation of cardiac tissue |
US7041096B2 (en) * | 2002-10-24 | 2006-05-09 | Synergetics Usa, Inc. | Electrosurgical generator apparatus |
US7044948B2 (en) | 2002-12-10 | 2006-05-16 | Sherwood Services Ag | Circuit for controlling arc energy from an electrosurgical generator |
EP1605866B1 (en) | 2003-03-03 | 2016-07-06 | Syntach AG | Electrical conduction block implant device |
US20030191396A1 (en) * | 2003-03-10 | 2003-10-09 | Sanghvi Narendra T | Tissue treatment method and apparatus |
US20040199179A1 (en) * | 2003-04-02 | 2004-10-07 | Elliott Christopher J. | Steerable ablation probe |
EP1617776B1 (en) | 2003-05-01 | 2015-09-02 | Covidien AG | System for programing and controlling an electrosurgical generator system |
US9060770B2 (en) | 2003-05-20 | 2015-06-23 | Ethicon Endo-Surgery, Inc. | Robotically-driven surgical instrument with E-beam driver |
US20070084897A1 (en) | 2003-05-20 | 2007-04-19 | Shelton Frederick E Iv | Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism |
JP4231743B2 (en) * | 2003-07-07 | 2009-03-04 | オリンパス株式会社 | Biological tissue resection device |
WO2005009200A2 (en) * | 2003-07-24 | 2005-02-03 | Dune Medical Devices Ltd. | Method and apparatus for examining a substance,particularly tissue, to characterize its type |
US7603158B2 (en) * | 2003-09-04 | 2009-10-13 | Adrian Nachman | Current density impedance imaging (CDII) |
RU2372117C2 (en) * | 2003-09-18 | 2009-11-10 | Аркюо Медикал, Инк. | Method of opto-thermo-mechanical impact onto biological tissue and device to this end |
AU2003286644B2 (en) | 2003-10-23 | 2009-09-10 | Covidien Ag | Thermocouple measurement circuit |
US7155270B2 (en) * | 2003-10-24 | 2006-12-26 | Biosense Webster, Inc. | Catheter with multi-spine mapping assembly |
WO2005039689A2 (en) * | 2003-10-24 | 2005-05-06 | Sinus Rhythm Technologies, Inc. | Methods and devices for creating cardiac electrical blocks |
US7179256B2 (en) * | 2003-10-24 | 2007-02-20 | Biosense Webster, Inc. | Catheter with ablation needle and mapping assembly |
US7396336B2 (en) | 2003-10-30 | 2008-07-08 | Sherwood Services Ag | Switched resonant ultrasonic power amplifier system |
US6958064B2 (en) * | 2003-11-14 | 2005-10-25 | Boston Scientific Scimed, Inc. | Systems and methods for performing simultaneous ablation |
SE526861C2 (en) | 2003-11-17 | 2005-11-15 | Syntach Ag | Tissue lesion creation device and a set of devices for the treatment of cardiac arrhythmia disorders |
US7131860B2 (en) | 2003-11-20 | 2006-11-07 | Sherwood Services Ag | Connector systems for electrosurgical generator |
ES2543832T3 (en) | 2003-12-24 | 2015-08-24 | The Regents Of The University Of California | Tissue ablation with irreversible electroporation |
US8298222B2 (en) | 2003-12-24 | 2012-10-30 | The Regents Of The University Of California | Electroporation to deliver chemotherapeutics and enhance tumor regression |
FR2864439B1 (en) * | 2003-12-30 | 2010-12-03 | Image Guided Therapy | DEVICE FOR TREATING A VOLUME OF BIOLOGICAL TISSUE BY LOCALIZED HYPERTHERMIA |
US9398967B2 (en) | 2004-03-02 | 2016-07-26 | Syntach Ag | Electrical conduction block implant device |
US7904145B2 (en) * | 2004-03-23 | 2011-03-08 | Dune Medical Devices Ltd. | Clean margin assessment tool |
US9750425B2 (en) | 2004-03-23 | 2017-09-05 | Dune Medical Devices Ltd. | Graphical user interfaces (GUI), methods and apparatus for data presentation |
US20050249667A1 (en) * | 2004-03-24 | 2005-11-10 | Tuszynski Jack A | Process for treating a biological organism |
JP4724883B2 (en) * | 2004-05-24 | 2011-07-13 | 独立行政法人産業技術総合研究所 | In vivo tissue identification device |
DE602005024952D1 (en) * | 2004-05-26 | 2011-01-05 | Medical Device Innovations Ltd | TISSUE DETECTION AND ABLATION DEVICE |
JP4767252B2 (en) | 2004-06-14 | 2011-09-07 | ヌームアールエックス・インコーポレーテッド | Lung access device |
JP5113519B2 (en) | 2004-07-08 | 2013-01-09 | ヌームアールエックス・インコーポレーテッド | Treatment device, treatment method and material for pleural effusion |
US7766891B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
US8215531B2 (en) | 2004-07-28 | 2012-07-10 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument having a medical substance dispenser |
US11896225B2 (en) | 2004-07-28 | 2024-02-13 | Cilag Gmbh International | Staple cartridge comprising a pan |
US20060047281A1 (en) | 2004-09-01 | 2006-03-02 | Syneron Medical Ltd. | Method and system for invasive skin treatment |
US20060079774A1 (en) * | 2004-10-08 | 2006-04-13 | Wendell Anderson | Microwave biopsy probe |
US7776035B2 (en) * | 2004-10-08 | 2010-08-17 | Covidien Ag | Cool-tip combined electrode introducer |
US7553309B2 (en) | 2004-10-08 | 2009-06-30 | Covidien Ag | Electrosurgical system employing multiple electrodes and method thereof |
US7282049B2 (en) | 2004-10-08 | 2007-10-16 | Sherwood Services Ag | Electrosurgical system employing multiple electrodes and method thereof |
US7628786B2 (en) | 2004-10-13 | 2009-12-08 | Covidien Ag | Universal foot switch contact port |
US8617163B2 (en) | 2004-10-15 | 2013-12-31 | Baxano Surgical, Inc. | Methods, systems and devices for carpal tunnel release |
US9101386B2 (en) | 2004-10-15 | 2015-08-11 | Amendia, Inc. | Devices and methods for treating tissue |
US20100331883A1 (en) | 2004-10-15 | 2010-12-30 | Schmitz Gregory P | Access and tissue modification systems and methods |
US20080312660A1 (en) * | 2007-06-15 | 2008-12-18 | Baxano, Inc. | Devices and methods for measuring the space around a nerve root |
US7887538B2 (en) | 2005-10-15 | 2011-02-15 | Baxano, Inc. | Methods and apparatus for tissue modification |
WO2006044727A2 (en) | 2004-10-15 | 2006-04-27 | Baxano, Inc. | Devices and methods for tissue removal |
US7857813B2 (en) | 2006-08-29 | 2010-12-28 | Baxano, Inc. | Tissue access guidewire system and method |
US9247952B2 (en) | 2004-10-15 | 2016-02-02 | Amendia, Inc. | Devices and methods for tissue access |
US8048080B2 (en) | 2004-10-15 | 2011-11-01 | Baxano, Inc. | Flexible tissue rasp |
US7578819B2 (en) | 2005-05-16 | 2009-08-25 | Baxano, Inc. | Spinal access and neural localization |
US8221397B2 (en) | 2004-10-15 | 2012-07-17 | Baxano, Inc. | Devices and methods for tissue modification |
US7738968B2 (en) | 2004-10-15 | 2010-06-15 | Baxano, Inc. | Devices and methods for selective surgical removal of tissue |
US20110190772A1 (en) | 2004-10-15 | 2011-08-04 | Vahid Saadat | Powered tissue modification devices and methods |
US8062300B2 (en) | 2006-05-04 | 2011-11-22 | Baxano, Inc. | Tissue removal with at least partially flexible devices |
US8257356B2 (en) | 2004-10-15 | 2012-09-04 | Baxano, Inc. | Guidewire exchange systems to treat spinal stenosis |
US8430881B2 (en) | 2004-10-15 | 2013-04-30 | Baxano, Inc. | Mechanical tissue modification devices and methods |
US7738969B2 (en) | 2004-10-15 | 2010-06-15 | Baxano, Inc. | Devices and methods for selective surgical removal of tissue |
US7938830B2 (en) | 2004-10-15 | 2011-05-10 | Baxano, Inc. | Powered tissue modification devices and methods |
US7959577B2 (en) | 2007-09-06 | 2011-06-14 | Baxano, Inc. | Method, system, and apparatus for neural localization |
CA2587857C (en) | 2004-11-23 | 2017-10-10 | Pneumrx, Inc. | Steerable device for accessing a target site and methods |
EP1819304B1 (en) * | 2004-12-09 | 2023-01-25 | Twelve, Inc. | Aortic valve repair |
US20110015549A1 (en) * | 2005-01-13 | 2011-01-20 | Shimon Eckhouse | Method and apparatus for treating a diseased nail |
US7355696B2 (en) * | 2005-02-01 | 2008-04-08 | Arryx, Inc | Method and apparatus for sorting cells |
GB0502384D0 (en) * | 2005-02-04 | 2005-03-16 | Instrumedical Ltd | Electro-surgical needle apparatus |
US9031667B2 (en) * | 2005-03-04 | 2015-05-12 | InterventionTechnology Pty Ltd | Minimal device and method for effecting hyperthermia derived anesthesia |
US7601149B2 (en) | 2005-03-07 | 2009-10-13 | Boston Scientific Scimed, Inc. | Apparatus for switching nominal and attenuated power between ablation probes |
US7678107B2 (en) * | 2005-03-10 | 2010-03-16 | Boston Scientific Scimed, Inc. | Medical needles and electrodes with improved bending stiffness |
US7942873B2 (en) * | 2005-03-25 | 2011-05-17 | Angiodynamics, Inc. | Cavity ablation apparatus and method |
CA2603025C (en) | 2005-03-29 | 2014-05-20 | Dune Medical Devices Ltd. | Electromagnetic sensors for tissue characterization |
US9474564B2 (en) | 2005-03-31 | 2016-10-25 | Covidien Ag | Method and system for compensating for external impedance of an energy carrying component when controlling an electrosurgical generator |
AU2006239957A1 (en) * | 2005-04-21 | 2006-11-02 | Epi-Sci, Llc | Method and system for detecting electrophysiological changes in pre-cancerous and cancerous tissue and epithelium |
US20080009764A1 (en) * | 2005-04-21 | 2008-01-10 | Epi-Sci, Llc | Method and system for detecting electrophysiological changes in pre-cancerous and cancerous tissue and epithelium |
US8114070B2 (en) * | 2005-06-24 | 2012-02-14 | Angiodynamics, Inc. | Methods and systems for treating BPH using electroporation |
US20060293730A1 (en) | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating restenosis sites using electroporation |
US7615050B2 (en) * | 2005-06-27 | 2009-11-10 | Boston Scientific Scimed, Inc. | Systems and methods for creating a lesion using transjugular approach |
US8080009B2 (en) | 2005-07-01 | 2011-12-20 | Halt Medical Inc. | Radio frequency ablation device for the destruction of tissue masses |
GB2434314B (en) | 2006-01-03 | 2011-06-15 | Microsulis Ltd | Microwave applicator with dipole antenna |
US8512330B2 (en) * | 2005-07-01 | 2013-08-20 | Halt Medical Inc. | Ablation method |
US11484312B2 (en) | 2005-08-31 | 2022-11-01 | Cilag Gmbh International | Staple cartridge comprising a staple driver arrangement |
US9237891B2 (en) | 2005-08-31 | 2016-01-19 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical stapling devices that produce formed staples having different lengths |
US7669746B2 (en) | 2005-08-31 | 2010-03-02 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US8317070B2 (en) | 2005-08-31 | 2012-11-27 | Ethicon Endo-Surgery, Inc. | Surgical stapling devices that produce formed staples having different lengths |
US10159482B2 (en) | 2005-08-31 | 2018-12-25 | Ethicon Llc | Fastener cartridge assembly comprising a fixed anvil and different staple heights |
US11246590B2 (en) | 2005-08-31 | 2022-02-15 | Cilag Gmbh International | Staple cartridge including staple drivers having different unfired heights |
US7934630B2 (en) | 2005-08-31 | 2011-05-03 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US20070066971A1 (en) * | 2005-09-21 | 2007-03-22 | Podhajsky Ronald J | Method and system for treating pain during an electrosurgical procedure |
US7879031B2 (en) | 2005-09-27 | 2011-02-01 | Covidien Ag | Cooled RF ablation needle |
US20070078453A1 (en) * | 2005-10-04 | 2007-04-05 | Johnson Kristin D | System and method for performing cardiac ablation |
US8062298B2 (en) | 2005-10-15 | 2011-11-22 | Baxano, Inc. | Flexible tissue removal devices and methods |
US8092456B2 (en) | 2005-10-15 | 2012-01-10 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US8366712B2 (en) | 2005-10-15 | 2013-02-05 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US8734438B2 (en) | 2005-10-21 | 2014-05-27 | Covidien Ag | Circuit and method for reducing stored energy in an electrosurgical generator |
US20070106317A1 (en) | 2005-11-09 | 2007-05-10 | Shelton Frederick E Iv | Hydraulically and electrically actuated articulation joints for surgical instruments |
US7842031B2 (en) * | 2005-11-18 | 2010-11-30 | Medtronic Cryocath Lp | Bioimpedance measurement system and method |
US8696656B2 (en) * | 2005-11-18 | 2014-04-15 | Medtronic Cryocath Lp | System and method for monitoring bioimpedance and respiration |
CN101316560B (en) * | 2005-12-02 | 2011-01-26 | 皇家飞利浦电子股份有限公司 | Automating the ablation procedure to minimize the need for manual intervention |
US9492226B2 (en) * | 2005-12-06 | 2016-11-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Graphical user interface for real-time RF lesion depth display |
US20090177111A1 (en) * | 2006-12-06 | 2009-07-09 | Miller Stephan P | System and method for displaying contact between a catheter and tissue |
US8403925B2 (en) * | 2006-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing lesions in tissue |
EP1962710B1 (en) | 2005-12-06 | 2015-08-12 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus for displaying catheter electrode-tissue contact in electro-anatomic mapping and navigation system |
US8332025B2 (en) * | 2005-12-06 | 2012-12-11 | Epi-Sci, Llc | Method and system for detecting electrophysiological changes in pre-cancerous and cancerous tissue and epithelium |
US9254163B2 (en) | 2005-12-06 | 2016-02-09 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US8449535B2 (en) * | 2005-12-06 | 2013-05-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
WO2007070361A2 (en) | 2005-12-06 | 2007-06-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US8603084B2 (en) | 2005-12-06 | 2013-12-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the formation of a lesion in tissue |
US8406866B2 (en) * | 2005-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
US10362959B2 (en) | 2005-12-06 | 2019-07-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the proximity of an electrode to tissue in a body |
US7751869B2 (en) * | 2005-12-09 | 2010-07-06 | Boston Scientific Scimed, Inc. | Radiation ablation tracking system and method |
US7947039B2 (en) | 2005-12-12 | 2011-05-24 | Covidien Ag | Laparoscopic apparatus for performing electrosurgical procedures |
US20070142884A1 (en) * | 2005-12-16 | 2007-06-21 | Acoustx Corporation | Methods and apparatuses for treating an esophageal disorder such as gastroesophageal reflux disease |
US20070142699A1 (en) * | 2005-12-16 | 2007-06-21 | Acoustx Corporation | Methods and implantable apparatuses for treating an esophageal disorder such as gastroesophageal reflux disease |
US20090036794A1 (en) * | 2005-12-29 | 2009-02-05 | Rikshospitalet-Radiumhospitalet Hf | Method and apparatus for determining local tissue impedance for positioning of a needle |
US7879029B2 (en) * | 2005-12-30 | 2011-02-01 | Biosense Webster, Inc. | System and method for selectively energizing catheter electrodes |
US20070156135A1 (en) * | 2006-01-03 | 2007-07-05 | Boris Rubinsky | System and methods for treating atrial fibrillation using electroporation |
WO2007084508A2 (en) * | 2006-01-13 | 2007-07-26 | Mirabilis Medica, Inc. | Apparatus for delivering high intensity focused ultrasound energy to a treatment site internal to a patient's body |
US8147485B2 (en) | 2006-01-24 | 2012-04-03 | Covidien Ag | System and method for tissue sealing |
CA2574935A1 (en) | 2006-01-24 | 2007-07-24 | Sherwood Services Ag | A method and system for controlling an output of a radio-frequency medical generator having an impedance based control algorithm |
US9186200B2 (en) | 2006-01-24 | 2015-11-17 | Covidien Ag | System and method for tissue sealing |
US7513896B2 (en) | 2006-01-24 | 2009-04-07 | Covidien Ag | Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling |
US8685016B2 (en) | 2006-01-24 | 2014-04-01 | Covidien Ag | System and method for tissue sealing |
CA2574934C (en) | 2006-01-24 | 2015-12-29 | Sherwood Services Ag | System and method for closed loop monitoring of monopolar electrosurgical apparatus |
US8216223B2 (en) | 2006-01-24 | 2012-07-10 | Covidien Ag | System and method for tissue sealing |
CA2575392C (en) | 2006-01-24 | 2015-07-07 | Sherwood Services Ag | System and method for tissue sealing |
US20110024477A1 (en) | 2009-02-06 | 2011-02-03 | Hall Steven G | Driven Surgical Stapler Improvements |
US7753904B2 (en) | 2006-01-31 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Endoscopic surgical instrument with a handle that can articulate with respect to the shaft |
US20070179491A1 (en) * | 2006-01-31 | 2007-08-02 | Medtronic, Inc. | Sensing needle for ablation therapy |
US8820603B2 (en) | 2006-01-31 | 2014-09-02 | Ethicon Endo-Surgery, Inc. | Accessing data stored in a memory of a surgical instrument |
US7845537B2 (en) | 2006-01-31 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Surgical instrument having recording capabilities |
US11278279B2 (en) | 2006-01-31 | 2022-03-22 | Cilag Gmbh International | Surgical instrument assembly |
US20070179496A1 (en) * | 2006-01-31 | 2007-08-02 | Medtronic, Inc. | Flexible catheter for ablation therapy |
US11224427B2 (en) | 2006-01-31 | 2022-01-18 | Cilag Gmbh International | Surgical stapling system including a console and retraction assembly |
US20120292367A1 (en) | 2006-01-31 | 2012-11-22 | Ethicon Endo-Surgery, Inc. | Robotically-controlled end effector |
US8708213B2 (en) | 2006-01-31 | 2014-04-29 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a feedback system |
US20110295295A1 (en) | 2006-01-31 | 2011-12-01 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical instrument having recording capabilities |
US8186555B2 (en) | 2006-01-31 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting and fastening instrument with mechanical closure system |
US11793518B2 (en) | 2006-01-31 | 2023-10-24 | Cilag Gmbh International | Powered surgical instruments with firing system lockout arrangements |
US20070197895A1 (en) | 2006-02-17 | 2007-08-23 | Sdgi Holdings, Inc. | Surgical instrument to assess tissue characteristics |
US7651493B2 (en) | 2006-03-03 | 2010-01-26 | Covidien Ag | System and method for controlling electrosurgical snares |
US8888800B2 (en) | 2006-03-13 | 2014-11-18 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US8157837B2 (en) | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Minimally invasive lung volume reduction device and method |
US9402633B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
GB2442045A (en) * | 2006-03-22 | 2008-03-26 | Alexander Macrae | Monitoring physiological changes |
JP2007252468A (en) * | 2006-03-22 | 2007-10-04 | Olympus Medical Systems Corp | Medical apparatus |
US20070225562A1 (en) | 2006-03-23 | 2007-09-27 | Ethicon Endo-Surgery, Inc. | Articulating endoscopic accessory channel |
US8992422B2 (en) | 2006-03-23 | 2015-03-31 | Ethicon Endo-Surgery, Inc. | Robotically-controlled endoscopic accessory channel |
WO2007112081A1 (en) | 2006-03-24 | 2007-10-04 | Micrablate | Transmission line with heat transfer ability |
CA2649119A1 (en) | 2006-04-13 | 2007-12-13 | Mirabilis Medica, Inc. | Methods and apparatus for the treatment of menometrorrhagia, endometrial pathology, and cervical neoplasia using high intensity focused ultrasound energy |
KR100785882B1 (en) * | 2006-04-14 | 2007-12-17 | 경희대학교 산학협력단 | Apparatus and method for detecting anomalies within a body |
US7651492B2 (en) | 2006-04-24 | 2010-01-26 | Covidien Ag | Arc based adaptive control system for an electrosurgical unit |
US20070255270A1 (en) * | 2006-04-27 | 2007-11-01 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
US20070258896A1 (en) * | 2006-05-02 | 2007-11-08 | Mirabel Medical Systems Ltd. | Contrast Agents In Medical Imaging |
US20070260174A1 (en) * | 2006-05-05 | 2007-11-08 | Searete Llc | Detecting a failure to maintain a regimen |
US20070260240A1 (en) | 2006-05-05 | 2007-11-08 | Sherwood Services Ag | Soft tissue RF transection and resection device |
US20090209955A1 (en) * | 2006-06-20 | 2009-08-20 | Forster David C | Prosthetic valve implant site preparation techniques |
US8322455B2 (en) | 2006-06-27 | 2012-12-04 | Ethicon Endo-Surgery, Inc. | Manually driven surgical cutting and fastening instrument |
ES2928065T3 (en) | 2006-06-28 | 2022-11-15 | Medtronic Ardian Luxembourg | Thermally induced renal neuromodulation systems |
US8457733B2 (en) | 2006-06-30 | 2013-06-04 | Andreas Linninger | Monitoring and controlling hydrocephalus |
US20080015573A1 (en) * | 2006-07-11 | 2008-01-17 | Cino Rossi | Medical device |
US11389235B2 (en) | 2006-07-14 | 2022-07-19 | Neuwave Medical, Inc. | Energy delivery systems and uses thereof |
US10376314B2 (en) | 2006-07-14 | 2019-08-13 | Neuwave Medical, Inc. | Energy delivery systems and uses thereof |
US7763018B2 (en) | 2006-07-28 | 2010-07-27 | Covidien Ag | Cool-tip thermocouple including two-piece hub |
JP2010503477A (en) * | 2006-09-12 | 2010-02-04 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | Method and apparatus for identifying tissue types |
US7680543B2 (en) * | 2006-09-14 | 2010-03-16 | Lazure Technologies, Llc | Tissue ablation and removal |
US7794457B2 (en) | 2006-09-28 | 2010-09-14 | Covidien Ag | Transformer for RF voltage sensing |
US10568652B2 (en) | 2006-09-29 | 2020-02-25 | Ethicon Llc | Surgical staples having attached drivers of different heights and stapling instruments for deploying the same |
US8220690B2 (en) | 2006-09-29 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Connected surgical staples and stapling instruments for deploying the same |
US7674249B2 (en) | 2006-10-16 | 2010-03-09 | The Regents Of The University Of California | Gels with predetermined conductivity used in electroporation of tissue |
US9028520B2 (en) | 2006-12-22 | 2015-05-12 | The Spectranetics Corporation | Tissue separating systems and methods |
US8961551B2 (en) | 2006-12-22 | 2015-02-24 | The Spectranetics Corporation | Retractable separating systems and methods |
US8226648B2 (en) | 2007-12-31 | 2012-07-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Pressure-sensitive flexible polymer bipolar electrode |
US10085798B2 (en) * | 2006-12-29 | 2018-10-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation electrode with tactile sensor |
US8652120B2 (en) | 2007-01-10 | 2014-02-18 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between control unit and sensor transponders |
US11291441B2 (en) | 2007-01-10 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with wireless communication between control unit and remote sensor |
US8684253B2 (en) | 2007-01-10 | 2014-04-01 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor |
US11039836B2 (en) | 2007-01-11 | 2021-06-22 | Cilag Gmbh International | Staple cartridge for use with a surgical stapling instrument |
US8827133B2 (en) | 2007-01-11 | 2014-09-09 | Ethicon Endo-Surgery, Inc. | Surgical stapling device having supports for a flexible drive mechanism |
US8211099B2 (en) | 2007-01-31 | 2012-07-03 | Tyco Healthcare Group Lp | Thermal feedback systems and methods of using the same |
US9566030B2 (en) | 2007-02-01 | 2017-02-14 | Ls Biopath, Inc. | Optical system for detection and characterization of abnormal tissue and cells |
US8417328B2 (en) | 2007-02-01 | 2013-04-09 | Ls Biopath, Inc. | Electrical systems for detection and characterization of abnormal tissue and cells |
US7655004B2 (en) | 2007-02-15 | 2010-02-02 | Ethicon Endo-Surgery, Inc. | Electroporation ablation apparatus, system, and method |
GB0703417D0 (en) * | 2007-02-22 | 2007-04-04 | Eschmann Holdings Ltd | Electro-surgical systems |
US8147423B2 (en) * | 2007-03-01 | 2012-04-03 | Dune Medical Devices, Ltd. | Tissue-characterization system and method |
US7815662B2 (en) | 2007-03-08 | 2010-10-19 | Ethicon Endo-Surgery, Inc. | Surgical suture anchors and deployment device |
US7669747B2 (en) | 2007-03-15 | 2010-03-02 | Ethicon Endo-Surgery, Inc. | Washer for use with a surgical stapling instrument |
US8893946B2 (en) | 2007-03-28 | 2014-11-25 | Ethicon Endo-Surgery, Inc. | Laparoscopic tissue thickness and clamp load measuring devices |
US8945114B2 (en) * | 2007-04-26 | 2015-02-03 | Medtronic, Inc. | Fluid sensor for ablation therapy |
US8075572B2 (en) | 2007-04-26 | 2011-12-13 | Ethicon Endo-Surgery, Inc. | Surgical suturing apparatus |
US8100922B2 (en) | 2007-04-27 | 2012-01-24 | Ethicon Endo-Surgery, Inc. | Curved needle suturing tool |
US20080275440A1 (en) * | 2007-05-03 | 2008-11-06 | Medtronic, Inc. | Post-ablation verification of lesion size |
US8777941B2 (en) | 2007-05-10 | 2014-07-15 | Covidien Lp | Adjustable impedance electrosurgical electrodes |
US7620507B2 (en) * | 2007-05-24 | 2009-11-17 | Battelle Energy Alliance, Llc | Impedance-estimation methods, modeling methods, articles of manufacture, impedance-modeling devices, and estimated-impedance monitoring systems |
US11857181B2 (en) | 2007-06-04 | 2024-01-02 | Cilag Gmbh International | Robotically-controlled shaft based rotary drive systems for surgical instruments |
US8931682B2 (en) | 2007-06-04 | 2015-01-13 | Ethicon Endo-Surgery, Inc. | Robotically-controlled shaft based rotary drive systems for surgical instruments |
US20090036958A1 (en) * | 2007-08-01 | 2009-02-05 | Primaeva Medical, Inc. | Methods and devices for treating tissue |
US8845630B2 (en) * | 2007-06-15 | 2014-09-30 | Syneron Medical Ltd | Devices and methods for percutaneous energy delivery |
US9486269B2 (en) | 2007-06-22 | 2016-11-08 | Covidien Lp | Electrosurgical systems and cartridges for use therewith |
US7753245B2 (en) | 2007-06-22 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments |
US9987468B2 (en) | 2007-06-29 | 2018-06-05 | Actuated Medical, Inc. | Reduced force device for intravascular access and guidewire placement |
US8328738B2 (en) | 2007-06-29 | 2012-12-11 | Actuated Medical, Inc. | Medical tool for reduced penetration force with feedback means |
US10219832B2 (en) | 2007-06-29 | 2019-03-05 | Actuated Medical, Inc. | Device and method for less forceful tissue puncture |
US11849941B2 (en) | 2007-06-29 | 2023-12-26 | Cilag Gmbh International | Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis |
US7834484B2 (en) | 2007-07-16 | 2010-11-16 | Tyco Healthcare Group Lp | Connection cable and method for activating a voltage-controlled generator |
US8361064B2 (en) * | 2007-07-16 | 2013-01-29 | Stockert Ruediger | Device for thermosurgery |
US8052604B2 (en) * | 2007-07-31 | 2011-11-08 | Mirabilis Medica Inc. | Methods and apparatus for engagement and coupling of an intracavitory imaging and high intensity focused ultrasound probe |
JP2009050334A (en) * | 2007-08-24 | 2009-03-12 | Ge Medical Systems Global Technology Co Llc | Ultrasonic diagnostic apparatus, ultrasonic probe, temperature calculation method and signal processing method |
US8262655B2 (en) | 2007-11-21 | 2012-09-11 | Ethicon Endo-Surgery, Inc. | Bipolar forceps |
US8579897B2 (en) | 2007-11-21 | 2013-11-12 | Ethicon Endo-Surgery, Inc. | Bipolar forceps |
US8568410B2 (en) | 2007-08-31 | 2013-10-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation surgical instruments |
US8181995B2 (en) | 2007-09-07 | 2012-05-22 | Tyco Healthcare Group Lp | Cool tip junction |
US8216220B2 (en) | 2007-09-07 | 2012-07-10 | Tyco Healthcare Group Lp | System and method for transmission of combined data stream |
US20090076500A1 (en) * | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-tine probe and treatment by activation of opposing tines |
US20160184006A1 (en) * | 2007-09-14 | 2016-06-30 | Lazure Scientific, Inc. | Ablation probe with deployable electrodes |
US8512332B2 (en) | 2007-09-21 | 2013-08-20 | Covidien Lp | Real-time arc control in electrosurgical generators |
US8480657B2 (en) | 2007-10-31 | 2013-07-09 | Ethicon Endo-Surgery, Inc. | Detachable distal overtube section and methods for forming a sealable opening in the wall of an organ |
US20090112059A1 (en) | 2007-10-31 | 2009-04-30 | Nobis Rudolph H | Apparatus and methods for closing a gastrotomy |
US8187270B2 (en) * | 2007-11-07 | 2012-05-29 | Mirabilis Medica Inc. | Hemostatic spark erosion tissue tunnel generator with integral treatment providing variable volumetric necrotization of tissue |
US8439907B2 (en) * | 2007-11-07 | 2013-05-14 | Mirabilis Medica Inc. | Hemostatic tissue tunnel generator for inserting treatment apparatus into tissue of a patient |
US8292880B2 (en) | 2007-11-27 | 2012-10-23 | Vivant Medical, Inc. | Targeted cooling of deployable microwave antenna |
US8192436B2 (en) | 2007-12-07 | 2012-06-05 | Baxano, Inc. | Tissue modification devices |
AU2008341168B2 (en) * | 2007-12-11 | 2014-08-21 | Epi-Sci, Llc | Electrical bioimpedance analysis as a biomarker of breast density and/or breast cancer risk |
US8290578B2 (en) * | 2007-12-28 | 2012-10-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for complex impedance compensation |
US8147443B2 (en) | 2007-12-28 | 2012-04-03 | Boston Scientific Scimed, Inc. | Indirect fluid flow measurement |
US9204927B2 (en) | 2009-05-13 | 2015-12-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for presenting information representative of lesion formation in tissue during an ablation procedure |
US10660690B2 (en) * | 2007-12-28 | 2020-05-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for measurement of an impedance using a catheter such as an ablation catheter |
US9078627B2 (en) | 2008-01-04 | 2015-07-14 | Texas Heart Institute | Introducer sheath with electrodes |
WO2009090632A2 (en) | 2008-01-17 | 2009-07-23 | Syneron Medical Ltd. | A hair removal apparatus for personal use and the method of using same |
CN101951851B (en) | 2008-01-24 | 2013-02-06 | 赛诺龙医疗公司 | A device and apparatus of adipose tissue treatment |
EP2247238B1 (en) * | 2008-01-29 | 2013-10-23 | St. Jude Medical AB | Mplantable medical device (imd) for monitoring permeability status of cell membranes. |
US8353902B2 (en) * | 2008-01-31 | 2013-01-15 | Vivant Medical, Inc. | Articulating ablation device and method |
US20090204005A1 (en) * | 2008-02-07 | 2009-08-13 | Broncus Technologies, Inc. | Puncture resistant catheter for sensing vessels and for creating passages in tissue |
US8343144B2 (en) * | 2008-02-11 | 2013-01-01 | Expandoheat, Llc | Apparatus and method for vessel sealing and tissue coagulation |
US9179912B2 (en) | 2008-02-14 | 2015-11-10 | Ethicon Endo-Surgery, Inc. | Robotically-controlled motorized surgical cutting and fastening instrument |
US8573465B2 (en) | 2008-02-14 | 2013-11-05 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical end effector system with rotary actuated closure systems |
US7819298B2 (en) | 2008-02-14 | 2010-10-26 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with control features operable with one hand |
BRPI0901282A2 (en) | 2008-02-14 | 2009-11-17 | Ethicon Endo Surgery Inc | surgical cutting and fixation instrument with rf electrodes |
US8636736B2 (en) | 2008-02-14 | 2014-01-28 | Ethicon Endo-Surgery, Inc. | Motorized surgical cutting and fastening instrument |
US7866527B2 (en) | 2008-02-14 | 2011-01-11 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with interlockable firing system |
US8758391B2 (en) | 2008-02-14 | 2014-06-24 | Ethicon Endo-Surgery, Inc. | Interchangeable tools for surgical instruments |
US11272927B2 (en) | 2008-02-15 | 2022-03-15 | Cilag Gmbh International | Layer arrangements for surgical staple cartridges |
US9770245B2 (en) | 2008-02-15 | 2017-09-26 | Ethicon Llc | Layer arrangements for surgical staple cartridges |
US8262680B2 (en) | 2008-03-10 | 2012-09-11 | Ethicon Endo-Surgery, Inc. | Anastomotic device |
US8409186B2 (en) | 2008-03-13 | 2013-04-02 | Covidien Lp | Crest factor enhancement in electrosurgical generators |
WO2009121009A2 (en) | 2008-03-27 | 2009-10-01 | The Regents Of The University Of California | Irreversible electroporation device for use in attenuating neointimal |
US8257349B2 (en) | 2008-03-28 | 2012-09-04 | Tyco Healthcare Group Lp | Electrosurgical apparatus with predictive RF source control |
ES2428719T3 (en) | 2008-03-31 | 2013-11-11 | Applied Medical Resources Corporation | Electrosurgical system with means to measure tissue permittivity and conductivity |
US20090264771A1 (en) * | 2008-04-22 | 2009-10-22 | Medtronic Vascular, Inc. | Ultrasonic Based Characterization of Plaque in Chronic Total Occlusions |
US20090270756A1 (en) * | 2008-04-23 | 2009-10-29 | Gamache Ronald W | Determining physiological characteristics of animal |
WO2009137609A2 (en) | 2008-05-06 | 2009-11-12 | Cellutions, Inc. | Apparatus and systems for treating a human tissue condition |
WO2009137800A2 (en) | 2008-05-09 | 2009-11-12 | Angiodynamics, Inc. | Electroporation device and method |
US8070759B2 (en) | 2008-05-30 | 2011-12-06 | Ethicon Endo-Surgery, Inc. | Surgical fastening device |
US8652150B2 (en) | 2008-05-30 | 2014-02-18 | Ethicon Endo-Surgery, Inc. | Multifunction surgical device |
US8114072B2 (en) | 2008-05-30 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | Electrical ablation device |
US8317806B2 (en) | 2008-05-30 | 2012-11-27 | Ethicon Endo-Surgery, Inc. | Endoscopic suturing tension controlling and indication devices |
US8679003B2 (en) | 2008-05-30 | 2014-03-25 | Ethicon Endo-Surgery, Inc. | Surgical device and endoscope including same |
US8771260B2 (en) | 2008-05-30 | 2014-07-08 | Ethicon Endo-Surgery, Inc. | Actuating and articulating surgical device |
US8906035B2 (en) | 2008-06-04 | 2014-12-09 | Ethicon Endo-Surgery, Inc. | Endoscopic drop off bag |
US8403926B2 (en) | 2008-06-05 | 2013-03-26 | Ethicon Endo-Surgery, Inc. | Manually articulating devices |
US8226639B2 (en) * | 2008-06-10 | 2012-07-24 | Tyco Healthcare Group Lp | System and method for output control of electrosurgical generator |
US8048100B2 (en) * | 2008-06-10 | 2011-11-01 | Terumo Cardiovascular Systems, Corp. | Blunt dissector for separating blood vessels from surrounding tissue |
WO2009155526A2 (en) | 2008-06-20 | 2009-12-23 | Angiodynamics, Inc. | Device and method for the ablation of fibrin sheath formation on a venous catheter |
US9681909B2 (en) | 2008-06-23 | 2017-06-20 | Angiodynamics, Inc. | Treatment devices and methods |
US8361112B2 (en) | 2008-06-27 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Surgical suture arrangement |
US8398641B2 (en) | 2008-07-01 | 2013-03-19 | Baxano, Inc. | Tissue modification devices and methods |
US9314253B2 (en) | 2008-07-01 | 2016-04-19 | Amendia, Inc. | Tissue modification devices and methods |
US8409206B2 (en) | 2008-07-01 | 2013-04-02 | Baxano, Inc. | Tissue modification devices and methods |
DE102008050635A1 (en) * | 2008-10-07 | 2010-04-15 | Erbe Elektromedizin Gmbh | Method and apparatus for controlling a cooled RF ablation probe |
US8262563B2 (en) | 2008-07-14 | 2012-09-11 | Ethicon Endo-Surgery, Inc. | Endoscopic translumenal articulatable steerable overtube |
US8888792B2 (en) | 2008-07-14 | 2014-11-18 | Ethicon Endo-Surgery, Inc. | Tissue apposition clip application devices and methods |
MX348805B (en) | 2008-07-14 | 2017-06-28 | Baxano Inc | Tissue modification devices. |
US9314293B2 (en) | 2008-07-16 | 2016-04-19 | Syneron Medical Ltd | RF electrode for aesthetic and body shaping devices and method of using same |
US20100017750A1 (en) | 2008-07-16 | 2010-01-21 | Avner Rosenberg | User interface |
US8608739B2 (en) | 2008-07-22 | 2013-12-17 | Covidien Lp | Electrosurgical devices, systems and methods of using the same |
US8216161B2 (en) * | 2008-08-06 | 2012-07-10 | Mirabilis Medica Inc. | Optimization and feedback control of HIFU power deposition through the frequency analysis of backscattered HIFU signals |
US9248318B2 (en) | 2008-08-06 | 2016-02-02 | Mirabilis Medica Inc. | Optimization and feedback control of HIFU power deposition through the analysis of detected signal characteristics |
WO2010019481A1 (en) | 2008-08-11 | 2010-02-18 | Conceptx Medical, Inc. | Systems and methods for treating dyspnea, including via electrical afferent signal blocking |
US8211125B2 (en) | 2008-08-15 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Sterile appliance delivery device for endoscopic procedures |
US8529563B2 (en) | 2008-08-25 | 2013-09-10 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US8211098B2 (en) | 2008-08-25 | 2012-07-03 | Vivant Medical, Inc. | Microwave antenna assembly having a dielectric body portion with radial partitions of dielectric material |
US8241204B2 (en) | 2008-08-29 | 2012-08-14 | Ethicon Endo-Surgery, Inc. | Articulating end cap |
US8480689B2 (en) | 2008-09-02 | 2013-07-09 | Ethicon Endo-Surgery, Inc. | Suturing device |
US8403924B2 (en) * | 2008-09-03 | 2013-03-26 | Vivant Medical, Inc. | Shielding for an isolation apparatus used in a microwave generator |
US8409200B2 (en) | 2008-09-03 | 2013-04-02 | Ethicon Endo-Surgery, Inc. | Surgical grasping device |
US8114119B2 (en) | 2008-09-09 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | Surgical grasping device |
US8632605B2 (en) | 2008-09-12 | 2014-01-21 | Pneumrx, Inc. | Elongated lung volume reduction devices, methods, and systems |
US20100100093A1 (en) * | 2008-09-16 | 2010-04-22 | Lazure Technologies, Llc. | System and method for controlled tissue heating for destruction of cancerous cells |
EP2334249B1 (en) | 2008-09-21 | 2013-03-13 | Syneron Medical Ltd. | A method and apparatus for personal skin treatment |
US8210411B2 (en) | 2008-09-23 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument |
US11648005B2 (en) | 2008-09-23 | 2023-05-16 | Cilag Gmbh International | Robotically-controlled motorized surgical instrument with an end effector |
US9005230B2 (en) | 2008-09-23 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Motorized surgical instrument |
US9386983B2 (en) | 2008-09-23 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Robotically-controlled motorized surgical instrument |
US8174267B2 (en) * | 2008-09-30 | 2012-05-08 | Vivant Medical, Inc. | Intermittent microwave energy delivery system |
US8180433B2 (en) * | 2008-09-30 | 2012-05-15 | Vivant Medical, Inc. | Microwave system calibration apparatus, system and method of use |
US8287527B2 (en) * | 2008-09-30 | 2012-10-16 | Vivant Medical, Inc. | Microwave system calibration apparatus and method of use |
DE102008049709B4 (en) * | 2008-09-30 | 2019-12-12 | Siemens Healthcare Gmbh | Method for selectively displaying a movement of the lung, computer program, image processing unit and magnetic resonance apparatus |
US8346370B2 (en) * | 2008-09-30 | 2013-01-01 | Vivant Medical, Inc. | Delivered energy generator for microwave ablation |
US8248075B2 (en) * | 2008-09-30 | 2012-08-21 | Vivant Medical, Inc. | System, apparatus and method for dissipating standing wave in a microwave delivery system |
US8242782B2 (en) | 2008-09-30 | 2012-08-14 | Vivant Medical, Inc. | Microwave ablation generator control system |
US20100082083A1 (en) * | 2008-09-30 | 2010-04-01 | Brannan Joseph D | Microwave system tuner |
US8337394B2 (en) | 2008-10-01 | 2012-12-25 | Ethicon Endo-Surgery, Inc. | Overtube with expandable tip |
CA2739425A1 (en) | 2008-10-03 | 2010-04-08 | Mirabilis Medica, Inc. | Method and apparatus for treating tissues with hifu |
US9050449B2 (en) | 2008-10-03 | 2015-06-09 | Mirabilis Medica, Inc. | System for treating a volume of tissue with high intensity focused ultrasound |
US8608045B2 (en) | 2008-10-10 | 2013-12-17 | Ethicon Endo-Sugery, Inc. | Powered surgical cutting and stapling apparatus with manually retractable firing system |
US8157834B2 (en) | 2008-11-25 | 2012-04-17 | Ethicon Endo-Surgery, Inc. | Rotational coupling device for surgical instrument with flexible actuators |
US8172772B2 (en) | 2008-12-11 | 2012-05-08 | Ethicon Endo-Surgery, Inc. | Specimen retrieval device |
US20100152725A1 (en) * | 2008-12-12 | 2010-06-17 | Angiodynamics, Inc. | Method and system for tissue treatment utilizing irreversible electroporation and thermal track coagulation |
US20100168568A1 (en) * | 2008-12-30 | 2010-07-01 | St. Jude Medical, Atrial Fibrillation Division Inc. | Combined Diagnostic and Therapeutic Device Using Aligned Energy Beams |
US8211100B2 (en) * | 2009-01-12 | 2012-07-03 | Tyco Healthcare Group Lp | Energy delivery algorithm for medical devices based on maintaining a fixed position on a tissue electrical conductivity v. temperature curve |
US8361066B2 (en) | 2009-01-12 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US8333759B2 (en) * | 2009-01-12 | 2012-12-18 | Covidien Lp | Energy delivery algorithm for medical devices |
US8167875B2 (en) * | 2009-01-12 | 2012-05-01 | Tyco Healthcare Group Lp | Energy delivery algorithm for medical devices |
US8262652B2 (en) | 2009-01-12 | 2012-09-11 | Tyco Healthcare Group Lp | Imaginary impedance process monitoring and intelligent shut-off |
US8828031B2 (en) | 2009-01-12 | 2014-09-09 | Ethicon Endo-Surgery, Inc. | Apparatus for forming an anastomosis |
US8753335B2 (en) | 2009-01-23 | 2014-06-17 | Angiodynamics, Inc. | Therapeutic energy delivery device with rotational mechanism |
EP2210567B1 (en) * | 2009-01-26 | 2013-07-31 | Lina Medical ApS | A bipolar electrosurgical instrument |
US8948838B2 (en) | 2009-01-27 | 2015-02-03 | Scibase Ab | Switch probe for multiple electrode measurement of impedance |
US20100191141A1 (en) * | 2009-01-27 | 2010-07-29 | Peter Aberg | Method and apparatus for diagnosing a diseased condition in tissue of a subject |
US9226772B2 (en) | 2009-01-30 | 2016-01-05 | Ethicon Endo-Surgery, Inc. | Surgical device |
US8252057B2 (en) | 2009-01-30 | 2012-08-28 | Ethicon Endo-Surgery, Inc. | Surgical access device |
US8037591B2 (en) | 2009-02-02 | 2011-10-18 | Ethicon Endo-Surgery, Inc. | Surgical scissors |
US8517239B2 (en) | 2009-02-05 | 2013-08-27 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument comprising a magnetic element driver |
CA2751664A1 (en) | 2009-02-06 | 2010-08-12 | Ethicon Endo-Surgery, Inc. | Driven surgical stapler improvements |
US8444036B2 (en) | 2009-02-06 | 2013-05-21 | Ethicon Endo-Surgery, Inc. | Motor driven surgical fastener device with mechanisms for adjusting a tissue gap within the end effector |
US8231603B2 (en) | 2009-02-10 | 2012-07-31 | Angiodynamics, Inc. | Irreversible electroporation and tissue regeneration |
US8211097B2 (en) * | 2009-02-13 | 2012-07-03 | Cutera, Inc. | Optimizing RF power spatial distribution using frequency control |
US8606366B2 (en) | 2009-02-18 | 2013-12-10 | Syneron Medical Ltd. | Skin treatment apparatus for personal use and method for using same |
EP2730313A1 (en) | 2009-02-25 | 2014-05-14 | Syneron Medical Ltd. | Electrical skin rejuvenation |
US9522039B2 (en) | 2009-03-11 | 2016-12-20 | Covidien Lp | Crest factor enhancement in electrosurgical generators |
MX2011009165A (en) | 2009-03-13 | 2011-09-26 | Baxano Inc | Flexible neural localization devices and methods. |
US8298225B2 (en) * | 2009-03-19 | 2012-10-30 | Tyco Healthcare Group Lp | System and method for return electrode monitoring |
US9277969B2 (en) | 2009-04-01 | 2016-03-08 | Covidien Lp | Microwave ablation system with user-controlled ablation size and method of use |
KR20120004398A (en) * | 2009-04-01 | 2012-01-12 | 시네론 메디컬 리미티드 | A method and apparatus for liposuction |
US8632534B2 (en) * | 2009-04-03 | 2014-01-21 | Angiodynamics, Inc. | Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD) |
WO2010118387A1 (en) | 2009-04-09 | 2010-10-14 | Virginia Tech Intellectual Properties, Inc. | Integration of very short electric pulses for minimally to noninvasive electroporation |
US20100268225A1 (en) * | 2009-04-15 | 2010-10-21 | Tyco Healthcare Group Lp | Methods for Image Analysis and Visualization of Medical Image Data Suitable for Use in Assessing Tissue Ablation and Systems and Methods for Controlling Tissue Ablation Using Same |
US20100268223A1 (en) * | 2009-04-15 | 2010-10-21 | Tyco Health Group Lp | Methods for Image Analysis and Visualization of Medical Image Data Suitable for Use in Assessing Tissue Ablation and Systems and Methods for Controlling Tissue Ablation Using Same |
US8523852B2 (en) | 2009-04-17 | 2013-09-03 | Domain Surgical, Inc. | Thermally adjustable surgical tool system |
US9078655B2 (en) | 2009-04-17 | 2015-07-14 | Domain Surgical, Inc. | Heated balloon catheter |
US9265556B2 (en) | 2009-04-17 | 2016-02-23 | Domain Surgical, Inc. | Thermally adjustable surgical tool, balloon catheters and sculpting of biologic materials |
US9107666B2 (en) | 2009-04-17 | 2015-08-18 | Domain Surgical, Inc. | Thermal resecting loop |
US9131977B2 (en) | 2009-04-17 | 2015-09-15 | Domain Surgical, Inc. | Layered ferromagnetic coated conductor thermal surgical tool |
WO2010127369A1 (en) * | 2009-05-01 | 2010-11-04 | Rational Biotechnology Inc. | Eit (electrical impedance tomography) guided sonoporation, ultrasound tissue ablation and their use thereof |
WO2010129899A1 (en) * | 2009-05-08 | 2010-11-11 | Cellutions, Inc. | Treatment system with a pulse forming network for achieving plasma in tissue |
USD630321S1 (en) | 2009-05-08 | 2011-01-04 | Angio Dynamics, Inc. | Probe handle |
US8663210B2 (en) | 2009-05-13 | 2014-03-04 | Novian Health, Inc. | Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy |
JP5809621B2 (en) | 2009-05-18 | 2015-11-11 | ヌームアールエックス・インコーポレーテッド | Implants for treating a patient's lungs |
US20100298646A1 (en) * | 2009-05-19 | 2010-11-25 | Tyco Healthcare Group Lp | Flexible access assembly with reinforced lumen |
US8246615B2 (en) * | 2009-05-19 | 2012-08-21 | Vivant Medical, Inc. | Tissue impedance measurement using a secondary frequency |
AU2010259071B2 (en) | 2009-06-09 | 2014-07-24 | Biosensors, Inc. | Non-invasive monitoring of blood metabolite levels |
US9895189B2 (en) | 2009-06-19 | 2018-02-20 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
US8394102B2 (en) | 2009-06-25 | 2013-03-12 | Baxano, Inc. | Surgical tools for treatment of spinal stenosis |
EP2859862B1 (en) | 2009-07-28 | 2017-06-14 | Neuwave Medical, Inc. | Ablation system |
US8932282B2 (en) | 2009-08-03 | 2015-01-13 | Covidien Lp | Power level transitioning in a surgical instrument |
US20110046618A1 (en) * | 2009-08-04 | 2011-02-24 | Minar Christopher D | Methods and systems for treating occluded blood vessels and other body cannula |
US10828100B2 (en) * | 2009-08-25 | 2020-11-10 | Covidien Lp | Microwave ablation with tissue temperature monitoring |
US20110071516A1 (en) * | 2009-09-24 | 2011-03-24 | Tyco Healthcare Group Lp | System and Method for Controlling Electrosurgical Output |
US8685015B2 (en) | 2009-09-24 | 2014-04-01 | Covidien Lp | System and method for multi-pole phase-shifted radio frequency application |
GB2474233A (en) | 2009-10-06 | 2011-04-13 | Uk Investments Associates Llc | Cooling pump comprising a detachable head portion |
US8568401B2 (en) | 2009-10-27 | 2013-10-29 | Covidien Lp | System for monitoring ablation size |
US20110098704A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US8608652B2 (en) | 2009-11-05 | 2013-12-17 | Ethicon Endo-Surgery, Inc. | Vaginal entry surgical devices, kit, system, and method |
CA2778997C (en) | 2009-11-05 | 2022-03-08 | Nimbus Concepts, Llc | Methods and systems for radio frequency neurotomy |
US20110112527A1 (en) * | 2009-11-06 | 2011-05-12 | Angiodynamics, Inc. | Flexible medical ablation device and method of use |
US8394092B2 (en) | 2009-11-17 | 2013-03-12 | Vivant Medical, Inc. | Electromagnetic energy delivery devices including an energy applicator array and electrosurgical systems including same |
US20110118732A1 (en) | 2009-11-19 | 2011-05-19 | The Regents Of The University Of California | Controlled irreversible electroporation |
US20110245756A1 (en) | 2009-12-03 | 2011-10-06 | Rishi Arora | Devices for material delivery, electroporation, sonoporation, and/or monitoring electrophysiological activity |
JP5701895B2 (en) | 2009-12-06 | 2015-04-15 | シネロン メディカル リミテッド | Method and apparatus for personal skin treatment |
US8353487B2 (en) | 2009-12-17 | 2013-01-15 | Ethicon Endo-Surgery, Inc. | User interface support devices for endoscopic surgical instruments |
US8496574B2 (en) | 2009-12-17 | 2013-07-30 | Ethicon Endo-Surgery, Inc. | Selectively positionable camera for surgical guide tube assembly |
US9028483B2 (en) | 2009-12-18 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US8506564B2 (en) | 2009-12-18 | 2013-08-13 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US8882759B2 (en) | 2009-12-18 | 2014-11-11 | Covidien Lp | Microwave ablation system with dielectric temperature probe |
US8851354B2 (en) | 2009-12-24 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Surgical cutting instrument that analyzes tissue thickness |
US8220688B2 (en) | 2009-12-24 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument with electric actuator directional control assembly |
US20110172659A1 (en) * | 2010-01-13 | 2011-07-14 | Vivant Medical, Inc. | Ablation Device With User Interface at Device Handle, System Including Same, and Method of Ablating Tissue Using Same |
EP2523620B1 (en) | 2010-01-15 | 2019-06-19 | Medtronic Advanced Energy LLC | Electrosurgical device |
US9005198B2 (en) | 2010-01-29 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US8568404B2 (en) | 2010-02-19 | 2013-10-29 | Covidien Lp | Bipolar electrode probe for ablation monitoring |
US20110208180A1 (en) * | 2010-02-25 | 2011-08-25 | Vivant Medical, Inc. | System and Method for Monitoring Ablation Size |
KR20130108067A (en) * | 2010-04-09 | 2013-10-02 | 베식스 바스큘라 인코포레이티드 | Power generating and control apparatus for the treatment of tissue |
WO2011134080A1 (en) * | 2010-04-26 | 2011-11-03 | Baylis Medical Company | Electrosurgical device & methods |
US9526911B1 (en) | 2010-04-27 | 2016-12-27 | Lazure Scientific, Inc. | Immune mediated cancer cell destruction, systems and methods |
JP6153865B2 (en) | 2010-05-03 | 2017-06-28 | ニューウェーブ メディカル, インコーポレイテッドNeuwave Medical, Inc. | Energy delivery system |
US20120123400A1 (en) * | 2010-05-10 | 2012-05-17 | David Francischelli | Methods and devices for controlling energy during ablation |
MX2012013280A (en) | 2010-05-21 | 2013-03-05 | Nimbus Concepts Llc | Systems and methods for tissue ablation. |
WO2012006533A1 (en) * | 2010-07-08 | 2012-01-12 | Misbah Huzaira Khan | Method and apparatus for minimally invasive, treatment of human adipose tissue using controlled cooling and radiofrequency current |
US8783543B2 (en) | 2010-07-30 | 2014-07-22 | Ethicon Endo-Surgery, Inc. | Tissue acquisition arrangements and methods for surgical stapling devices |
DE102010039790A1 (en) * | 2010-08-26 | 2012-03-01 | Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. | Apparatus for invasive characterization of biological materials, has signal generator which is designed to generate chirp signal or maximum length sequence signal, where detector is designed to detect tapped signal |
US9289212B2 (en) | 2010-09-17 | 2016-03-22 | Ethicon Endo-Surgery, Inc. | Surgical instruments and batteries for surgical instruments |
US8632525B2 (en) | 2010-09-17 | 2014-01-21 | Ethicon Endo-Surgery, Inc. | Power control arrangements for surgical instruments and batteries |
WO2012042443A1 (en) | 2010-09-29 | 2012-04-05 | Koninklijke Philips Electronics N.V. | System and method for temperature feedback for adaptive radio frequency ablation |
US9301753B2 (en) | 2010-09-30 | 2016-04-05 | Ethicon Endo-Surgery, Llc | Expandable tissue thickness compensator |
US9220501B2 (en) | 2010-09-30 | 2015-12-29 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensators |
US8978954B2 (en) | 2010-09-30 | 2015-03-17 | Ethicon Endo-Surgery, Inc. | Staple cartridge comprising an adjustable distal portion |
US11849952B2 (en) | 2010-09-30 | 2023-12-26 | Cilag Gmbh International | Staple cartridge comprising staples positioned within a compressible portion thereof |
US9517063B2 (en) | 2012-03-28 | 2016-12-13 | Ethicon Endo-Surgery, Llc | Movable member for use with a tissue thickness compensator |
US9351730B2 (en) | 2011-04-29 | 2016-05-31 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator comprising channels |
US9364233B2 (en) | 2010-09-30 | 2016-06-14 | Ethicon Endo-Surgery, Llc | Tissue thickness compensators for circular surgical staplers |
BR112013007717B1 (en) | 2010-09-30 | 2020-09-24 | Ethicon Endo-Surgery, Inc. | SURGICAL CLAMPING SYSTEM |
US9592050B2 (en) | 2010-09-30 | 2017-03-14 | Ethicon Endo-Surgery, Llc | End effector comprising a distal tissue abutment member |
US11298125B2 (en) | 2010-09-30 | 2022-04-12 | Cilag Gmbh International | Tissue stapler having a thickness compensator |
US9629814B2 (en) | 2010-09-30 | 2017-04-25 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator configured to redistribute compressive forces |
US9220500B2 (en) | 2010-09-30 | 2015-12-29 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator comprising structure to produce a resilient load |
US11812965B2 (en) | 2010-09-30 | 2023-11-14 | Cilag Gmbh International | Layer of material for a surgical end effector |
US10945731B2 (en) | 2010-09-30 | 2021-03-16 | Ethicon Llc | Tissue thickness compensator comprising controlled release and expansion |
US9216019B2 (en) | 2011-09-23 | 2015-12-22 | Ethicon Endo-Surgery, Inc. | Surgical stapler with stationary staple drivers |
US9320523B2 (en) | 2012-03-28 | 2016-04-26 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator comprising tissue ingrowth features |
US8695866B2 (en) | 2010-10-01 | 2014-04-15 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a power control circuit |
JP6143362B2 (en) | 2010-10-01 | 2017-06-07 | アプライド メディカル リソーシーズ コーポレイション | Electrosurgical instrument with jaws and / or electrodes and electrosurgical amplifier |
WO2012054560A1 (en) * | 2010-10-21 | 2012-04-26 | Highland Instruments, Inc. | Methods for detecting a condition |
CN107007348B (en) | 2010-10-25 | 2019-05-31 | 美敦力Af卢森堡有限责任公司 | For the estimation of nerve modulation treatment and device, the system and method for feedback |
US10292763B2 (en) | 2016-01-25 | 2019-05-21 | Biosense Webster (Israel) Ltd. | Temperature controlled short duration ablation |
US10405920B2 (en) | 2016-01-25 | 2019-09-10 | Biosense Webster (Israel) Ltd. | Temperature controlled short duration ablation |
US10441354B2 (en) * | 2016-01-25 | 2019-10-15 | Biosense Webster (Israel) Ltd. | Temperature controlled short duration ablation |
WO2012092364A2 (en) * | 2010-12-28 | 2012-07-05 | G & L Consulting, Llc | Method for sympathetic rebalancing of patient |
EP2665433B1 (en) | 2011-01-19 | 2021-03-10 | Fractyl Laboratories Inc. | Devices for the treatment of tissue |
US9125677B2 (en) | 2011-01-22 | 2015-09-08 | Arcuo Medical, Inc. | Diagnostic and feedback control system for efficacy and safety of laser application for tissue reshaping and regeneration |
US10092291B2 (en) | 2011-01-25 | 2018-10-09 | Ethicon Endo-Surgery, Inc. | Surgical instrument with selectively rigidizable features |
US9265557B2 (en) | 2011-01-31 | 2016-02-23 | Medtronic Ablation Frontiers Llc | Multi frequency and multi polarity complex impedance measurements to assess ablation lesions |
EP2672903A4 (en) * | 2011-02-10 | 2017-07-12 | Actuated Medical, Inc. | Medical tool with electromechanical control and feedback |
US9254169B2 (en) | 2011-02-28 | 2016-02-09 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9233241B2 (en) | 2011-02-28 | 2016-01-12 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9314620B2 (en) | 2011-02-28 | 2016-04-19 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US10413349B2 (en) | 2011-03-04 | 2019-09-17 | Covidien Lp | System and methods for identifying tissue and vessels |
WO2012125785A1 (en) | 2011-03-17 | 2012-09-20 | Ethicon Endo-Surgery, Inc. | Hand held surgical device for manipulating an internal magnet assembly within a patient |
US20120239024A1 (en) * | 2011-03-17 | 2012-09-20 | Vivant Medical, Inc. | Energy-Based Ablation Completion Algorithm |
EP2704657A4 (en) | 2011-04-08 | 2014-12-31 | Domain Surgical Inc | Impedance matching circuit |
US8932279B2 (en) | 2011-04-08 | 2015-01-13 | Domain Surgical, Inc. | System and method for cooling of a heated surgical instrument and/or surgical site and treating tissue |
US9539050B2 (en) * | 2011-04-12 | 2017-01-10 | Covidien Lp | System and method for process monitoring and intelligent shut-off |
JP6297970B2 (en) | 2011-04-12 | 2018-03-20 | サーメディカル・インコーポレイテッド | Ablation apparatus, system and method |
CA2834649C (en) | 2011-04-29 | 2021-02-16 | Ethicon Endo-Surgery, Inc. | Staple cartridge comprising staples positioned within a compressible portion thereof |
US11207064B2 (en) | 2011-05-27 | 2021-12-28 | Cilag Gmbh International | Automated end effector component reloading system for use with a robotic system |
US9072535B2 (en) | 2011-05-27 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments with rotatable staple deployment arrangements |
US9217739B2 (en) * | 2011-06-02 | 2015-12-22 | Dune Medical Devices Ltd. | Tissue sampling for pathological study |
CN107647939A (en) | 2011-06-21 | 2018-02-02 | 托尔福公司 | Artificial heart valve film device and related system |
US10201385B2 (en) * | 2011-09-01 | 2019-02-12 | Biosense Webster (Israel) Ltd. | Catheter adapted for direct tissue contact |
ES2562990T3 (en) * | 2011-09-05 | 2016-03-09 | Venus Concept Ltd | Improved aesthetic device to beautify the skin |
WO2013036566A1 (en) * | 2011-09-09 | 2013-03-14 | Ams Research Corporation | Split surgical laser fiber |
US9526558B2 (en) | 2011-09-13 | 2016-12-27 | Domain Surgical, Inc. | Sealing and/or cutting instrument |
EP2755716B1 (en) * | 2011-09-15 | 2020-04-15 | Cold Plasma Medical Technologies, Inc. | Unipolar cold plasma device and associated method |
US9050084B2 (en) | 2011-09-23 | 2015-06-09 | Ethicon Endo-Surgery, Inc. | Staple cartridge including collapsible deck arrangement |
JP6133309B2 (en) | 2011-10-19 | 2017-05-24 | トゥエルヴ, インコーポレイテッド | Prosthetic heart valve device |
JP6151705B2 (en) | 2011-10-19 | 2017-06-21 | トゥエルヴ, インコーポレイテッド | Devices, systems and methods for heart valve replacement |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
JP2013111269A (en) * | 2011-11-29 | 2013-06-10 | Tohoku Univ | Nerve probe puncturing tool |
KR102151368B1 (en) | 2011-12-06 | 2020-09-04 | 도메인 서지컬, 인크. | System and method of controlling power delivery to a surgical instrument |
JP2015503963A (en) | 2011-12-21 | 2015-02-05 | ニューウェーブ メディカル, インコーポレイテッドNeuwave Medical, Inc. | Energy supply system and method of use thereof |
US10076383B2 (en) | 2012-01-25 | 2018-09-18 | Covidien Lp | Electrosurgical device having a multiplexer |
US9414881B2 (en) | 2012-02-08 | 2016-08-16 | Angiodynamics, Inc. | System and method for increasing a target zone for electrical ablation |
US9044230B2 (en) | 2012-02-13 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status |
US8986199B2 (en) | 2012-02-17 | 2015-03-24 | Ethicon Endo-Surgery, Inc. | Apparatus and methods for cleaning the lens of an endoscope |
WO2015077571A1 (en) | 2013-11-22 | 2015-05-28 | Fractyl Laboratories, Inc. | Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract |
KR102086184B1 (en) | 2012-02-27 | 2020-03-06 | 프랙틸 래브러토리스 인코포레이티드 | Heat ablation systems,devices and methods for the treatment of tissue |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
DE112013001594B4 (en) * | 2012-03-21 | 2019-10-17 | Günter Farin | Apparatus and method for measuring and controlling thermal effects in high frequency surgery |
US9192308B2 (en) * | 2012-03-27 | 2015-11-24 | Covidien Lp | Microwave-shielded tissue sensor probe |
JP6305979B2 (en) | 2012-03-28 | 2018-04-04 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Tissue thickness compensator with multiple layers |
JP6224070B2 (en) | 2012-03-28 | 2017-11-01 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Retainer assembly including tissue thickness compensator |
CN104334098B (en) | 2012-03-28 | 2017-03-22 | 伊西康内外科公司 | Tissue thickness compensator comprising capsules defining a low pressure environment |
DE112013001753T5 (en) * | 2012-03-29 | 2015-02-19 | Spiration, Inc. | Devices, methods and systems for the identification and treatment of lung tissue |
US8899709B2 (en) * | 2012-04-19 | 2014-12-02 | Hewlett-Packard Development Company, L.P. | Determining an issue with an inkjet nozzle using an impedance difference |
AU2013249043B2 (en) | 2012-04-19 | 2017-04-27 | Fractyl Health, Inc. | Tissue expansion devices, system and methods |
EP2840993A4 (en) | 2012-04-24 | 2016-03-30 | Cibiem Inc | Endovascular catheters and methods for carotid body ablation |
US20130296840A1 (en) | 2012-05-01 | 2013-11-07 | Medtronic Ablation Frontiers Llc | Systems and methods for detecting tissue contact during ablation |
US9060778B2 (en) | 2012-04-26 | 2015-06-23 | Medtronic Ablation Frontiers Llc | Intermittent short circuit detection on a multi-electrode catheter |
US9216050B2 (en) | 2012-05-01 | 2015-12-22 | Medtronic Ablation Frontiers Llc | Detection of microbubble formation during catheter ablation |
US9095350B2 (en) * | 2012-05-01 | 2015-08-04 | Medtronic Ablation Frontiers Llc | Impedance detection of venous placement of multi-electrode catheters |
US20130304051A1 (en) | 2012-05-08 | 2013-11-14 | Greatbatch Ltd. | Transseptal needle apparatus |
US8986264B2 (en) | 2012-05-08 | 2015-03-24 | Greatbatch Ltd. | Transseptal needle apparatus |
US9358039B2 (en) | 2012-05-08 | 2016-06-07 | Greatbatch Ltd. | Transseptal needle apparatus |
US9427255B2 (en) | 2012-05-14 | 2016-08-30 | Ethicon Endo-Surgery, Inc. | Apparatus for introducing a steerable camera assembly into a patient |
US9402677B2 (en) | 2012-06-01 | 2016-08-02 | Cibiem, Inc. | Methods and devices for cryogenic carotid body ablation |
US9101358B2 (en) | 2012-06-15 | 2015-08-11 | Ethicon Endo-Surgery, Inc. | Articulatable surgical instrument comprising a firing drive |
US11278284B2 (en) | 2012-06-28 | 2022-03-22 | Cilag Gmbh International | Rotary drive arrangements for surgical instruments |
US20140005718A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Multi-functional powered surgical device with external dissection features |
US20140001234A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Coupling arrangements for attaching surgical end effectors to drive systems therefor |
US9649111B2 (en) | 2012-06-28 | 2017-05-16 | Ethicon Endo-Surgery, Llc | Replaceable clip cartridge for a clip applier |
US20140001231A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Firing system lockout arrangements for surgical instruments |
US9289256B2 (en) | 2012-06-28 | 2016-03-22 | Ethicon Endo-Surgery, Llc | Surgical end effectors having angled tissue-contacting surfaces |
BR112014032776B1 (en) | 2012-06-28 | 2021-09-08 | Ethicon Endo-Surgery, Inc | SURGICAL INSTRUMENT SYSTEM AND SURGICAL KIT FOR USE WITH A SURGICAL INSTRUMENT SYSTEM |
CN104487005B (en) | 2012-06-28 | 2017-09-08 | 伊西康内外科公司 | Empty squeeze latching member |
US9529025B2 (en) | 2012-06-29 | 2016-12-27 | Covidien Lp | Systems and methods for measuring the frequency of signals generated by high frequency medical devices |
US9554847B2 (en) * | 2012-07-02 | 2017-01-31 | Biosense Webster (Israel) Ltd. | Real time assessment of ablation from electrocardiogram signals |
US9078662B2 (en) | 2012-07-03 | 2015-07-14 | Ethicon Endo-Surgery, Inc. | Endoscopic cap electrode and method for using the same |
US9956341B2 (en) * | 2012-07-03 | 2018-05-01 | Milestone Scientific, Inc. | Drug infusion with pressure sensing and non-continuous flow for identification of and injection into fluid-filled anatomic spaces |
US9144459B2 (en) | 2012-07-19 | 2015-09-29 | Cook Medical Technologies Llc | Endoscopic ultrasound ablation needle |
EP3714826A1 (en) | 2012-07-30 | 2020-09-30 | Fractyl Laboratories, Inc. | Electrical energy ablation systems and devices for the treatment of tissue |
US9545290B2 (en) | 2012-07-30 | 2017-01-17 | Ethicon Endo-Surgery, Inc. | Needle probe guide |
US10314649B2 (en) | 2012-08-02 | 2019-06-11 | Ethicon Endo-Surgery, Inc. | Flexible expandable electrode and method of intraluminal delivery of pulsed power |
US9572623B2 (en) | 2012-08-02 | 2017-02-21 | Ethicon Endo-Surgery, Inc. | Reusable electrode and disposable sheath |
US9044254B2 (en) * | 2012-08-07 | 2015-06-02 | Covidien Lp | Microwave ablation catheter and method of utilizing the same |
WO2014026055A1 (en) | 2012-08-09 | 2014-02-13 | Fractyl Laboratories Inc. | Ablation systems, devices and methods for the treatment of tissue |
EP3603501A1 (en) | 2012-08-09 | 2020-02-05 | University of Iowa Research Foundation | Catheter systems for surrounding a tissue structure |
US9277957B2 (en) | 2012-08-15 | 2016-03-08 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
US10022176B2 (en) | 2012-08-15 | 2018-07-17 | Thermedical, Inc. | Low profile fluid enhanced ablation therapy devices and methods |
US20140081289A1 (en) | 2012-09-14 | 2014-03-20 | The Spectranetics Corporation | Lead removal sleeve |
US9993283B2 (en) | 2012-10-02 | 2018-06-12 | Covidien Lp | Selectively deformable ablation device |
EP2903626A4 (en) | 2012-10-05 | 2016-10-19 | Fractyl Lab Inc | Methods, systems and devices for performing multiple treatments on a patient |
KR101468419B1 (en) * | 2012-12-04 | 2014-12-03 | 삼성메디슨 주식회사 | Medical system and method for providing measurement information using three-dimensional calliper |
US9901399B2 (en) | 2012-12-17 | 2018-02-27 | Covidien Lp | Ablation probe with tissue sensing configuration |
US9888956B2 (en) | 2013-01-22 | 2018-02-13 | Angiodynamics, Inc. | Integrated pump and generator device and method of use |
WO2014121664A1 (en) * | 2013-02-07 | 2014-08-14 | 上海魅丽纬叶医疗科技有限公司 | Radio frequency ablation method, system and radio frequency ablation device thereof |
US10098527B2 (en) | 2013-02-27 | 2018-10-16 | Ethidcon Endo-Surgery, Inc. | System for performing a minimally invasive surgical procedure |
US9700309B2 (en) | 2013-03-01 | 2017-07-11 | Ethicon Llc | Articulatable surgical instruments with conductive pathways for signal communication |
MX368026B (en) | 2013-03-01 | 2019-09-12 | Ethicon Endo Surgery Inc | Articulatable surgical instruments with conductive pathways for signal communication. |
MX364729B (en) | 2013-03-01 | 2019-05-06 | Ethicon Endo Surgery Inc | Surgical instrument with a soft stop. |
US9877707B2 (en) | 2013-03-07 | 2018-01-30 | Kyphon SÀRL | Systems and methods for track coagulation |
US9456872B2 (en) | 2013-03-13 | 2016-10-04 | The Spectranetics Corporation | Laser ablation catheter |
US9283040B2 (en) | 2013-03-13 | 2016-03-15 | The Spectranetics Corporation | Device and method of ablative cutting with helical tip |
US10383691B2 (en) | 2013-03-13 | 2019-08-20 | The Spectranetics Corporation | Last catheter with helical internal lumen |
US9883885B2 (en) | 2013-03-13 | 2018-02-06 | The Spectranetics Corporation | System and method of ablative cutting and pulsed vacuum aspiration |
US9291663B2 (en) | 2013-03-13 | 2016-03-22 | The Spectranetics Corporation | Alarm for lead insulation abnormality |
US9629629B2 (en) | 2013-03-14 | 2017-04-25 | Ethicon Endo-Surgey, LLC | Control systems for surgical instruments |
US10835279B2 (en) | 2013-03-14 | 2020-11-17 | Spectranetics Llc | Distal end supported tissue slitting apparatus |
US9629623B2 (en) | 2013-03-14 | 2017-04-25 | Ethicon Endo-Surgery, Llc | Drive system lockout arrangements for modular surgical instruments |
US10448999B2 (en) | 2013-03-15 | 2019-10-22 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
EP4331519A2 (en) | 2013-03-15 | 2024-03-06 | Medtronic Holding Company Sàrl | A system for treating tissue |
US10842532B2 (en) | 2013-03-15 | 2020-11-24 | Spectranetics Llc | Medical device for removing an implanted object |
US9918737B2 (en) | 2013-03-15 | 2018-03-20 | The Spectranetics Corporation | Medical device for removing an implanted object |
US9668765B2 (en) | 2013-03-15 | 2017-06-06 | The Spectranetics Corporation | Retractable blade for lead removal device |
US9925366B2 (en) | 2013-03-15 | 2018-03-27 | The Spectranetics Corporation | Surgical instrument for removing an implanted object |
US9610396B2 (en) | 2013-03-15 | 2017-04-04 | Thermedical, Inc. | Systems and methods for visualizing fluid enhanced ablation therapy |
US9980743B2 (en) | 2013-03-15 | 2018-05-29 | The Spectranetics Corporation | Medical device for removing an implanted object using laser cut hypotubes |
US9033972B2 (en) * | 2013-03-15 | 2015-05-19 | Thermedical, Inc. | Methods and devices for fluid enhanced microwave ablation therapy |
BR112015026109B1 (en) | 2013-04-16 | 2022-02-22 | Ethicon Endo-Surgery, Inc | surgical instrument |
US10405857B2 (en) | 2013-04-16 | 2019-09-10 | Ethicon Llc | Powered linear surgical stapler |
US10111747B2 (en) | 2013-05-20 | 2018-10-30 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US9574644B2 (en) | 2013-05-30 | 2017-02-21 | Ethicon Endo-Surgery, Llc | Power module for use with a surgical instrument |
EP3003461B1 (en) | 2013-06-04 | 2019-05-01 | Fractyl Laboratories, Inc. | Systems and devices for reducing the luminal surface area of the gastrointestinal tract |
US9872719B2 (en) | 2013-07-24 | 2018-01-23 | Covidien Lp | Systems and methods for generating electrosurgical energy using a multistage power converter |
US9655670B2 (en) | 2013-07-29 | 2017-05-23 | Covidien Lp | Systems and methods for measuring tissue impedance through an electrosurgical cable |
CN106028966B (en) | 2013-08-23 | 2018-06-22 | 伊西康内外科有限责任公司 | For the firing member restoring device of powered surgical instrument |
US9808249B2 (en) | 2013-08-23 | 2017-11-07 | Ethicon Llc | Attachment portions for surgical instrument assemblies |
US11166672B2 (en) | 2013-10-18 | 2021-11-09 | Atlantic Health System, Inc. | Nerve protecting dissection device |
US10022090B2 (en) * | 2013-10-18 | 2018-07-17 | Atlantic Health System, Inc. | Nerve protecting dissection device |
US10433902B2 (en) | 2013-10-23 | 2019-10-08 | Medtronic Ardian Luxembourg S.A.R.L. | Current control methods and systems |
EP3046494A1 (en) * | 2013-11-13 | 2016-07-27 | Gyrus ACMI, Inc., d.b.a. Olympus Surgical Technologies America | Fibroid ablation positioning device and methods |
US9993279B2 (en) * | 2013-12-06 | 2018-06-12 | Medtronic Cryocath Lp | Distal balloon impedance and temperature recording to monitor pulmonary vein ablation and occlusion |
EP3091921B1 (en) | 2014-01-06 | 2019-06-19 | Farapulse, Inc. | Apparatus for renal denervation ablation |
US10166321B2 (en) | 2014-01-09 | 2019-01-01 | Angiodynamics, Inc. | High-flow port and infusion needle systems |
WO2015110938A1 (en) | 2014-01-27 | 2015-07-30 | Ecole Polytechnique Federale De Lausanne (Epfl) | Device and method for testing a material response to a compound |
WO2015123350A2 (en) * | 2014-02-11 | 2015-08-20 | Shifamed Holdings, Llc | Methods and device for bronchial intervention |
US9962161B2 (en) | 2014-02-12 | 2018-05-08 | Ethicon Llc | Deliverable surgical instrument |
JP6462004B2 (en) | 2014-02-24 | 2019-01-30 | エシコン エルエルシー | Fastening system with launcher lockout |
US20140166726A1 (en) | 2014-02-24 | 2014-06-19 | Ethicon Endo-Surgery, Inc. | Staple cartridge including a barbed staple |
WO2015134383A1 (en) | 2014-03-03 | 2015-09-11 | The Spectranetics Corporation | Multiple configuration surgical cutting device |
EP3116408B1 (en) | 2014-03-12 | 2018-12-19 | Cibiem, Inc. | Ultrasound ablation catheter |
US10959774B2 (en) | 2014-03-24 | 2021-03-30 | Fractyl Laboratories, Inc. | Injectate delivery devices, systems and methods |
US9913642B2 (en) | 2014-03-26 | 2018-03-13 | Ethicon Llc | Surgical instrument comprising a sensor system |
EP3875139A1 (en) * | 2014-03-26 | 2021-09-08 | Venclose, Inc. | Venous disease treatment |
US9820738B2 (en) | 2014-03-26 | 2017-11-21 | Ethicon Llc | Surgical instrument comprising interactive systems |
BR112016021943B1 (en) | 2014-03-26 | 2022-06-14 | Ethicon Endo-Surgery, Llc | SURGICAL INSTRUMENT FOR USE BY AN OPERATOR IN A SURGICAL PROCEDURE |
US9733663B2 (en) | 2014-03-26 | 2017-08-15 | Ethicon Llc | Power management through segmented circuit and variable voltage protection |
US9750499B2 (en) | 2014-03-26 | 2017-09-05 | Ethicon Llc | Surgical stapling instrument system |
US9801627B2 (en) | 2014-09-26 | 2017-10-31 | Ethicon Llc | Fastener cartridge for creating a flexible staple line |
BR112016023807B1 (en) | 2014-04-16 | 2022-07-12 | Ethicon Endo-Surgery, Llc | CARTRIDGE SET OF FASTENERS FOR USE WITH A SURGICAL INSTRUMENT |
CN106456176B (en) | 2014-04-16 | 2019-06-28 | 伊西康内外科有限责任公司 | Fastener cartridge including the extension with various configuration |
US20150297225A1 (en) | 2014-04-16 | 2015-10-22 | Ethicon Endo-Surgery, Inc. | Fastener cartridges including extensions having different configurations |
US10299792B2 (en) | 2014-04-16 | 2019-05-28 | Ethicon Llc | Fastener cartridge comprising non-uniform fasteners |
BR112016023825B1 (en) | 2014-04-16 | 2022-08-02 | Ethicon Endo-Surgery, Llc | STAPLE CARTRIDGE FOR USE WITH A SURGICAL STAPLER AND STAPLE CARTRIDGE FOR USE WITH A SURGICAL INSTRUMENT |
US10610292B2 (en) | 2014-04-25 | 2020-04-07 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology |
WO2015171921A2 (en) * | 2014-05-07 | 2015-11-12 | Mickelson Steven R | Methods and apparatus for selective tissue ablation |
US10357306B2 (en) | 2014-05-14 | 2019-07-23 | Domain Surgical, Inc. | Planar ferromagnetic coated surgical tip and method for making |
KR102537276B1 (en) | 2014-05-16 | 2023-05-26 | 어플라이드 메디컬 리소시스 코포레이션 | Electrosurgical system |
KR102420273B1 (en) | 2014-05-30 | 2022-07-13 | 어플라이드 메디컬 리소시스 코포레이션 | Electrosurgical instrument for fusing and cutting tissue and an electrosurgical generator |
US10405924B2 (en) | 2014-05-30 | 2019-09-10 | The Spectranetics Corporation | System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port |
WO2015192018A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
WO2015192027A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US10045781B2 (en) | 2014-06-13 | 2018-08-14 | Ethicon Llc | Closure lockout systems for surgical instruments |
US11185367B2 (en) | 2014-07-16 | 2021-11-30 | Fractyl Health, Inc. | Methods and systems for treating diabetes and related diseases and disorders |
EP3169260B1 (en) | 2014-07-16 | 2019-09-25 | Fractyl Laboratories, Inc. | System for treating diabetes and related diseases and disorders |
US9844641B2 (en) | 2014-07-16 | 2017-12-19 | Fractyl Laboratories, Inc. | Systems, devices and methods for performing medical procedures in the intestine |
WO2016018754A1 (en) | 2014-07-28 | 2016-02-04 | Boston Scientific Scimed, Inc. | Multiple lead electrode probe for controlled tissue ablation |
US10390838B1 (en) | 2014-08-20 | 2019-08-27 | Pneumrx, Inc. | Tuned strength chronic obstructive pulmonary disease treatment |
US10135242B2 (en) | 2014-09-05 | 2018-11-20 | Ethicon Llc | Smart cartridge wake up operation and data retention |
BR112017004361B1 (en) | 2014-09-05 | 2023-04-11 | Ethicon Llc | ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT |
US11311294B2 (en) | 2014-09-05 | 2022-04-26 | Cilag Gmbh International | Powered medical device including measurement of closure state of jaws |
GB2531619A (en) * | 2014-09-12 | 2016-04-27 | Innovarius Ltd | Apparatus and method for providing hyperthermia therapy |
US10105142B2 (en) | 2014-09-18 | 2018-10-23 | Ethicon Llc | Surgical stapler with plurality of cutting elements |
US11523821B2 (en) | 2014-09-26 | 2022-12-13 | Cilag Gmbh International | Method for creating a flexible staple line |
CN107427300B (en) | 2014-09-26 | 2020-12-04 | 伊西康有限责任公司 | Surgical suture buttress and buttress material |
FR3026631B1 (en) | 2014-10-03 | 2016-12-09 | Ecole Polytech | IMPLANTABLE MEDICAL DEVICE WITH SENSORS |
US10076325B2 (en) | 2014-10-13 | 2018-09-18 | Ethicon Llc | Surgical stapling apparatus comprising a tissue stop |
EP3206613B1 (en) | 2014-10-14 | 2019-07-03 | Farapulse, Inc. | Apparatus for rapid and safe pulmonary vein cardiac ablation |
US9924944B2 (en) | 2014-10-16 | 2018-03-27 | Ethicon Llc | Staple cartridge comprising an adjunct material |
US10517594B2 (en) | 2014-10-29 | 2019-12-31 | Ethicon Llc | Cartridge assemblies for surgical staplers |
US11141153B2 (en) | 2014-10-29 | 2021-10-12 | Cilag Gmbh International | Staple cartridges comprising driver arrangements |
US9844376B2 (en) | 2014-11-06 | 2017-12-19 | Ethicon Llc | Staple cartridge comprising a releasable adjunct material |
US10736636B2 (en) | 2014-12-10 | 2020-08-11 | Ethicon Llc | Articulatable surgical instrument system |
US10085748B2 (en) | 2014-12-18 | 2018-10-02 | Ethicon Llc | Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors |
US9844375B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Drive arrangements for articulatable surgical instruments |
US10117649B2 (en) | 2014-12-18 | 2018-11-06 | Ethicon Llc | Surgical instrument assembly comprising a lockable articulation system |
US10188385B2 (en) | 2014-12-18 | 2019-01-29 | Ethicon Llc | Surgical instrument system comprising lockable systems |
BR112017012996B1 (en) | 2014-12-18 | 2022-11-08 | Ethicon Llc | SURGICAL INSTRUMENT WITH AN ANvil WHICH IS SELECTIVELY MOVABLE ABOUT AN IMMOVABLE GEOMETRIC AXIS DIFFERENT FROM A STAPLE CARTRIDGE |
US9968355B2 (en) | 2014-12-18 | 2018-05-15 | Ethicon Llc | Surgical instruments with articulatable end effectors and improved firing beam support arrangements |
US9844374B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member |
US9987000B2 (en) | 2014-12-18 | 2018-06-05 | Ethicon Llc | Surgical instrument assembly comprising a flexible articulation system |
US10420603B2 (en) | 2014-12-23 | 2019-09-24 | Applied Medical Resources Corporation | Bipolar electrosurgical sealer and divider |
USD748259S1 (en) | 2014-12-29 | 2016-01-26 | Applied Medical Resources Corporation | Electrosurgical instrument |
USD765243S1 (en) | 2015-02-20 | 2016-08-30 | The Spectranetics Corporation | Medical device handle |
USD770616S1 (en) | 2015-02-20 | 2016-11-01 | The Spectranetics Corporation | Medical device handle |
US10321907B2 (en) | 2015-02-27 | 2019-06-18 | Ethicon Llc | System for monitoring whether a surgical instrument needs to be serviced |
US10226250B2 (en) | 2015-02-27 | 2019-03-12 | Ethicon Llc | Modular stapling assembly |
US11154301B2 (en) | 2015-02-27 | 2021-10-26 | Cilag Gmbh International | Modular stapling assembly |
US10180463B2 (en) | 2015-02-27 | 2019-01-15 | Ethicon Llc | Surgical apparatus configured to assess whether a performance parameter of the surgical apparatus is within an acceptable performance band |
US9924961B2 (en) | 2015-03-06 | 2018-03-27 | Ethicon Endo-Surgery, Llc | Interactive feedback system for powered surgical instruments |
US10245033B2 (en) | 2015-03-06 | 2019-04-02 | Ethicon Llc | Surgical instrument comprising a lockable battery housing |
US9901342B2 (en) | 2015-03-06 | 2018-02-27 | Ethicon Endo-Surgery, Llc | Signal and power communication system positioned on a rotatable shaft |
US10687806B2 (en) | 2015-03-06 | 2020-06-23 | Ethicon Llc | Adaptive tissue compression techniques to adjust closure rates for multiple tissue types |
US9993248B2 (en) | 2015-03-06 | 2018-06-12 | Ethicon Endo-Surgery, Llc | Smart sensors with local signal processing |
US10045776B2 (en) | 2015-03-06 | 2018-08-14 | Ethicon Llc | Control techniques and sub-processor contained within modular shaft with select control processing from handle |
US10617412B2 (en) | 2015-03-06 | 2020-04-14 | Ethicon Llc | System for detecting the mis-insertion of a staple cartridge into a surgical stapler |
US9808246B2 (en) | 2015-03-06 | 2017-11-07 | Ethicon Endo-Surgery, Llc | Method of operating a powered surgical instrument |
US10548504B2 (en) | 2015-03-06 | 2020-02-04 | Ethicon Llc | Overlaid multi sensor radio frequency (RF) electrode system to measure tissue compression |
US9895148B2 (en) | 2015-03-06 | 2018-02-20 | Ethicon Endo-Surgery, Llc | Monitoring speed control and precision incrementing of motor for powered surgical instruments |
US10441279B2 (en) | 2015-03-06 | 2019-10-15 | Ethicon Llc | Multiple level thresholds to modify operation of powered surgical instruments |
JP2020121162A (en) | 2015-03-06 | 2020-08-13 | エシコン エルエルシーEthicon LLC | Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement |
US10390825B2 (en) | 2015-03-31 | 2019-08-27 | Ethicon Llc | Surgical instrument with progressive rotary drive systems |
CN115737104A (en) | 2015-03-31 | 2023-03-07 | 昂科赛克医疗公司 | Systems and methods for improved tissue sensing-based electroporation |
US20160317224A1 (en) * | 2015-04-30 | 2016-11-03 | Covidien Lp | Microwave ablation planning and procedure systems |
WO2016191529A1 (en) * | 2015-05-26 | 2016-12-01 | Georgia Tech Research Corporation | Bioelectronic devices, systems, and uses thereof |
US10178992B2 (en) | 2015-06-18 | 2019-01-15 | Ethicon Llc | Push/pull articulation drive systems for articulatable surgical instruments |
US10940292B2 (en) | 2015-07-08 | 2021-03-09 | Actuated Medical, Inc. | Reduced force device for intravascular access and guidewire placement |
JP6072394B1 (en) * | 2015-07-27 | 2017-02-01 | オリンパス株式会社 | Energy treatment system and energy control device |
US10617418B2 (en) | 2015-08-17 | 2020-04-14 | Ethicon Llc | Implantable layers for a surgical instrument |
US10238490B2 (en) | 2015-08-21 | 2019-03-26 | Twelve, Inc. | Implant heart valve devices, mitral valve repair devices and associated systems and methods |
US10357251B2 (en) | 2015-08-26 | 2019-07-23 | Ethicon Llc | Surgical staples comprising hardness variations for improved fastening of tissue |
US11793543B2 (en) | 2015-09-18 | 2023-10-24 | Obvius Robotics, Inc. | Device and method for automated insertion of penetrating member |
US10105139B2 (en) | 2015-09-23 | 2018-10-23 | Ethicon Llc | Surgical stapler having downstream current-based motor control |
US10327769B2 (en) | 2015-09-23 | 2019-06-25 | Ethicon Llc | Surgical stapler having motor control based on a drive system component |
US10076326B2 (en) | 2015-09-23 | 2018-09-18 | Ethicon Llc | Surgical stapler having current mirror-based motor control |
US10363036B2 (en) | 2015-09-23 | 2019-07-30 | Ethicon Llc | Surgical stapler having force-based motor control |
US10238386B2 (en) | 2015-09-23 | 2019-03-26 | Ethicon Llc | Surgical stapler having motor control based on an electrical parameter related to a motor current |
US10085751B2 (en) | 2015-09-23 | 2018-10-02 | Ethicon Llc | Surgical stapler having temperature-based motor control |
US10299878B2 (en) | 2015-09-25 | 2019-05-28 | Ethicon Llc | Implantable adjunct systems for determining adjunct skew |
US10271849B2 (en) | 2015-09-30 | 2019-04-30 | Ethicon Llc | Woven constructs with interlocked standing fibers |
US10524788B2 (en) | 2015-09-30 | 2020-01-07 | Ethicon Llc | Compressible adjunct with attachment regions |
US11890015B2 (en) | 2015-09-30 | 2024-02-06 | Cilag Gmbh International | Compressible adjunct with crossing spacer fibers |
US10980539B2 (en) | 2015-09-30 | 2021-04-20 | Ethicon Llc | Implantable adjunct comprising bonded layers |
FR3042873A1 (en) | 2015-10-23 | 2017-04-28 | Ecole Polytech | METHOD AND SYSTEM FOR DISCRIMINATING CELLS |
CA3003192A1 (en) | 2015-10-26 | 2017-05-04 | Neuwave Medical, Inc. | A device for delivering microwave energy and uses thereof |
US10751123B2 (en) * | 2015-10-30 | 2020-08-25 | Washington University | Thermoablation probe |
US10441339B2 (en) | 2015-11-17 | 2019-10-15 | Medtronic Holding Company Sárl | Spinal tissue ablation apparatus, system, and method |
US11324442B1 (en) * | 2015-11-25 | 2022-05-10 | Maquet Cardiovascular Llc | Broadband impedance spectroscopy and its use for tissue welding |
US10299905B2 (en) * | 2015-12-28 | 2019-05-28 | Ethicon, Inc. | Applicator instruments having off-axis surgical fastener delivery |
US10265068B2 (en) | 2015-12-30 | 2019-04-23 | Ethicon Llc | Surgical instruments with separable motors and motor control circuits |
US10368865B2 (en) | 2015-12-30 | 2019-08-06 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10292704B2 (en) | 2015-12-30 | 2019-05-21 | Ethicon Llc | Mechanisms for compensating for battery pack failure in powered surgical instruments |
US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US20170189097A1 (en) | 2016-01-05 | 2017-07-06 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10307206B2 (en) | 2016-01-25 | 2019-06-04 | Biosense Webster (Israel) Ltd. | Temperature controlled short duration ablation |
CN108882932B (en) | 2016-02-09 | 2021-07-23 | 伊西康有限责任公司 | Surgical instrument with asymmetric articulation configuration |
US10588625B2 (en) | 2016-02-09 | 2020-03-17 | Ethicon Llc | Articulatable surgical instruments with off-axis firing beam arrangements |
US10952678B2 (en) * | 2016-02-09 | 2021-03-23 | Cvdevices, Llc | Devices and systems for tissue engagement and methods of using the same |
US11213293B2 (en) | 2016-02-09 | 2022-01-04 | Cilag Gmbh International | Articulatable surgical instruments with single articulation link arrangements |
US11224426B2 (en) | 2016-02-12 | 2022-01-18 | Cilag Gmbh International | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10258331B2 (en) | 2016-02-12 | 2019-04-16 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10448948B2 (en) | 2016-02-12 | 2019-10-22 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
WO2017155999A1 (en) | 2016-03-07 | 2017-09-14 | Hansa Medical Products, Inc. | Apparatus and method for forming an opening in patient's tissue |
US10617413B2 (en) | 2016-04-01 | 2020-04-14 | Ethicon Llc | Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts |
US11064997B2 (en) | 2016-04-01 | 2021-07-20 | Cilag Gmbh International | Surgical stapling instrument |
WO2017176101A1 (en) * | 2016-04-05 | 2017-10-12 | Частное Учреждение "Назарбаев Университет Рисеч Энд Инновейшн Систем" | Method for distributed temperature sensing during thermal ablation of a tumour using a fibre optic temperature sensor with a linearly chirped bragg grating |
FR3049843A1 (en) | 2016-04-06 | 2017-10-13 | Instent | MEDICAL DEVICE PROVIDED WITH SENSORS |
WO2017216645A2 (en) * | 2016-04-11 | 2017-12-21 | Instent Sas | Medical device making treatment recommendations based on sensed characteristics of a lesion |
US11607239B2 (en) | 2016-04-15 | 2023-03-21 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
MX2018012563A (en) | 2016-04-15 | 2019-07-08 | Neuwave Medical Inc | Systems for energy delivery. |
US11179150B2 (en) | 2016-04-15 | 2021-11-23 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US10492783B2 (en) | 2016-04-15 | 2019-12-03 | Ethicon, Llc | Surgical instrument with improved stop/start control during a firing motion |
US10335145B2 (en) | 2016-04-15 | 2019-07-02 | Ethicon Llc | Modular surgical instrument with configurable operating mode |
US10828028B2 (en) | 2016-04-15 | 2020-11-10 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US10405859B2 (en) | 2016-04-15 | 2019-09-10 | Ethicon Llc | Surgical instrument with adjustable stop/start control during a firing motion |
US10456137B2 (en) | 2016-04-15 | 2019-10-29 | Ethicon Llc | Staple formation detection mechanisms |
US10357247B2 (en) | 2016-04-15 | 2019-07-23 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US10426467B2 (en) | 2016-04-15 | 2019-10-01 | Ethicon Llc | Surgical instrument with detection sensors |
US10363037B2 (en) | 2016-04-18 | 2019-07-30 | Ethicon Llc | Surgical instrument system comprising a magnetic lockout |
US11317917B2 (en) | 2016-04-18 | 2022-05-03 | Cilag Gmbh International | Surgical stapling system comprising a lockable firing assembly |
US20170296173A1 (en) | 2016-04-18 | 2017-10-19 | Ethicon Endo-Surgery, Llc | Method for operating a surgical instrument |
US10638976B2 (en) | 2016-04-28 | 2020-05-05 | Biosense Webster (Israel) Ltd | Method of constructing irrigated balloon catheter |
US10660700B2 (en) | 2016-04-28 | 2020-05-26 | Biosense Webster (Israel) Ltd. | Irrigated balloon catheter with flexible circuit electrode assembly |
US20170347896A1 (en) * | 2016-06-02 | 2017-12-07 | Biosense Webster (Israel) Ltd. | Balloon catheter and related impedance-based methods for detecting occlusion |
CN109069272A (en) | 2016-04-29 | 2018-12-21 | 美敦力瓦斯科尔勒公司 | Prosthetic heart valve equipment and associated system and method with the anchor log with tether |
WO2017218734A1 (en) | 2016-06-16 | 2017-12-21 | Iowa Approach, Inc. | Systems, apparatuses, and methods for guide wire delivery |
AU2017289267B2 (en) | 2016-06-27 | 2021-08-12 | Galvanize Therapeutics, Inc. | Generator and a catheter with an electrode and a method for treating a lung passageway |
US11633176B2 (en) * | 2016-08-03 | 2023-04-25 | Boston Scientific Scimed Inc. | Positioning devices, methods, and systems |
US9743984B1 (en) | 2016-08-11 | 2017-08-29 | Thermedical, Inc. | Devices and methods for delivering fluid to tissue during ablation therapy |
DE102016220157A1 (en) * | 2016-10-14 | 2018-04-19 | Olympus Winter & Ibe Gmbh | High-frequency generator |
US11568990B2 (en) | 2016-11-21 | 2023-01-31 | Sensome SAS | Characterizing and identifying biological structure |
US20180168598A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Staple forming pocket arrangements comprising zoned forming surface grooves |
US20180168615A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument |
US20180168609A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Firing assembly comprising a fuse |
US10973516B2 (en) | 2016-12-21 | 2021-04-13 | Ethicon Llc | Surgical end effectors and adaptable firing members therefor |
US10485543B2 (en) | 2016-12-21 | 2019-11-26 | Ethicon Llc | Anvil having a knife slot width |
US10568625B2 (en) | 2016-12-21 | 2020-02-25 | Ethicon Llc | Staple cartridges and arrangements of staples and staple cavities therein |
US10881401B2 (en) | 2016-12-21 | 2021-01-05 | Ethicon Llc | Staple firing member comprising a missing cartridge and/or spent cartridge lockout |
US10426471B2 (en) | 2016-12-21 | 2019-10-01 | Ethicon Llc | Surgical instrument with multiple failure response modes |
US20180168625A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Surgical stapling instruments with smart staple cartridges |
US11419606B2 (en) | 2016-12-21 | 2022-08-23 | Cilag Gmbh International | Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems |
US10736629B2 (en) | 2016-12-21 | 2020-08-11 | Ethicon Llc | Surgical tool assemblies with clutching arrangements for shifting between closure systems with closure stroke reduction features and articulation and firing systems |
US11134942B2 (en) | 2016-12-21 | 2021-10-05 | Cilag Gmbh International | Surgical stapling instruments and staple-forming anvils |
US10980536B2 (en) | 2016-12-21 | 2021-04-20 | Ethicon Llc | No-cartridge and spent cartridge lockout arrangements for surgical staplers |
US20180168575A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Surgical stapling systems |
JP6983893B2 (en) | 2016-12-21 | 2021-12-17 | エシコン エルエルシーEthicon LLC | Lockout configuration for surgical end effectors and replaceable tool assemblies |
US10492785B2 (en) | 2016-12-21 | 2019-12-03 | Ethicon Llc | Shaft assembly comprising a lockout |
MX2019007311A (en) | 2016-12-21 | 2019-11-18 | Ethicon Llc | Surgical stapling systems. |
US10537325B2 (en) | 2016-12-21 | 2020-01-21 | Ethicon Llc | Staple forming pocket arrangement to accommodate different types of staples |
JP7010956B2 (en) | 2016-12-21 | 2022-01-26 | エシコン エルエルシー | How to staple tissue |
WO2018167877A1 (en) * | 2017-03-15 | 2018-09-20 | オリンパス株式会社 | Energy source device |
US20180344200A1 (en) * | 2017-05-31 | 2018-12-06 | Cardiac Pacemakers, Inc. | Electrical impedance tomography using the internal thoracic vein |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
EP3614942A2 (en) | 2017-04-28 | 2020-03-04 | Stryker Corporation | Control console and accessories for rf nerve ablation and methods of operating the same |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US10610296B2 (en) * | 2017-05-31 | 2020-04-07 | Biosense Webster (Israel) Ltd. | Cardiac electrophysiology machine including catheter stability while estimating impedance drop |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US10368864B2 (en) | 2017-06-20 | 2019-08-06 | Ethicon Llc | Systems and methods for controlling displaying motor velocity for a surgical instrument |
US10390841B2 (en) | 2017-06-20 | 2019-08-27 | Ethicon Llc | Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation |
USD890784S1 (en) | 2017-06-20 | 2020-07-21 | Ethicon Llc | Display panel with changeable graphical user interface |
US11090046B2 (en) | 2017-06-20 | 2021-08-17 | Cilag Gmbh International | Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument |
US11382638B2 (en) | 2017-06-20 | 2022-07-12 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance |
US11071554B2 (en) | 2017-06-20 | 2021-07-27 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements |
US10813639B2 (en) | 2017-06-20 | 2020-10-27 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions |
US10881399B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument |
US10646220B2 (en) | 2017-06-20 | 2020-05-12 | Ethicon Llc | Systems and methods for controlling displacement member velocity for a surgical instrument |
US11653914B2 (en) | 2017-06-20 | 2023-05-23 | Cilag Gmbh International | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector |
US10888321B2 (en) | 2017-06-20 | 2021-01-12 | Ethicon Llc | Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument |
USD879808S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with graphical user interface |
USD879809S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with changeable graphical user interface |
US11517325B2 (en) | 2017-06-20 | 2022-12-06 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval |
US10307170B2 (en) | 2017-06-20 | 2019-06-04 | Ethicon Llc | Method for closed loop control of motor velocity of a surgical stapling and cutting instrument |
US10327767B2 (en) | 2017-06-20 | 2019-06-25 | Ethicon Llc | Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation |
US10881396B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Surgical instrument with variable duration trigger arrangement |
US10980537B2 (en) | 2017-06-20 | 2021-04-20 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations |
US10624633B2 (en) | 2017-06-20 | 2020-04-21 | Ethicon Llc | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument |
US10779820B2 (en) | 2017-06-20 | 2020-09-22 | Ethicon Llc | Systems and methods for controlling motor speed according to user input for a surgical instrument |
KR102066045B1 (en) * | 2017-06-23 | 2020-02-11 | 주식회사 루트로닉 | The apparatus of rf-treatment comprising micro niddle, the method of controlling |
US10856869B2 (en) | 2017-06-27 | 2020-12-08 | Ethicon Llc | Surgical anvil arrangements |
US11324503B2 (en) | 2017-06-27 | 2022-05-10 | Cilag Gmbh International | Surgical firing member arrangements |
US11266405B2 (en) | 2017-06-27 | 2022-03-08 | Cilag Gmbh International | Surgical anvil manufacturing methods |
US10631859B2 (en) | 2017-06-27 | 2020-04-28 | Ethicon Llc | Articulation systems for surgical instruments |
US10772629B2 (en) | 2017-06-27 | 2020-09-15 | Ethicon Llc | Surgical anvil arrangements |
US10993716B2 (en) | 2017-06-27 | 2021-05-04 | Ethicon Llc | Surgical anvil arrangements |
USD869655S1 (en) | 2017-06-28 | 2019-12-10 | Ethicon Llc | Surgical fastener cartridge |
US10211586B2 (en) | 2017-06-28 | 2019-02-19 | Ethicon Llc | Surgical shaft assemblies with watertight housings |
USD851762S1 (en) | 2017-06-28 | 2019-06-18 | Ethicon Llc | Anvil |
US11246592B2 (en) | 2017-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical instrument comprising an articulation system lockable to a frame |
US11259805B2 (en) | 2017-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical instrument comprising firing member supports |
US10903685B2 (en) | 2017-06-28 | 2021-01-26 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies forming capacitive channels |
EP3420947B1 (en) | 2017-06-28 | 2022-05-25 | Cilag GmbH International | Surgical instrument comprising selectively actuatable rotatable couplers |
US11564686B2 (en) | 2017-06-28 | 2023-01-31 | Cilag Gmbh International | Surgical shaft assemblies with flexible interfaces |
USD854151S1 (en) | 2017-06-28 | 2019-07-16 | Ethicon Llc | Surgical instrument shaft |
USD906355S1 (en) | 2017-06-28 | 2020-12-29 | Ethicon Llc | Display screen or portion thereof with a graphical user interface for a surgical instrument |
US11389161B2 (en) | 2017-06-28 | 2022-07-19 | Cilag Gmbh International | Surgical instrument comprising selectively actuatable rotatable couplers |
US10716614B2 (en) | 2017-06-28 | 2020-07-21 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies with increased contact pressure |
US10765427B2 (en) | 2017-06-28 | 2020-09-08 | Ethicon Llc | Method for articulating a surgical instrument |
US10588633B2 (en) | 2017-06-28 | 2020-03-17 | Ethicon Llc | Surgical instruments with open and closable jaws and axially movable firing member that is initially parked in close proximity to the jaws prior to firing |
US11007022B2 (en) | 2017-06-29 | 2021-05-18 | Ethicon Llc | Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument |
US10258418B2 (en) | 2017-06-29 | 2019-04-16 | Ethicon Llc | System for controlling articulation forces |
US10398434B2 (en) | 2017-06-29 | 2019-09-03 | Ethicon Llc | Closed loop velocity control of closure member for robotic surgical instrument |
US10898183B2 (en) | 2017-06-29 | 2021-01-26 | Ethicon Llc | Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing |
US10932772B2 (en) | 2017-06-29 | 2021-03-02 | Ethicon Llc | Methods for closed loop velocity control for robotic surgical instrument |
EP3658220B1 (en) * | 2017-07-28 | 2021-07-07 | Scandinavian ChemoTech AB | A device, e.g. a dynamic electro enhanced pain control (deepc) device, for delivery of electrical pulses to a desired body part of a mammal |
US11304695B2 (en) | 2017-08-03 | 2022-04-19 | Cilag Gmbh International | Surgical system shaft interconnection |
US11944300B2 (en) | 2017-08-03 | 2024-04-02 | Cilag Gmbh International | Method for operating a surgical system bailout |
US11471155B2 (en) | 2017-08-03 | 2022-10-18 | Cilag Gmbh International | Surgical system bailout |
JP2020533050A (en) | 2017-09-12 | 2020-11-19 | ファラパルス,インコーポレイテッド | Systems, devices, and methods for ventricular focal ablation |
USD907647S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
US11399829B2 (en) | 2017-09-29 | 2022-08-02 | Cilag Gmbh International | Systems and methods of initiating a power shutdown mode for a surgical instrument |
US10729501B2 (en) | 2017-09-29 | 2020-08-04 | Ethicon Llc | Systems and methods for language selection of a surgical instrument |
USD907648S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
US10765429B2 (en) | 2017-09-29 | 2020-09-08 | Ethicon Llc | Systems and methods for providing alerts according to the operational state of a surgical instrument |
USD917500S1 (en) | 2017-09-29 | 2021-04-27 | Ethicon Llc | Display screen or portion thereof with graphical user interface |
US10796471B2 (en) | 2017-09-29 | 2020-10-06 | Ethicon Llc | Systems and methods of displaying a knife position for a surgical instrument |
US10743872B2 (en) | 2017-09-29 | 2020-08-18 | Ethicon Llc | System and methods for controlling a display of a surgical instrument |
US11134944B2 (en) | 2017-10-30 | 2021-10-05 | Cilag Gmbh International | Surgical stapler knife motion controls |
US11090075B2 (en) | 2017-10-30 | 2021-08-17 | Cilag Gmbh International | Articulation features for surgical end effector |
US10842490B2 (en) | 2017-10-31 | 2020-11-24 | Ethicon Llc | Cartridge body design with force reduction based on firing completion |
US10779903B2 (en) | 2017-10-31 | 2020-09-22 | Ethicon Llc | Positive shaft rotation lock activated by jaw closure |
US11045648B2 (en) | 2017-11-14 | 2021-06-29 | Boston Scientific Scimed, Inc. | Irreversible electroporation through a combination of substance injection and electrical field application |
WO2019097296A1 (en) * | 2017-11-17 | 2019-05-23 | Medtronic Ardian Luxembourg S.A.R.L. | Systems, devices, and associated methods for neuromodulation with enhanced nerve targeting |
US10743874B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Sealed adapters for use with electromechanical surgical instruments |
US11197670B2 (en) | 2017-12-15 | 2021-12-14 | Cilag Gmbh International | Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed |
US10828033B2 (en) | 2017-12-15 | 2020-11-10 | Ethicon Llc | Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto |
US10743875B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member |
US10966718B2 (en) | 2017-12-15 | 2021-04-06 | Ethicon Llc | Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments |
US11071543B2 (en) | 2017-12-15 | 2021-07-27 | Cilag Gmbh International | Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges |
US10779825B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments |
US10687813B2 (en) | 2017-12-15 | 2020-06-23 | Ethicon Llc | Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments |
US10779826B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Methods of operating surgical end effectors |
US11033267B2 (en) | 2017-12-15 | 2021-06-15 | Ethicon Llc | Systems and methods of controlling a clamping member firing rate of a surgical instrument |
US10869666B2 (en) | 2017-12-15 | 2020-12-22 | Ethicon Llc | Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument |
US11006955B2 (en) | 2017-12-15 | 2021-05-18 | Ethicon Llc | End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments |
USD910847S1 (en) | 2017-12-19 | 2021-02-16 | Ethicon Llc | Surgical instrument assembly |
US11020112B2 (en) | 2017-12-19 | 2021-06-01 | Ethicon Llc | Surgical tools configured for interchangeable use with different controller interfaces |
US10729509B2 (en) | 2017-12-19 | 2020-08-04 | Ethicon Llc | Surgical instrument comprising closure and firing locking mechanism |
US10716565B2 (en) | 2017-12-19 | 2020-07-21 | Ethicon Llc | Surgical instruments with dual articulation drivers |
US10835330B2 (en) | 2017-12-19 | 2020-11-17 | Ethicon Llc | Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly |
US11045270B2 (en) | 2017-12-19 | 2021-06-29 | Cilag Gmbh International | Robotic attachment comprising exterior drive actuator |
US11751867B2 (en) | 2017-12-21 | 2023-09-12 | Cilag Gmbh International | Surgical instrument comprising sequenced systems |
US11129680B2 (en) | 2017-12-21 | 2021-09-28 | Cilag Gmbh International | Surgical instrument comprising a projector |
US11076853B2 (en) | 2017-12-21 | 2021-08-03 | Cilag Gmbh International | Systems and methods of displaying a knife position during transection for a surgical instrument |
US11311290B2 (en) | 2017-12-21 | 2022-04-26 | Cilag Gmbh International | Surgical instrument comprising an end effector dampener |
WO2019147619A1 (en) * | 2018-01-23 | 2019-08-01 | Boston Scientific Scimed, Inc. | Enhanced needle array and therapies for tumor ablation |
WO2019148127A1 (en) | 2018-01-29 | 2019-08-01 | Medtronic, Inc. | Cardiac surgical instrument and connector with built-in electrogram (egm) filtering circuitry |
US11672596B2 (en) | 2018-02-26 | 2023-06-13 | Neuwave Medical, Inc. | Energy delivery devices with flexible and adjustable tips |
US11083871B2 (en) | 2018-05-03 | 2021-08-10 | Thermedical, Inc. | Selectively deployable catheter ablation devices |
CN112118798A (en) | 2018-05-07 | 2020-12-22 | 法拉普尔赛股份有限公司 | Systems, devices, and methods for filtering high voltage noise induced by pulsed electric field ablation |
EP3790486A1 (en) | 2018-05-07 | 2021-03-17 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
JP7399881B2 (en) | 2018-05-07 | 2023-12-18 | ファラパルス,インコーポレイテッド | epicardial ablation catheter |
US11918277B2 (en) | 2018-07-16 | 2024-03-05 | Thermedical, Inc. | Inferred maximum temperature monitoring for irrigated ablation therapy |
US11253256B2 (en) | 2018-08-20 | 2022-02-22 | Cilag Gmbh International | Articulatable motor powered surgical instruments with dedicated articulation motor arrangements |
US10779821B2 (en) | 2018-08-20 | 2020-09-22 | Ethicon Llc | Surgical stapler anvils with tissue stop features configured to avoid tissue pinch |
US10842492B2 (en) | 2018-08-20 | 2020-11-24 | Ethicon Llc | Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system |
US11045192B2 (en) | 2018-08-20 | 2021-06-29 | Cilag Gmbh International | Fabricating techniques for surgical stapler anvils |
US11291440B2 (en) | 2018-08-20 | 2022-04-05 | Cilag Gmbh International | Method for operating a powered articulatable surgical instrument |
US10856870B2 (en) | 2018-08-20 | 2020-12-08 | Ethicon Llc | Switching arrangements for motor powered articulatable surgical instruments |
US11083458B2 (en) | 2018-08-20 | 2021-08-10 | Cilag Gmbh International | Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions |
US11324501B2 (en) | 2018-08-20 | 2022-05-10 | Cilag Gmbh International | Surgical stapling devices with improved closure members |
US11207065B2 (en) | 2018-08-20 | 2021-12-28 | Cilag Gmbh International | Method for fabricating surgical stapler anvils |
USD914878S1 (en) | 2018-08-20 | 2021-03-30 | Ethicon Llc | Surgical instrument anvil |
US11039834B2 (en) | 2018-08-20 | 2021-06-22 | Cilag Gmbh International | Surgical stapler anvils with staple directing protrusions and tissue stability features |
US10912559B2 (en) | 2018-08-20 | 2021-02-09 | Ethicon Llc | Reinforced deformable anvil tip for surgical stapler anvil |
US11540881B2 (en) | 2018-08-23 | 2023-01-03 | Boston Scientific Scimed, Inc. | Microwave ablation probe with radiofrequency impedance sensing |
AU2019335013A1 (en) | 2018-09-05 | 2021-03-25 | Applied Medical Resources Corporation | Electrosurgical generator control system |
WO2020061359A1 (en) | 2018-09-20 | 2020-03-26 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
EP3880099A1 (en) | 2018-11-16 | 2021-09-22 | Applied Medical Resources Corporation | Electrosurgical system |
US11135004B2 (en) | 2018-12-24 | 2021-10-05 | Industrial Technology Research Institute | Ablation device |
US11071860B2 (en) | 2019-02-06 | 2021-07-27 | Oncosec Medical Incorporated | Systems and methods for detecting fault conditions in electroporation therapy |
US11832879B2 (en) | 2019-03-08 | 2023-12-05 | Neuwave Medical, Inc. | Systems and methods for energy delivery |
US11696761B2 (en) | 2019-03-25 | 2023-07-11 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11147553B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11147551B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11172929B2 (en) | 2019-03-25 | 2021-11-16 | Cilag Gmbh International | Articulation drive arrangements for surgical systems |
US11432816B2 (en) | 2019-04-30 | 2022-09-06 | Cilag Gmbh International | Articulation pin for a surgical instrument |
US11471157B2 (en) | 2019-04-30 | 2022-10-18 | Cilag Gmbh International | Articulation control mapping for a surgical instrument |
US11253254B2 (en) | 2019-04-30 | 2022-02-22 | Cilag Gmbh International | Shaft rotation actuator on a surgical instrument |
US11903581B2 (en) | 2019-04-30 | 2024-02-20 | Cilag Gmbh International | Methods for stapling tissue using a surgical instrument |
US11452528B2 (en) | 2019-04-30 | 2022-09-27 | Cilag Gmbh International | Articulation actuators for a surgical instrument |
US11426251B2 (en) | 2019-04-30 | 2022-08-30 | Cilag Gmbh International | Articulation directional lights on a surgical instrument |
US11648009B2 (en) | 2019-04-30 | 2023-05-16 | Cilag Gmbh International | Rotatable jaw tip for a surgical instrument |
SG11202111518WA (en) | 2019-05-09 | 2021-11-29 | Gyrus Acmi Inc D/B/A Olympus Surgical Technologies America | Electrosurgical systems and methods |
EP3975901A4 (en) * | 2019-05-24 | 2023-06-21 | Kansas State University Research Foundation | Minimally invasive microwave ablation device |
USD968422S1 (en) | 2019-05-31 | 2022-11-01 | Biosense Webster (Israel) Ltd. | Display screen with transitional graphical user interface |
USD968421S1 (en) | 2019-05-31 | 2022-11-01 | Biosense Webster (Israel) Ltd. | Display screen with a graphical user interface |
USD969138S1 (en) | 2019-05-31 | 2022-11-08 | Biosense Webster (Israel) Ltd. | Display screen with a graphical user interface |
US11298127B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Interational | Surgical stapling system having a lockout mechanism for an incompatible cartridge |
US11771419B2 (en) | 2019-06-28 | 2023-10-03 | Cilag Gmbh International | Packaging for a replaceable component of a surgical stapling system |
US11553971B2 (en) | 2019-06-28 | 2023-01-17 | Cilag Gmbh International | Surgical RFID assemblies for display and communication |
US11241235B2 (en) | 2019-06-28 | 2022-02-08 | Cilag Gmbh International | Method of using multiple RFID chips with a surgical assembly |
US11464601B2 (en) | 2019-06-28 | 2022-10-11 | Cilag Gmbh International | Surgical instrument comprising an RFID system for tracking a movable component |
US11399837B2 (en) | 2019-06-28 | 2022-08-02 | Cilag Gmbh International | Mechanisms for motor control adjustments of a motorized surgical instrument |
US11376098B2 (en) | 2019-06-28 | 2022-07-05 | Cilag Gmbh International | Surgical instrument system comprising an RFID system |
US11219455B2 (en) | 2019-06-28 | 2022-01-11 | Cilag Gmbh International | Surgical instrument including a lockout key |
US11638587B2 (en) | 2019-06-28 | 2023-05-02 | Cilag Gmbh International | RFID identification systems for surgical instruments |
US11426167B2 (en) | 2019-06-28 | 2022-08-30 | Cilag Gmbh International | Mechanisms for proper anvil attachment surgical stapling head assembly |
US11523822B2 (en) | 2019-06-28 | 2022-12-13 | Cilag Gmbh International | Battery pack including a circuit interrupter |
US11246678B2 (en) | 2019-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical stapling system having a frangible RFID tag |
US11051807B2 (en) | 2019-06-28 | 2021-07-06 | Cilag Gmbh International | Packaging assembly including a particulate trap |
US11684434B2 (en) | 2019-06-28 | 2023-06-27 | Cilag Gmbh International | Surgical RFID assemblies for instrument operational setting control |
US11497492B2 (en) | 2019-06-28 | 2022-11-15 | Cilag Gmbh International | Surgical instrument including an articulation lock |
US11298132B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Inlernational | Staple cartridge including a honeycomb extension |
US11660163B2 (en) | 2019-06-28 | 2023-05-30 | Cilag Gmbh International | Surgical system with RFID tags for updating motor assembly parameters |
US11224497B2 (en) | 2019-06-28 | 2022-01-18 | Cilag Gmbh International | Surgical systems with multiple RFID tags |
US11627959B2 (en) | 2019-06-28 | 2023-04-18 | Cilag Gmbh International | Surgical instruments including manual and powered system lockouts |
US11259803B2 (en) | 2019-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical stapling system having an information encryption protocol |
US11478241B2 (en) | 2019-06-28 | 2022-10-25 | Cilag Gmbh International | Staple cartridge including projections |
US11291451B2 (en) | 2019-06-28 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with battery compatibility verification functionality |
EP3996617A4 (en) * | 2019-07-10 | 2023-08-23 | David Cohen | Apparatus for treatment of tumors using a treatment object and powering of the treatment object |
US11937882B2 (en) * | 2019-08-27 | 2024-03-26 | Biosense Webster (Israel) Ltd. | ENT tools |
EP4025130A1 (en) | 2019-09-04 | 2022-07-13 | Arga' Medtech Sa | Ablation assembly to treat target regions of tissue in organs |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
CN114945338A (en) | 2019-10-15 | 2022-08-26 | 波士顿科学国际有限公司 | Control system and user interface for an ablation system |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
US20220395189A1 (en) * | 2019-11-27 | 2022-12-15 | Blossom Innovations, LLC | Devices, systems and methods for tissue detection, position determination and tissue ablation |
US11701111B2 (en) | 2019-12-19 | 2023-07-18 | Cilag Gmbh International | Method for operating a surgical stapling instrument |
US11529137B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11607219B2 (en) | 2019-12-19 | 2023-03-21 | Cilag Gmbh International | Staple cartridge comprising a detachable tissue cutting knife |
US11504122B2 (en) | 2019-12-19 | 2022-11-22 | Cilag Gmbh International | Surgical instrument comprising a nested firing member |
US11291447B2 (en) | 2019-12-19 | 2022-04-05 | Cilag Gmbh International | Stapling instrument comprising independent jaw closing and staple firing systems |
US11234698B2 (en) | 2019-12-19 | 2022-02-01 | Cilag Gmbh International | Stapling system comprising a clamp lockout and a firing lockout |
US11559304B2 (en) | 2019-12-19 | 2023-01-24 | Cilag Gmbh International | Surgical instrument comprising a rapid closure mechanism |
US11529139B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Motor driven surgical instrument |
US11464512B2 (en) | 2019-12-19 | 2022-10-11 | Cilag Gmbh International | Staple cartridge comprising a curved deck surface |
US11931033B2 (en) | 2019-12-19 | 2024-03-19 | Cilag Gmbh International | Staple cartridge comprising a latch lockout |
US11576672B2 (en) | 2019-12-19 | 2023-02-14 | Cilag Gmbh International | Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw |
US11304696B2 (en) | 2019-12-19 | 2022-04-19 | Cilag Gmbh International | Surgical instrument comprising a powered articulation system |
US11446029B2 (en) | 2019-12-19 | 2022-09-20 | Cilag Gmbh International | Staple cartridge comprising projections extending from a curved deck surface |
US11911032B2 (en) | 2019-12-19 | 2024-02-27 | Cilag Gmbh International | Staple cartridge comprising a seating cam |
US11844520B2 (en) | 2019-12-19 | 2023-12-19 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US20210361337A1 (en) * | 2020-05-21 | 2021-11-25 | Covidien Lp | Independent control of dual rf bipolar electrosurgery |
USD966512S1 (en) | 2020-06-02 | 2022-10-11 | Cilag Gmbh International | Staple cartridge |
USD976401S1 (en) | 2020-06-02 | 2023-01-24 | Cilag Gmbh International | Staple cartridge |
USD967421S1 (en) | 2020-06-02 | 2022-10-18 | Cilag Gmbh International | Staple cartridge |
USD975851S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD975850S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD975278S1 (en) | 2020-06-02 | 2023-01-10 | Cilag Gmbh International | Staple cartridge |
USD974560S1 (en) | 2020-06-02 | 2023-01-03 | Cilag Gmbh International | Staple cartridge |
JP2023528084A (en) | 2020-06-07 | 2023-07-03 | アルガ′ メドテック エスア | Ablation device for treating target areas of tissue within an organ |
US20210401491A1 (en) * | 2020-06-29 | 2021-12-30 | Biosense Webster (Israel) Ltd. | Estimating progress of irreversible electroporation ablation based on amplitude of measured bipolar signals |
US11819265B2 (en) | 2020-07-28 | 2023-11-21 | Biosense Webster (Israel) Ltd. | Cautious irreversible-electroporation (IRE) protocol for avoiding bubble generation |
US20220031351A1 (en) | 2020-07-28 | 2022-02-03 | Cilag Gmbh International | Surgical instruments with differential articulation joint arrangements for accommodating flexible actuators |
US20220071692A1 (en) | 2020-09-08 | 2022-03-10 | Biosense Webster (Israel) Ltd. | Impedance based irreversible-electroporation (ire) |
US11779330B2 (en) | 2020-10-29 | 2023-10-10 | Cilag Gmbh International | Surgical instrument comprising a jaw alignment system |
USD980425S1 (en) | 2020-10-29 | 2023-03-07 | Cilag Gmbh International | Surgical instrument assembly |
US11896217B2 (en) | 2020-10-29 | 2024-02-13 | Cilag Gmbh International | Surgical instrument comprising an articulation lock |
US11717289B2 (en) | 2020-10-29 | 2023-08-08 | Cilag Gmbh International | Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable |
US11617577B2 (en) | 2020-10-29 | 2023-04-04 | Cilag Gmbh International | Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable |
US11517390B2 (en) | 2020-10-29 | 2022-12-06 | Cilag Gmbh International | Surgical instrument comprising a limited travel switch |
USD1013170S1 (en) | 2020-10-29 | 2024-01-30 | Cilag Gmbh International | Surgical instrument assembly |
US11534259B2 (en) | 2020-10-29 | 2022-12-27 | Cilag Gmbh International | Surgical instrument comprising an articulation indicator |
US11844518B2 (en) | 2020-10-29 | 2023-12-19 | Cilag Gmbh International | Method for operating a surgical instrument |
US11452526B2 (en) | 2020-10-29 | 2022-09-27 | Cilag Gmbh International | Surgical instrument comprising a staged voltage regulation start-up system |
US11931025B2 (en) | 2020-10-29 | 2024-03-19 | Cilag Gmbh International | Surgical instrument comprising a releasable closure drive lock |
US11653920B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Powered surgical instruments with communication interfaces through sterile barrier |
US11737751B2 (en) | 2020-12-02 | 2023-08-29 | Cilag Gmbh International | Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings |
US11678882B2 (en) | 2020-12-02 | 2023-06-20 | Cilag Gmbh International | Surgical instruments with interactive features to remedy incidental sled movements |
US11849943B2 (en) | 2020-12-02 | 2023-12-26 | Cilag Gmbh International | Surgical instrument with cartridge release mechanisms |
US11627960B2 (en) | 2020-12-02 | 2023-04-18 | Cilag Gmbh International | Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections |
US11653915B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Surgical instruments with sled location detection and adjustment features |
US11944296B2 (en) | 2020-12-02 | 2024-04-02 | Cilag Gmbh International | Powered surgical instruments with external connectors |
US11890010B2 (en) | 2020-12-02 | 2024-02-06 | Cllag GmbH International | Dual-sided reinforced reload for surgical instruments |
US11744581B2 (en) | 2020-12-02 | 2023-09-05 | Cilag Gmbh International | Powered surgical instruments with multi-phase tissue treatment |
US11793514B2 (en) | 2021-02-26 | 2023-10-24 | Cilag Gmbh International | Staple cartridge comprising sensor array which may be embedded in cartridge body |
US11812964B2 (en) | 2021-02-26 | 2023-11-14 | Cilag Gmbh International | Staple cartridge comprising a power management circuit |
US11744583B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Distal communication array to tune frequency of RF systems |
US11751869B2 (en) | 2021-02-26 | 2023-09-12 | Cilag Gmbh International | Monitoring of multiple sensors over time to detect moving characteristics of tissue |
US11701113B2 (en) | 2021-02-26 | 2023-07-18 | Cilag Gmbh International | Stapling instrument comprising a separate power antenna and a data transfer antenna |
US11730473B2 (en) | 2021-02-26 | 2023-08-22 | Cilag Gmbh International | Monitoring of manufacturing life-cycle |
US11723657B2 (en) | 2021-02-26 | 2023-08-15 | Cilag Gmbh International | Adjustable communication based on available bandwidth and power capacity |
US11925349B2 (en) | 2021-02-26 | 2024-03-12 | Cilag Gmbh International | Adjustment to transfer parameters to improve available power |
US11749877B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Stapling instrument comprising a signal antenna |
US11696757B2 (en) | 2021-02-26 | 2023-07-11 | Cilag Gmbh International | Monitoring of internal systems to detect and track cartridge motion status |
US11826042B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Surgical instrument comprising a firing drive including a selectable leverage mechanism |
US11723658B2 (en) | 2021-03-22 | 2023-08-15 | Cilag Gmbh International | Staple cartridge comprising a firing lockout |
US11759202B2 (en) | 2021-03-22 | 2023-09-19 | Cilag Gmbh International | Staple cartridge comprising an implantable layer |
US11826012B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising a pulsed motor-driven firing rack |
US11717291B2 (en) | 2021-03-22 | 2023-08-08 | Cilag Gmbh International | Staple cartridge comprising staples configured to apply different tissue compression |
US11806011B2 (en) | 2021-03-22 | 2023-11-07 | Cilag Gmbh International | Stapling instrument comprising tissue compression systems |
US11737749B2 (en) | 2021-03-22 | 2023-08-29 | Cilag Gmbh International | Surgical stapling instrument comprising a retraction system |
US11786239B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Surgical instrument articulation joint arrangements comprising multiple moving linkage features |
US11857183B2 (en) | 2021-03-24 | 2024-01-02 | Cilag Gmbh International | Stapling assembly components having metal substrates and plastic bodies |
US11903582B2 (en) | 2021-03-24 | 2024-02-20 | Cilag Gmbh International | Leveraging surfaces for cartridge installation |
US11849945B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Rotary-driven surgical stapling assembly comprising eccentrically driven firing member |
US11944336B2 (en) | 2021-03-24 | 2024-04-02 | Cilag Gmbh International | Joint arrangements for multi-planar alignment and support of operational drive shafts in articulatable surgical instruments |
US11832816B2 (en) | 2021-03-24 | 2023-12-05 | Cilag Gmbh International | Surgical stapling assembly comprising nonplanar staples and planar staples |
US11744603B2 (en) | 2021-03-24 | 2023-09-05 | Cilag Gmbh International | Multi-axis pivot joints for surgical instruments and methods for manufacturing same |
US11896219B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Mating features between drivers and underside of a cartridge deck |
US11896218B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Method of using a powered stapling device |
US11849944B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Drivers for fastener cartridge assemblies having rotary drive screws |
US11786243B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Firing members having flexible portions for adapting to a load during a surgical firing stroke |
US11793516B2 (en) | 2021-03-24 | 2023-10-24 | Cilag Gmbh International | Surgical staple cartridge comprising longitudinal support beam |
US11826047B2 (en) | 2021-05-28 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising jaw mounts |
KR102650606B1 (en) * | 2021-10-15 | 2024-03-21 | 가톨릭대학교 산학협력단 | Method and apparatus for supplying current for cancer treatment |
US11877745B2 (en) | 2021-10-18 | 2024-01-23 | Cilag Gmbh International | Surgical stapling assembly having longitudinally-repeating staple leg clusters |
CN114098910B (en) * | 2021-10-28 | 2023-08-29 | 北京派尔特医疗科技股份有限公司 | Cutting control method and device applied to ultrasonic knife and storage medium |
US11937816B2 (en) | 2021-10-28 | 2024-03-26 | Cilag Gmbh International | Electrical lead arrangements for surgical instruments |
WO2023178123A2 (en) * | 2022-03-15 | 2023-09-21 | NovaScan, Inc. | Techniques for determining tissue types |
WO2023205486A1 (en) * | 2022-04-22 | 2023-10-26 | Worcester Polytechnic Institute | Colonoscopy probe device |
US20230355215A1 (en) * | 2022-05-05 | 2023-11-09 | Fujifilm Sonosite, Inc. | Detecting electromagnetic emissions on ultrasound systems |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5341807A (en) * | 1992-06-30 | 1994-08-30 | American Cardiac Ablation Co., Inc. | Ablation catheter positioning system |
US5683384A (en) * | 1993-11-08 | 1997-11-04 | Zomed | Multiple antenna ablation apparatus |
US5735847A (en) * | 1995-08-15 | 1998-04-07 | Zomed International, Inc. | Multiple antenna ablation apparatus and method with cooling element |
US6235023B1 (en) * | 1995-08-15 | 2001-05-22 | Rita Medical Systems, Inc. | Cell necrosis apparatus |
US20020026188A1 (en) * | 2000-03-31 | 2002-02-28 | Balbierz Daniel J. | Tissue biopsy and treatment apparatus and method |
US6770070B1 (en) * | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
US20050107781A1 (en) * | 2003-11-18 | 2005-05-19 | Isaac Ostrovsky | System and method for tissue ablation |
US6962587B2 (en) * | 2000-07-25 | 2005-11-08 | Rita Medical Systems, Inc. | Method for detecting and treating tumors using localized impedance measurement |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3871359A (en) * | 1973-06-25 | 1975-03-18 | Interscience Technology Corp | Impedance measuring system |
CA1244889A (en) * | 1983-01-24 | 1988-11-15 | Kureha Chemical Ind Co Ltd | Device for hyperthermia |
US5564417A (en) * | 1991-01-24 | 1996-10-15 | Non-Invasive Technology, Inc. | Pathlength corrected oximeter and the like |
US5540737A (en) | 1991-06-26 | 1996-07-30 | Massachusetts Institute Of Technology | Minimally invasive monopole phased array hyperthermia applicators and method for treating breast carcinomas |
US6277112B1 (en) | 1996-07-16 | 2001-08-21 | Arthrocare Corporation | Methods for electrosurgical spine surgery |
US5697882A (en) | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US6142992A (en) | 1993-05-10 | 2000-11-07 | Arthrocare Corporation | Power supply for limiting power in electrosurgery |
US5227730A (en) | 1992-09-14 | 1993-07-13 | Kdc Technology Corp. | Microwave needle dielectric sensors |
US5620479A (en) | 1992-11-13 | 1997-04-15 | The Regents Of The University Of California | Method and apparatus for thermal therapy of tumors |
US5458597A (en) * | 1993-11-08 | 1995-10-17 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5536267A (en) | 1993-11-08 | 1996-07-16 | Zomed International | Multiple electrode ablation apparatus |
US5728143A (en) * | 1995-08-15 | 1998-03-17 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US6056744A (en) | 1994-06-24 | 2000-05-02 | Conway Stuart Medical, Inc. | Sphincter treatment apparatus |
US5810742A (en) | 1994-10-24 | 1998-09-22 | Transcan Research & Development Co., Ltd. | Tissue characterization based on impedance images and on impedance measurements |
US6106524A (en) * | 1995-03-03 | 2000-08-22 | Neothermia Corporation | Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue |
US5630426A (en) * | 1995-03-03 | 1997-05-20 | Neovision Corporation | Apparatus and method for characterization and treatment of tumors |
US6080150A (en) * | 1995-08-15 | 2000-06-27 | Rita Medical Systems, Inc. | Cell necrosis apparatus |
US5800484A (en) | 1995-08-15 | 1998-09-01 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus with expanded electrodes |
US6059780A (en) * | 1995-08-15 | 2000-05-09 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method with cooling element |
US5980517A (en) * | 1995-08-15 | 1999-11-09 | Rita Medical Systems, Inc. | Cell necrosis apparatus |
US6330478B1 (en) * | 1995-08-15 | 2001-12-11 | Rita Medical Systems, Inc. | Cell necrosis apparatus |
US5807272A (en) | 1995-10-31 | 1998-09-15 | Worcester Polytechnic Institute | Impedance spectroscopy system for ischemia monitoring and detection |
US6016452A (en) | 1996-03-19 | 2000-01-18 | Kasevich; Raymond S. | Dynamic heating method and radio frequency thermal treatment |
US5873849A (en) * | 1997-04-24 | 1999-02-23 | Ichor Medical Systems, Inc. | Electrodes and electrode arrays for generating electroporation inducing electrical fields |
US6009347A (en) * | 1998-01-27 | 1999-12-28 | Genetronics, Inc. | Electroporation apparatus with connective electrode template |
US6050994A (en) | 1998-05-05 | 2000-04-18 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method using controllable duty cycle with alternate phasing |
US6059778A (en) | 1998-05-05 | 2000-05-09 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method using unipolar and bipolar techniques |
US6558378B2 (en) | 1998-05-05 | 2003-05-06 | Cardiac Pacemakers, Inc. | RF ablation system and method having automatic temperature control |
US6171305B1 (en) | 1998-05-05 | 2001-01-09 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method having high output impedance drivers |
US6312425B1 (en) | 1998-05-05 | 2001-11-06 | Cardiac Pacemakers, Inc. | RF ablation catheter tip electrode with multiple thermal sensors |
JP2000005180A (en) * | 1998-06-25 | 2000-01-11 | Olympus Optical Co Ltd | Acoustic impedance measuring device |
US6478793B1 (en) * | 1999-06-11 | 2002-11-12 | Sherwood Services Ag | Ablation treatment of bone metastases |
US7008421B2 (en) * | 2002-08-21 | 2006-03-07 | Resect Medical, Inc. | Apparatus and method for tissue resection |
US6497704B2 (en) * | 2001-04-04 | 2002-12-24 | Moshe Ein-Gal | Electrosurgical apparatus |
-
2001
- 2001-07-25 CA CA002416581A patent/CA2416581A1/en not_active Abandoned
- 2001-07-25 AU AU2001279026A patent/AU2001279026B2/en not_active Ceased
- 2001-07-25 WO PCT/US2001/023553 patent/WO2002032335A1/en active IP Right Grant
- 2001-07-25 EP EP01957265A patent/EP1304971A1/en not_active Withdrawn
- 2001-07-25 JP JP2002535574A patent/JP2004520865A/en active Pending
- 2001-07-25 US US09/916,214 patent/US7419487B2/en not_active Expired - Lifetime
- 2001-07-25 US US09/916,235 patent/US6962587B2/en not_active Expired - Lifetime
- 2001-07-26 AU AU7902601A patent/AU7902601A/en active Pending
-
2008
- 2008-07-24 US US12/178,684 patent/US20080281314A1/en not_active Abandoned
-
2012
- 2012-09-11 US US13/609,369 patent/US8540710B2/en not_active Expired - Fee Related
-
2013
- 2013-10-15 US US13/975,755 patent/US20140081255A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5341807A (en) * | 1992-06-30 | 1994-08-30 | American Cardiac Ablation Co., Inc. | Ablation catheter positioning system |
US5683384A (en) * | 1993-11-08 | 1997-11-04 | Zomed | Multiple antenna ablation apparatus |
US5735847A (en) * | 1995-08-15 | 1998-04-07 | Zomed International, Inc. | Multiple antenna ablation apparatus and method with cooling element |
US6235023B1 (en) * | 1995-08-15 | 2001-05-22 | Rita Medical Systems, Inc. | Cell necrosis apparatus |
US6770070B1 (en) * | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
US20020026188A1 (en) * | 2000-03-31 | 2002-02-28 | Balbierz Daniel J. | Tissue biopsy and treatment apparatus and method |
US6962587B2 (en) * | 2000-07-25 | 2005-11-08 | Rita Medical Systems, Inc. | Method for detecting and treating tumors using localized impedance measurement |
US20050107781A1 (en) * | 2003-11-18 | 2005-05-19 | Isaac Ostrovsky | System and method for tissue ablation |
Cited By (250)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10772682B2 (en) | 2003-06-23 | 2020-09-15 | Angiodynamics, Inc. | Radiation applicator for microwave medical treatment |
US9770295B2 (en) | 2003-06-23 | 2017-09-26 | Angiodynamics, Inc. | Radiation applicator for microwave medical treatment |
US9788896B2 (en) | 2004-07-02 | 2017-10-17 | Angiodynamics, Inc. | Radiation applicator and method of radiating tissue |
US10959772B2 (en) | 2008-04-29 | 2021-03-30 | Virginia Tech Intellectual Properties, Inc. | Blood-brain barrier disruption using electrical energy |
US10470822B2 (en) | 2008-04-29 | 2019-11-12 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US11655466B2 (en) | 2008-04-29 | 2023-05-23 | Virginia Tech Intellectual Properties, Inc. | Methods of reducing adverse effects of non-thermal ablation |
US10117707B2 (en) | 2008-04-29 | 2018-11-06 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10154874B2 (en) | 2008-04-29 | 2018-12-18 | Virginia Tech Intellectual Properties, Inc. | Immunotherapeutic methods using irreversible electroporation |
US10238447B2 (en) | 2008-04-29 | 2019-03-26 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
US10245105B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Electroporation with cooling to treat tissue |
US10245098B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Acute blood-brain barrier disruption using electrical energy based therapy |
US10272178B2 (en) | 2008-04-29 | 2019-04-30 | Virginia Tech Intellectual Properties Inc. | Methods for blood-brain barrier disruption using electrical energy |
US10286108B2 (en) | 2008-04-29 | 2019-05-14 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation to create tissue scaffolds |
US11453873B2 (en) | 2008-04-29 | 2022-09-27 | Virginia Tech Intellectual Properties, Inc. | Methods for delivery of biphasic electrical pulses for non-thermal ablation |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
US10828086B2 (en) | 2008-04-29 | 2020-11-10 | Virginia Tech Intellectual Properties, Inc. | Immunotherapeutic methods using irreversible electroporation |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10828085B2 (en) | 2008-04-29 | 2020-11-10 | Virginia Tech Intellectual Properties, Inc. | Immunotherapeutic methods using irreversible electroporation |
US11737810B2 (en) | 2008-04-29 | 2023-08-29 | Virginia Tech Intellectual Properties, Inc. | Immunotherapeutic methods using electroporation |
US11607271B2 (en) | 2008-04-29 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US10537379B2 (en) | 2008-04-29 | 2020-01-21 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US11890046B2 (en) | 2008-04-29 | 2024-02-06 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
US10448989B2 (en) | 2009-04-09 | 2019-10-22 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
US10292755B2 (en) | 2009-04-09 | 2019-05-21 | Virginia Tech Intellectual Properties, Inc. | High frequency electroporation for cancer therapy |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
US11707629B2 (en) | 2009-05-28 | 2023-07-25 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US11931096B2 (en) | 2010-10-13 | 2024-03-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US9757196B2 (en) | 2011-09-28 | 2017-09-12 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US11779395B2 (en) | 2011-09-28 | 2023-10-10 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US11871901B2 (en) | 2012-05-20 | 2024-01-16 | Cilag Gmbh International | Method for situational awareness for surgical network or surgical network connected device capable of adjusting function based on a sensed situation or usage |
US11039887B2 (en) | 2013-08-09 | 2021-06-22 | The General Hospital Corporation | Method and apparatus for treating dermal melasma |
US11083523B2 (en) | 2013-08-09 | 2021-08-10 | The General Hospital Corporation | Method and apparatus for treating dermal melasma |
US11071587B2 (en) | 2013-08-09 | 2021-07-27 | The General Hospital Corporation | Method and apparatus for treating dermal melasma |
US10471254B2 (en) | 2014-05-12 | 2019-11-12 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11406820B2 (en) | 2014-05-12 | 2022-08-09 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11504192B2 (en) | 2014-10-30 | 2022-11-22 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11903690B2 (en) | 2014-12-15 | 2024-02-20 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US10694972B2 (en) | 2014-12-15 | 2020-06-30 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US10660691B2 (en) | 2015-10-07 | 2020-05-26 | Angiodynamics, Inc. | Multiple use subassembly with integrated fluid delivery system for use with single or dual-lumen peristaltic tubing |
WO2017217760A1 (en) * | 2016-06-14 | 2017-12-21 | (주)더스탠다드 | Therapeutic device employing endoscope-interworking electrode |
IT201600068691A1 (en) * | 2016-07-01 | 2018-01-01 | Igea S P A | HANDLING AND CONTROL SYSTEM FOR EXPANDABLE ELECTRODES OF A HANDPIECE USED IN AN ELECTRO-PORTION PROCESS |
EP3284432A1 (en) * | 2016-07-01 | 2018-02-21 | IGEA S.p.A. | Handling and control system for expandable electrodes of a handpiece for use in an electro-poration process |
US11723710B2 (en) | 2016-11-17 | 2023-08-15 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
US11109878B2 (en) | 2017-10-30 | 2021-09-07 | Cilag Gmbh International | Surgical clip applier comprising an automatic clip feeding system |
US11801098B2 (en) | 2017-10-30 | 2023-10-31 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11026687B2 (en) | 2017-10-30 | 2021-06-08 | Cilag Gmbh International | Clip applier comprising clip advancing systems |
US11026713B2 (en) | 2017-10-30 | 2021-06-08 | Cilag Gmbh International | Surgical clip applier configured to store clips in a stored state |
US11696778B2 (en) | 2017-10-30 | 2023-07-11 | Cilag Gmbh International | Surgical dissectors configured to apply mechanical and electrical energy |
US11026712B2 (en) | 2017-10-30 | 2021-06-08 | Cilag Gmbh International | Surgical instruments comprising a shifting mechanism |
US11207090B2 (en) | 2017-10-30 | 2021-12-28 | Cilag Gmbh International | Surgical instruments comprising a biased shifting mechanism |
US11648022B2 (en) | 2017-10-30 | 2023-05-16 | Cilag Gmbh International | Surgical instrument systems comprising battery arrangements |
US11045197B2 (en) | 2017-10-30 | 2021-06-29 | Cilag Gmbh International | Clip applier comprising a movable clip magazine |
US11051836B2 (en) | 2017-10-30 | 2021-07-06 | Cilag Gmbh International | Surgical clip applier comprising an empty clip cartridge lockout |
US10932806B2 (en) | 2017-10-30 | 2021-03-02 | Ethicon Llc | Reactive algorithm for surgical system |
US11229436B2 (en) | 2017-10-30 | 2022-01-25 | Cilag Gmbh International | Surgical system comprising a surgical tool and a surgical hub |
US11602366B2 (en) | 2017-10-30 | 2023-03-14 | Cilag Gmbh International | Surgical suturing instrument configured to manipulate tissue using mechanical and electrical power |
US11564756B2 (en) | 2017-10-30 | 2023-01-31 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11759224B2 (en) | 2017-10-30 | 2023-09-19 | Cilag Gmbh International | Surgical instrument systems comprising handle arrangements |
US11071560B2 (en) | 2017-10-30 | 2021-07-27 | Cilag Gmbh International | Surgical clip applier comprising adaptive control in response to a strain gauge circuit |
US11564703B2 (en) | 2017-10-30 | 2023-01-31 | Cilag Gmbh International | Surgical suturing instrument comprising a capture width which is larger than trocar diameter |
US11793537B2 (en) | 2017-10-30 | 2023-10-24 | Cilag Gmbh International | Surgical instrument comprising an adaptive electrical system |
US11510741B2 (en) | 2017-10-30 | 2022-11-29 | Cilag Gmbh International | Method for producing a surgical instrument comprising a smart electrical system |
US10980560B2 (en) | 2017-10-30 | 2021-04-20 | Ethicon Llc | Surgical instrument systems comprising feedback mechanisms |
US11819231B2 (en) | 2017-10-30 | 2023-11-21 | Cilag Gmbh International | Adaptive control programs for a surgical system comprising more than one type of cartridge |
US11413042B2 (en) | 2017-10-30 | 2022-08-16 | Cilag Gmbh International | Clip applier comprising a reciprocating clip advancing member |
US11103268B2 (en) | 2017-10-30 | 2021-08-31 | Cilag Gmbh International | Surgical clip applier comprising adaptive firing control |
US11406390B2 (en) | 2017-10-30 | 2022-08-09 | Cilag Gmbh International | Clip applier comprising interchangeable clip reloads |
US10772651B2 (en) | 2017-10-30 | 2020-09-15 | Ethicon Llc | Surgical instruments comprising a system for articulation and rotation compensation |
US10959744B2 (en) | 2017-10-30 | 2021-03-30 | Ethicon Llc | Surgical dissectors and manufacturing techniques |
US11123070B2 (en) | 2017-10-30 | 2021-09-21 | Cilag Gmbh International | Clip applier comprising a rotatable clip magazine |
US11129636B2 (en) | 2017-10-30 | 2021-09-28 | Cilag Gmbh International | Surgical instruments comprising an articulation drive that provides for high articulation angles |
US11911045B2 (en) | 2017-10-30 | 2024-02-27 | Cllag GmbH International | Method for operating a powered articulating multi-clip applier |
US11317919B2 (en) | 2017-10-30 | 2022-05-03 | Cilag Gmbh International | Clip applier comprising a clip crimping system |
US11141160B2 (en) | 2017-10-30 | 2021-10-12 | Cilag Gmbh International | Clip applier comprising a motor controller |
US11311342B2 (en) | 2017-10-30 | 2022-04-26 | Cilag Gmbh International | Method for communicating with surgical instrument systems |
US11291510B2 (en) | 2017-10-30 | 2022-04-05 | Cilag Gmbh International | Method of hub communication with surgical instrument systems |
US11291465B2 (en) | 2017-10-30 | 2022-04-05 | Cilag Gmbh International | Surgical instruments comprising a lockable end effector socket |
US11925373B2 (en) | 2017-10-30 | 2024-03-12 | Cilag Gmbh International | Surgical suturing instrument comprising a non-circular needle |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
EP3501595A1 (en) * | 2017-12-22 | 2019-06-26 | IGEA S.p.A. | Handpiece having of expandable electrodes used for electroporation |
US11633237B2 (en) | 2017-12-28 | 2023-04-25 | Cilag Gmbh International | Usage and technique analysis of surgeon / staff performance against a baseline to optimize device utilization and performance for both current and future procedures |
US11744604B2 (en) | 2017-12-28 | 2023-09-05 | Cilag Gmbh International | Surgical instrument with a hardware-only control circuit |
US11202570B2 (en) | 2017-12-28 | 2021-12-21 | Cilag Gmbh International | Communication hub and storage device for storing parameters and status of a surgical device to be shared with cloud based analytics systems |
US11937769B2 (en) | 2017-12-28 | 2024-03-26 | Cilag Gmbh International | Method of hub communication, processing, storage and display |
US11179175B2 (en) | 2017-12-28 | 2021-11-23 | Cilag Gmbh International | Controlling an ultrasonic surgical instrument according to tissue location |
US11213359B2 (en) | 2017-12-28 | 2022-01-04 | Cilag Gmbh International | Controllers for robot-assisted surgical platforms |
US11931110B2 (en) | 2017-12-28 | 2024-03-19 | Cilag Gmbh International | Surgical instrument comprising a control system that uses input from a strain gage circuit |
US11918302B2 (en) | 2017-12-28 | 2024-03-05 | Cilag Gmbh International | Sterile field interactive control displays |
US11179208B2 (en) | 2017-12-28 | 2021-11-23 | Cilag Gmbh International | Cloud-based medical analytics for security and authentication trends and reactive measures |
US11234756B2 (en) | 2017-12-28 | 2022-02-01 | Cilag Gmbh International | Powered surgical tool with predefined adjustable control algorithm for controlling end effector parameter |
US11257589B2 (en) | 2017-12-28 | 2022-02-22 | Cilag Gmbh International | Real-time analysis of comprehensive cost of all instrumentation used in surgery utilizing data fluidity to track instruments through stocking and in-house processes |
US11179204B2 (en) | 2017-12-28 | 2021-11-23 | Cilag Gmbh International | Wireless pairing of a surgical device with another device within a sterile surgical field based on the usage and situational awareness of devices |
US11253315B2 (en) | 2017-12-28 | 2022-02-22 | Cilag Gmbh International | Increasing radio frequency to create pad-less monopolar loop |
US10595887B2 (en) | 2017-12-28 | 2020-03-24 | Ethicon Llc | Systems for adjusting end effector parameters based on perioperative information |
US11903587B2 (en) | 2017-12-28 | 2024-02-20 | Cilag Gmbh International | Adjustment to the surgical stapling control based on situational awareness |
US10695081B2 (en) | 2017-12-28 | 2020-06-30 | Ethicon Llc | Controlling a surgical instrument according to sensed closure parameters |
US11266468B2 (en) | 2017-12-28 | 2022-03-08 | Cilag Gmbh International | Cooperative utilization of data derived from secondary sources by intelligent surgical hubs |
US11166772B2 (en) | 2017-12-28 | 2021-11-09 | Cilag Gmbh International | Surgical hub coordination of control and communication of operating room devices |
US11273001B2 (en) | 2017-12-28 | 2022-03-15 | Cilag Gmbh International | Surgical hub and modular device response adjustment based on situational awareness |
US11903601B2 (en) | 2017-12-28 | 2024-02-20 | Cilag Gmbh International | Surgical instrument comprising a plurality of drive systems |
US11896443B2 (en) | 2017-12-28 | 2024-02-13 | Cilag Gmbh International | Control of a surgical system through a surgical barrier |
US11278281B2 (en) | 2017-12-28 | 2022-03-22 | Cilag Gmbh International | Interactive surgical system |
US11284936B2 (en) | 2017-12-28 | 2022-03-29 | Cilag Gmbh International | Surgical instrument having a flexible electrode |
US11896322B2 (en) | 2017-12-28 | 2024-02-13 | Cilag Gmbh International | Sensing the patient position and contact utilizing the mono-polar return pad electrode to provide situational awareness to the hub |
US11890065B2 (en) | 2017-12-28 | 2024-02-06 | Cilag Gmbh International | Surgical system to limit displacement |
US11160605B2 (en) | 2017-12-28 | 2021-11-02 | Cilag Gmbh International | Surgical evacuation sensing and motor control |
US10755813B2 (en) | 2017-12-28 | 2020-08-25 | Ethicon Llc | Communication of smoke evacuation system parameters to hub or cloud in smoke evacuation module for interactive surgical platform |
US11291495B2 (en) | 2017-12-28 | 2022-04-05 | Cilag Gmbh International | Interruption of energy due to inadvertent capacitive coupling |
US10758310B2 (en) | 2017-12-28 | 2020-09-01 | Ethicon Llc | Wireless pairing of a surgical device with another device within a sterile surgical field based on the usage and situational awareness of devices |
US11864845B2 (en) | 2017-12-28 | 2024-01-09 | Cilag Gmbh International | Sterile field interactive control displays |
US11864728B2 (en) | 2017-12-28 | 2024-01-09 | Cilag Gmbh International | Characterization of tissue irregularities through the use of mono-chromatic light refractivity |
US11304763B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Image capturing of the areas outside the abdomen to improve placement and control of a surgical device in use |
US11304699B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Method for adaptive control schemes for surgical network control and interaction |
US11304720B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Activation of energy devices |
US11308075B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Surgical network, instrument, and cloud responses based on validation of received dataset and authentication of its source and integrity |
US11304745B2 (en) | 2017-12-28 | 2022-04-19 | Cilag Gmbh International | Surgical evacuation sensing and display |
US11311306B2 (en) | 2017-12-28 | 2022-04-26 | Cilag Gmbh International | Surgical systems for detecting end effector tissue distribution irregularities |
US11857152B2 (en) | 2017-12-28 | 2024-01-02 | Cilag Gmbh International | Surgical hub spatial awareness to determine devices in operating theater |
US11147607B2 (en) | 2017-12-28 | 2021-10-19 | Cilag Gmbh International | Bipolar combination device that automatically adjusts pressure based on energy modality |
US11844579B2 (en) | 2017-12-28 | 2023-12-19 | Cilag Gmbh International | Adjustments based on airborne particle properties |
US11132462B2 (en) | 2017-12-28 | 2021-09-28 | Cilag Gmbh International | Data stripping method to interrogate patient records and create anonymized record |
US11832840B2 (en) | 2017-12-28 | 2023-12-05 | Cilag Gmbh International | Surgical instrument having a flexible circuit |
US11832899B2 (en) | 2017-12-28 | 2023-12-05 | Cilag Gmbh International | Surgical systems with autonomously adjustable control programs |
US11324557B2 (en) | 2017-12-28 | 2022-05-10 | Cilag Gmbh International | Surgical instrument with a sensing array |
US10849697B2 (en) | 2017-12-28 | 2020-12-01 | Ethicon Llc | Cloud interface for coupled surgical devices |
US11818052B2 (en) | 2017-12-28 | 2023-11-14 | Cilag Gmbh International | Surgical network determination of prioritization of communication, interaction, or processing based on system or device needs |
US10892995B2 (en) | 2017-12-28 | 2021-01-12 | Ethicon Llc | Surgical network determination of prioritization of communication, interaction, or processing based on system or device needs |
US10892899B2 (en) | 2017-12-28 | 2021-01-12 | Ethicon Llc | Self describing data packets generated at an issuing instrument |
US11786251B2 (en) | 2017-12-28 | 2023-10-17 | Cilag Gmbh International | Method for adaptive control schemes for surgical network control and interaction |
US11786245B2 (en) | 2017-12-28 | 2023-10-17 | Cilag Gmbh International | Surgical systems with prioritized data transmission capabilities |
US11364075B2 (en) | 2017-12-28 | 2022-06-21 | Cilag Gmbh International | Radio frequency energy device for delivering combined electrical signals |
US11779337B2 (en) | 2017-12-28 | 2023-10-10 | Cilag Gmbh International | Method of using reinforced flexible circuits with multiple sensors to optimize performance of radio frequency devices |
US11376002B2 (en) | 2017-12-28 | 2022-07-05 | Cilag Gmbh International | Surgical instrument cartridge sensor assemblies |
US10898622B2 (en) | 2017-12-28 | 2021-01-26 | Ethicon Llc | Surgical evacuation system with a communication circuit for communication between a filter and a smoke evacuation device |
US11382697B2 (en) | 2017-12-28 | 2022-07-12 | Cilag Gmbh International | Surgical instruments comprising button circuits |
US11389164B2 (en) | 2017-12-28 | 2022-07-19 | Cilag Gmbh International | Method of using reinforced flexible circuits with multiple sensors to optimize performance of radio frequency devices |
US11771487B2 (en) | 2017-12-28 | 2023-10-03 | Cilag Gmbh International | Mechanisms for controlling different electromechanical systems of an electrosurgical instrument |
US11775682B2 (en) | 2017-12-28 | 2023-10-03 | Cilag Gmbh International | Data stripping method to interrogate patient records and create anonymized record |
US11114195B2 (en) | 2017-12-28 | 2021-09-07 | Cilag Gmbh International | Surgical instrument with a tissue marking assembly |
US10932872B2 (en) | 2017-12-28 | 2021-03-02 | Ethicon Llc | Cloud-based medical analytics for linking of local usage trends with the resource acquisition behaviors of larger data set |
US11109866B2 (en) | 2017-12-28 | 2021-09-07 | Cilag Gmbh International | Method for circular stapler control algorithm adjustment based on situational awareness |
US11410259B2 (en) | 2017-12-28 | 2022-08-09 | Cilag Gmbh International | Adaptive control program updates for surgical devices |
US11100631B2 (en) | 2017-12-28 | 2021-08-24 | Cilag Gmbh International | Use of laser light and red-green-blue coloration to determine properties of back scattered light |
US11419630B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Surgical system distributed processing |
US11424027B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Method for operating surgical instrument systems |
US11419667B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Ultrasonic energy device which varies pressure applied by clamp arm to provide threshold control pressure at a cut progression location |
US11423007B2 (en) | 2017-12-28 | 2022-08-23 | Cilag Gmbh International | Adjustment of device control programs based on stratified contextual data in addition to the data |
US11432885B2 (en) | 2017-12-28 | 2022-09-06 | Cilag Gmbh International | Sensing arrangements for robot-assisted surgical platforms |
US11446052B2 (en) | 2017-12-28 | 2022-09-20 | Cilag Gmbh International | Variation of radio frequency and ultrasonic power level in cooperation with varying clamp arm pressure to achieve predefined heat flux or power applied to tissue |
US11751958B2 (en) | 2017-12-28 | 2023-09-12 | Cilag Gmbh International | Surgical hub coordination of control and communication of operating room devices |
US11737668B2 (en) | 2017-12-28 | 2023-08-29 | Cilag Gmbh International | Communication hub and storage device for storing parameters and status of a surgical device to be shared with cloud based analytics systems |
US10943454B2 (en) | 2017-12-28 | 2021-03-09 | Ethicon Llc | Detection and escalation of security responses of surgical instruments to increasing severity threats |
US11464559B2 (en) | 2017-12-28 | 2022-10-11 | Cilag Gmbh International | Estimating state of ultrasonic end effector and control system therefor |
US10944728B2 (en) | 2017-12-28 | 2021-03-09 | Ethicon Llc | Interactive surgical systems with encrypted communication capabilities |
US11464535B2 (en) | 2017-12-28 | 2022-10-11 | Cilag Gmbh International | Detection of end effector emersion in liquid |
US11712303B2 (en) | 2017-12-28 | 2023-08-01 | Cilag Gmbh International | Surgical instrument comprising a control circuit |
US10966791B2 (en) | 2017-12-28 | 2021-04-06 | Ethicon Llc | Cloud-based medical analytics for medical facility segmented individualization of instrument function |
US11096693B2 (en) | 2017-12-28 | 2021-08-24 | Cilag Gmbh International | Adjustment of staple height of at least one row of staples based on the sensed tissue thickness or force in closing |
US11701185B2 (en) | 2017-12-28 | 2023-07-18 | Cilag Gmbh International | Wireless pairing of a surgical device with another device within a sterile surgical field based on the usage and situational awareness of devices |
US11696760B2 (en) | 2017-12-28 | 2023-07-11 | Cilag Gmbh International | Safety systems for smart powered surgical stapling |
US11678881B2 (en) | 2017-12-28 | 2023-06-20 | Cilag Gmbh International | Spatial awareness of surgical hubs in operating rooms |
US11529187B2 (en) | 2017-12-28 | 2022-12-20 | Cilag Gmbh International | Surgical evacuation sensor arrangements |
US11672605B2 (en) | 2017-12-28 | 2023-06-13 | Cilag Gmbh International | Sterile field interactive control displays |
US11540855B2 (en) | 2017-12-28 | 2023-01-03 | Cilag Gmbh International | Controlling activation of an ultrasonic surgical instrument according to the presence of tissue |
US11559307B2 (en) | 2017-12-28 | 2023-01-24 | Cilag Gmbh International | Method of robotic hub communication, detection, and control |
US11559308B2 (en) | 2017-12-28 | 2023-01-24 | Cilag Gmbh International | Method for smart energy device infrastructure |
US11076921B2 (en) | 2017-12-28 | 2021-08-03 | Cilag Gmbh International | Adaptive control program updates for surgical hubs |
US11069012B2 (en) | 2017-12-28 | 2021-07-20 | Cilag Gmbh International | Interactive surgical systems with condition handling of devices and data capabilities |
US11571234B2 (en) | 2017-12-28 | 2023-02-07 | Cilag Gmbh International | Temperature control of ultrasonic end effector and control system therefor |
US11576677B2 (en) | 2017-12-28 | 2023-02-14 | Cilag Gmbh International | Method of hub communication, processing, display, and cloud analytics |
US11666331B2 (en) | 2017-12-28 | 2023-06-06 | Cilag Gmbh International | Systems for detecting proximity of surgical end effector to cancerous tissue |
US11589932B2 (en) | 2017-12-28 | 2023-02-28 | Cilag Gmbh International | Usage and technique analysis of surgeon / staff performance against a baseline to optimize device utilization and performance for both current and future procedures |
US11589888B2 (en) | 2017-12-28 | 2023-02-28 | Cilag Gmbh International | Method for controlling smart energy devices |
US11659023B2 (en) | 2017-12-28 | 2023-05-23 | Cilag Gmbh International | Method of hub communication |
US11596291B2 (en) | 2017-12-28 | 2023-03-07 | Cilag Gmbh International | Method of compressing tissue within a stapling device and simultaneously displaying of the location of the tissue within the jaws |
US11601371B2 (en) | 2017-12-28 | 2023-03-07 | Cilag Gmbh International | Surgical network determination of prioritization of communication, interaction, or processing based on system or device needs |
US11602393B2 (en) | 2017-12-28 | 2023-03-14 | Cilag Gmbh International | Surgical evacuation sensing and generator control |
US11058498B2 (en) | 2017-12-28 | 2021-07-13 | Cilag Gmbh International | Cooperative surgical actions for robot-assisted surgical platforms |
US11056244B2 (en) | 2017-12-28 | 2021-07-06 | Cilag Gmbh International | Automated data scaling, alignment, and organizing based on predefined parameters within surgical networks |
US11051876B2 (en) | 2017-12-28 | 2021-07-06 | Cilag Gmbh International | Surgical evacuation flow paths |
US11612408B2 (en) | 2017-12-28 | 2023-03-28 | Cilag Gmbh International | Determining tissue composition via an ultrasonic system |
US11612444B2 (en) | 2017-12-28 | 2023-03-28 | Cilag Gmbh International | Adjustment of a surgical device function based on situational awareness |
US10987178B2 (en) | 2017-12-28 | 2021-04-27 | Ethicon Llc | Surgical hub control arrangements |
US11045591B2 (en) | 2017-12-28 | 2021-06-29 | Cilag Gmbh International | Dual in-series large and small droplet filters |
US11026751B2 (en) | 2017-12-28 | 2021-06-08 | Cilag Gmbh International | Display of alignment of staple cartridge to prior linear staple line |
US11013563B2 (en) | 2017-12-28 | 2021-05-25 | Ethicon Llc | Drive arrangements for robot-assisted surgical platforms |
US11464532B2 (en) | 2018-03-08 | 2022-10-11 | Cilag Gmbh International | Methods for estimating and controlling state of ultrasonic end effector |
US11399858B2 (en) | 2018-03-08 | 2022-08-02 | Cilag Gmbh International | Application of smart blade technology |
US11701139B2 (en) | 2018-03-08 | 2023-07-18 | Cilag Gmbh International | Methods for controlling temperature in ultrasonic device |
US11534196B2 (en) | 2018-03-08 | 2022-12-27 | Cilag Gmbh International | Using spectroscopy to determine device use state in combo instrument |
US11678927B2 (en) | 2018-03-08 | 2023-06-20 | Cilag Gmbh International | Detection of large vessels during parenchymal dissection using a smart blade |
US11701162B2 (en) | 2018-03-08 | 2023-07-18 | Cilag Gmbh International | Smart blade application for reusable and disposable devices |
US11678901B2 (en) | 2018-03-08 | 2023-06-20 | Cilag Gmbh International | Vessel sensing for adaptive advanced hemostasis |
WO2019173191A1 (en) * | 2018-03-08 | 2019-09-12 | Ethicon Llc | Using spectroscopy to determine device use state in combo instrument |
US11259830B2 (en) | 2018-03-08 | 2022-03-01 | Cilag Gmbh International | Methods for controlling temperature in ultrasonic device |
US11707293B2 (en) | 2018-03-08 | 2023-07-25 | Cilag Gmbh International | Ultrasonic sealing algorithm with temperature control |
EP3536263A1 (en) * | 2018-03-08 | 2019-09-11 | Ethicon LLC | Using spectroscopy to determine device use state in combo instrument |
US11589915B2 (en) | 2018-03-08 | 2023-02-28 | Cilag Gmbh International | In-the-jaw classifier based on a model |
US11617597B2 (en) | 2018-03-08 | 2023-04-04 | Cilag Gmbh International | Application of smart ultrasonic blade technology |
US11298148B2 (en) | 2018-03-08 | 2022-04-12 | Cilag Gmbh International | Live time tissue classification using electrical parameters |
US11344326B2 (en) | 2018-03-08 | 2022-05-31 | Cilag Gmbh International | Smart blade technology to control blade instability |
US11389188B2 (en) | 2018-03-08 | 2022-07-19 | Cilag Gmbh International | Start temperature of blade |
US11457944B2 (en) | 2018-03-08 | 2022-10-04 | Cilag Gmbh International | Adaptive advanced tissue treatment pad saver mode |
US11844545B2 (en) | 2018-03-08 | 2023-12-19 | Cilag Gmbh International | Calcified vessel identification |
US11839396B2 (en) | 2018-03-08 | 2023-12-12 | Cilag Gmbh International | Fine dissection mode for tissue classification |
US11317937B2 (en) | 2018-03-08 | 2022-05-03 | Cilag Gmbh International | Determining the state of an ultrasonic end effector |
US11337746B2 (en) | 2018-03-08 | 2022-05-24 | Cilag Gmbh International | Smart blade and power pulsing |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
US11259806B2 (en) | 2018-03-28 | 2022-03-01 | Cilag Gmbh International | Surgical stapling devices with features for blocking advancement of a camming assembly of an incompatible cartridge installed therein |
US11471156B2 (en) | 2018-03-28 | 2022-10-18 | Cilag Gmbh International | Surgical stapling devices with improved rotary driven closure systems |
US11207067B2 (en) | 2018-03-28 | 2021-12-28 | Cilag Gmbh International | Surgical stapling device with separate rotary driven closure and firing systems and firing member that engages both jaws while firing |
US11937817B2 (en) | 2018-03-28 | 2024-03-26 | Cilag Gmbh International | Surgical instruments with asymmetric jaw arrangements and separate closure and firing systems |
US11406382B2 (en) | 2018-03-28 | 2022-08-09 | Cilag Gmbh International | Staple cartridge comprising a lockout key configured to lift a firing member |
US11589865B2 (en) | 2018-03-28 | 2023-02-28 | Cilag Gmbh International | Methods for controlling a powered surgical stapler that has separate rotary closure and firing systems |
US11213294B2 (en) | 2018-03-28 | 2022-01-04 | Cilag Gmbh International | Surgical instrument comprising co-operating lockout features |
US11931027B2 (en) | 2018-03-28 | 2024-03-19 | Cilag Gmbh Interntional | Surgical instrument comprising an adaptive control system |
US11219453B2 (en) | 2018-03-28 | 2022-01-11 | Cilag Gmbh International | Surgical stapling devices with cartridge compatible closure and firing lockout arrangements |
US10973520B2 (en) | 2018-03-28 | 2021-04-13 | Ethicon Llc | Surgical staple cartridge with firing member driven camming assembly that has an onboard tissue cutting feature |
US11090047B2 (en) | 2018-03-28 | 2021-08-17 | Cilag Gmbh International | Surgical instrument comprising an adaptive control system |
US11197668B2 (en) | 2018-03-28 | 2021-12-14 | Cilag Gmbh International | Surgical stapling assembly comprising a lockout and an exterior access orifice to permit artificial unlocking of the lockout |
US11096688B2 (en) | 2018-03-28 | 2021-08-24 | Cilag Gmbh International | Rotary driven firing members with different anvil and channel engagement features |
US11278280B2 (en) | 2018-03-28 | 2022-03-22 | Cilag Gmbh International | Surgical instrument comprising a jaw closure lockout |
US11166716B2 (en) | 2018-03-28 | 2021-11-09 | Cilag Gmbh International | Stapling instrument comprising a deactivatable lockout |
US11129611B2 (en) | 2018-03-28 | 2021-09-28 | Cilag Gmbh International | Surgical staplers with arrangements for maintaining a firing member thereof in a locked configuration unless a compatible cartridge has been installed therein |
US11291445B2 (en) | 2019-02-19 | 2022-04-05 | Cilag Gmbh International | Surgical staple cartridges with integral authentication keys |
US11517309B2 (en) | 2019-02-19 | 2022-12-06 | Cilag Gmbh International | Staple cartridge retainer with retractable authentication key |
US11291444B2 (en) | 2019-02-19 | 2022-04-05 | Cilag Gmbh International | Surgical stapling assembly with cartridge based retainer configured to unlock a closure lockout |
US11298129B2 (en) | 2019-02-19 | 2022-04-12 | Cilag Gmbh International | Method for providing an authentication lockout in a surgical stapler with a replaceable cartridge |
US11464511B2 (en) | 2019-02-19 | 2022-10-11 | Cilag Gmbh International | Surgical staple cartridges with movable authentication key arrangements |
US11369377B2 (en) | 2019-02-19 | 2022-06-28 | Cilag Gmbh International | Surgical stapling assembly with cartridge based retainer configured to unlock a firing lockout |
US11272931B2 (en) | 2019-02-19 | 2022-03-15 | Cilag Gmbh International | Dual cam cartridge based feature for unlocking a surgical stapler lockout |
US11317915B2 (en) | 2019-02-19 | 2022-05-03 | Cilag Gmbh International | Universal cartridge based key feature that unlocks multiple lockout arrangements in different surgical staplers |
US11259807B2 (en) | 2019-02-19 | 2022-03-01 | Cilag Gmbh International | Staple cartridges with cam surfaces configured to engage primary and secondary portions of a lockout of a surgical stapling device |
US11751872B2 (en) | 2019-02-19 | 2023-09-12 | Cilag Gmbh International | Insertable deactivator element for surgical stapler lockouts |
US11331101B2 (en) | 2019-02-19 | 2022-05-17 | Cilag Gmbh International | Deactivator element for defeating surgical stapling device lockouts |
US11298130B2 (en) | 2019-02-19 | 2022-04-12 | Cilag Gmbh International | Staple cartridge retainer with frangible authentication key |
US11357503B2 (en) | 2019-02-19 | 2022-06-14 | Cilag Gmbh International | Staple cartridge retainers with frangible retention features and methods of using same |
US11925350B2 (en) | 2019-02-19 | 2024-03-12 | Cilag Gmbh International | Method for providing an authentication lockout in a surgical stapler with a replaceable cartridge |
US11331100B2 (en) | 2019-02-19 | 2022-05-17 | Cilag Gmbh International | Staple cartridge retainer system with authentication keys |
EP3941353A4 (en) * | 2019-03-18 | 2022-12-14 | The Regents of the University of California | Systems and methods for compact laser wakefield accelerated electrons and x-rays |
US11952568B2 (en) | 2019-04-05 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of biphasic electrical pulses for non-thermal ablation |
USD952144S1 (en) | 2019-06-25 | 2022-05-17 | Cilag Gmbh International | Surgical staple cartridge retainer with firing system authentication key |
USD964564S1 (en) | 2019-06-25 | 2022-09-20 | Cilag Gmbh International | Surgical staple cartridge retainer with a closure system authentication key |
USD950728S1 (en) | 2019-06-25 | 2022-05-03 | Cilag Gmbh International | Surgical staple cartridge |
US11950835B2 (en) | 2020-06-29 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
US11957405B2 (en) | 2020-10-16 | 2024-04-16 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
Also Published As
Publication number | Publication date |
---|---|
US7419487B2 (en) | 2008-09-02 |
EP1304971A1 (en) | 2003-05-02 |
US6962587B2 (en) | 2005-11-08 |
US8540710B2 (en) | 2013-09-24 |
AU7902601A (en) | 2002-04-29 |
US20020077627A1 (en) | 2002-06-20 |
AU2001279026B2 (en) | 2005-12-22 |
US20130006228A1 (en) | 2013-01-03 |
US20030109871A1 (en) | 2003-06-12 |
WO2002032335A1 (en) | 2002-04-25 |
JP2004520865A (en) | 2004-07-15 |
CA2416581A1 (en) | 2002-04-25 |
US20080281314A1 (en) | 2008-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8540710B2 (en) | Methods and apparatuses for tissue treatment | |
US7344533B2 (en) | Impedance controlled tissue ablation apparatus and method | |
AU2001279026A1 (en) | Apparatus for detecting and treating tumors using localized impedance measurement | |
AU2002327779A1 (en) | Impedance controlled tissue ablation apparatus and method | |
US10271829B2 (en) | Heat-sensitive optical probes | |
US6641580B1 (en) | Infusion array ablation apparatus | |
US6632222B1 (en) | Tissue ablation apparatus | |
US6569159B1 (en) | Cell necrosis apparatus | |
US6071280A (en) | Multiple electrode ablation apparatus | |
US6660002B1 (en) | RF treatment apparatus | |
US6869430B2 (en) | Tissue biopsy and treatment apparatus and method | |
EP2684534A1 (en) | Heat-distribution indicators and electrosurgical systems including same | |
AU2001251134A1 (en) | Tissue biopsy and treatment apparatus and method | |
EP2394598B1 (en) | Energy applicator temperature monitoring for assessing ablation size |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT, ILLINOIS Free format text: SECURITY AGREEMENT;ASSIGNOR:ANGIODYNAMICS, INC.;REEL/FRAME:031315/0720 Effective date: 20130919 Owner name: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT Free format text: SECURITY AGREEMENT;ASSIGNOR:ANGIODYNAMICS, INC.;REEL/FRAME:031315/0720 Effective date: 20130919 |
|
AS | Assignment |
Owner name: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT, ILLINOIS Free format text: SECURITY INTEREST;ASSIGNOR:ANGIODYNAMICS, INC.;REEL/FRAME:040613/0049 Effective date: 20161107 Owner name: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT Free format text: SECURITY INTEREST;ASSIGNOR:ANGIODYNAMICS, INC.;REEL/FRAME:040613/0049 Effective date: 20161107 |
|
AS | Assignment |
Owner name: ANGIODYNAMICS, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:040688/0540 Effective date: 20161107 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |